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This report describes ambulatory
medical care visits to nonfederally
employed, office-based physicians in
the United States during 1995 and
1996. Statistics are presented on
selected physician, patient, and visit
characteristics.
Methods
The data in this report were
collected in the 1995 and 1996 National
Ambulatory Medical Care Surveys
(NAMCS). The NAMCS is part of the
ambulatory care component of the
National Health Care Survey (NHCS),
which measures health care utilization
across a variety of providers. The
NAMCS is a national probability sample
survey of visits to nonfederally
employed, office-based physicians in
the United States. Sample data were
weighted to produce annual estimates.
Estimates are presented in this report
as annual averages unless otherwise
noted.
Results
During 1995–96, an estimated 1.4
billion visits were made to physician
offices in the United States, an annual
average of 715.8 million visits. The visit
rate was 2.7 visits per person per year.
This rate did not differ significantly from
visit rates observed in any previous
survey year. Females made
59.4 percent of the visits, or 3.2 visits
per person annually. This was higher
than the visit rate for males. White
persons had a higher visit rate than
black persons. Six of every 10 visits
were to primary care providers.
Injury-related visits accounted for
11.8 percent of all office visits, or 84.6
million per year. The annual rate of
injury-related office visits was 32.2 visits
per 100 persons. The most frequent
reason for visiting the physician was for
a general medical examination
(6.8 percent). Cough was the most
frequent symptomatic reason. Acute
respiratory infections and essential
hypertension were the diagnoses
reported most frequently.
Keywords: office visits c physician c
diagnoses c injury c diagnostic
services c medicationsNational Ambulatory
Medical Care Survey:
1995–96 Summary
by Susan M. Schappert and Cheryl Nelson, Division of Health C
StatisticsHighlights
+ Females had a higher annual rate o
office visits (3.2 visits per person)
compared with males (2.3 visits per
person) and made 59.4 percent of
the visits.
+ The visit rate increased with each
successive age group from 15–24
years to 75 years and older. Person
75 years and older made 6.1 visits
per person annually.
+ More than 6 of every 10 office visits
(61.5 percent) were made to primar
care physicians.
+ Doctors of osteopathy received 15.9
visits per 100 persons, compared
with 256.1 visits per 100 persons to
doctors of medicine.
+ More than one-half (54.1 percent) o
the visits were the result of a
symptomatic complaint, with
respiratory symptoms accounting fo
11.3 percent of the total.
+ Acute respiratory infections
(excluding pharyngitis) and essentia
hypertension were the most frequen
principal diagnoses rendered by
physicians, cited at 4.1 percent and
3.5 percent of visits annually.
+ There was an annual average of 32
injury-related office visits per 100
persons. Back problems (upper and
lower) accounted for the largest
proportion of injury-related visits
overall (11.1 percent).
+ Seven of every 10 office visits
included one or more diagnostic or
screening services either ordered o
performed.
+ One-third (34.7 percent) of the visits
included some type of therapeutic o
preventive service other thanmedication. Diet counseling was
mentioned most frequently, at
13.2 percent of the visits.
Ambulatory surgery was performed
at 5.0 percent of the visits.
+ Medications were provided or
prescribed at 6 of every 10 visits
(64.1 percent). Four therapeutic
classes—cardiovascular-renal drugs,
antimicrobial agents, pain relief
drugs, and respiratory tract
drugs—together accounted for
one-half of all drugs mentioned at
office visits.
+ Nearly one-half of office visits were
expected to be paid for with private
insurance (46.5 percent). About
one-quarter of the total
(24.4 percent) were covered under
an HMO or other prepaid plan.
+ Eighty-six percent of office visits
were made by established patients.
The majority of these were return
visits for the care of previously
treated problems.
Introduction
This report presents national
estimates of the provision and utilization
of ambulatory medical care services in
physician offices in the United States
during 1995 and 1996. The estimates are
based on data from the National
Ambulatory Medical Care Survey
(NAMCS). The NAMCS, a probability
sample survey, is conducted by the
Division of Health Care Statistics,
National Center for Health Statistics





























Page 2 [ Series 13, No. 142The NAMCS began in 1973 and
was conducted annually through 1981.
was next conducted in 1985 and
resumed an annual schedule in 1989.
Summary reports for previous data yea
are available (1–15). A complete list of
publications using NAMCS data is
available from the Ambulatory Care
Statistics Branch.
Physician office visits are described
in terms of patient characteristics (age,
sex, and race), physician practice
characteristics (specialty, professional
status, geographic location, solo or
group practice, prepaid plan
participation), and visit characteristics
(patient’s principal reason for visit,
physician’s principal diagnosis,
injury-related visits, diagnostic and
therapeutic services, and other
characteristics). The appendixes includ
a description of the survey’s statistical
design, guidelines for judging the
precision of estimates, definition of
terms used in the survey, and copies o
the survey instrument. A complete
description of the background and
methodology of the survey has been
published (16), and summaries of
general findings from the 1995 and 199
NAMCS are available (17,18).
NAMCS data are also available in
micro-data format on CD-ROM, as
public-use data tapes, and as
downloadable files from the NCHS
home page on the Internet. Questions
regarding this report, future reports, or
the NAMCS may be directed to the
Ambulatory Care Statistics Branch by
calling 301-436-7132.
Methods
The data presented in this report a
from the 1995 and 1996 NAMCS. Thes
surveys were conducted from January
1995, through December 31, 1995, and
from January 1, 1996, through
December 29, 1996. The NAMCS is
part of the National Health Care Surve
which measures health care utilization
across various types of providers. This
report does not include visits to hospita
emergency or outpatient departments,
visits for ambulatory surgery at
hospital-based or freestanding surgeryunits. These types of ambulatory settin
are covered by the National Hospital
Ambulatory Medical Care Survey and
the National Survey of Ambulatory
Surgery, respectively.
The target universe of NAMCS
includes visits made in the United Stat
to offices of nonfederally employed
physicians (excluding those in the
specialties of anesthesiology, radiology
and pathology) who were classified by
the American Medical Association
(AMA) and the American Osteopathic
Association (AOA) as ‘‘office-based,
patient care.’’ Visits to private,
nonhospital-based clinics and health
maintenance organizations (HMO’s)
were within the scope of the survey, bu
those that took place in
government-operated facilities and
hospital-based outpatient departments
were not. Telephone contacts and visit
made outside the physician’s office we
also excluded.
NAMCS utilizes a multistage
probability sample design involving
samples of primary sampling units
(PSU’s), physician practices within
PSU’s, and patient visits within
physician practices. The PSU’s are
counties, groups of counties, county
equivalents (such as parishes or
independent cities), or towns and
townships (for some PSU’s in New
England).
The samples for the 1995 and 199
NAMCS included a total of 6,897
nonfederally employed, office-based
physicians. The samples were selected
from the master files of the AMA and
the AOA. Physicians were also screen
at the time of the survey to ensure tha
they were eligible for survey
participation. Of those screened, 4,729
physicians were eligible (in scope) to
participate in the survey. The remainin
2,168 physicians were ineligible (out o
scope) due to reasons of being retired
employed primarily in research,
teaching, or adminstration, or other
reasons. The survey response rate,
averaged across the 2 years, was
72 percent for in-scope physicians.
Sample physicians were asked to
complete Patient Record forms for a
systematic random sample of office
visits occurring during a randomly
assigned 1-week reporting period. Thes Patient Record (appendix III) is the
survey instrument used by physicians
participating in the NAMCS to record
information about their patients’ office
visits. Responding physicians completed
a total of 66,680 Patient Record forms
in 1995 and 1996.
The U.S. Bureau of the Census,
Housing Surveys Branch, was
responsible for the survey’s data
collection. Processing operations and
medical coding were performed by
Analytic Sciences, Inc., Durham, North
Carolina.
Several medical classification
systems were used to code data from th
NAMCS. The Patient Record form
(PRF) contains an item on the patient’s
expressed reason for the visit. In this
item, the respondent was asked to recor
the patient’s ‘‘complaint(s), symptom(s),
or other reason(s) for this visit in the
patient’s (or patient surrogate’s) own
words.’’ Up to three reasons for visit
were coded for each record according to
A Reason for Visit Classification for
Ambulatory Care(RVC) (19).
The PRF also contains an item on
the cause of injury for injury-related
visits. Up to three external causes of
injury were coded according to the
‘‘Supplementary Classification of
External Causes of Injury and
Poisoning’’ found in theInternational
Classification of Diseases, 9th Revision
Clinical Modification (ICD–9–CM) (20).
The physician’s diagnosis was
collected in item 11 on the PRF. The
respondent was asked to record the
principal diagnosis or problem
associated with the patient’s most
important reason for the current visit as
well as any other significant current
diagnoses. Up to three diagnoses per
visit were coded according to the
ICD–9–CM (20).
In the medication item, physicians
were instructed to record all new or
continued medications ordered, supplied
or administered at the visit, including
prescription and nonprescription
preparations, immunization and
desensitizing agents, and anesthetics. U
to six medications, called drug
mentions, could be coded per visit
according to a classification system
developed at NCHS. A report describing



























Series 13, No. 142 [ Page 3collect and process drug information is
available (21). Therapeutic classificatio
of the drugs mentioned on the PRF’s
was determined using theNational Drug
Code Directory, 1995 edition (22).
As used in the NAMCS, the term
‘‘drug’’ is interchangeable with the term
‘‘medication’’ and the term
‘‘prescribing’’ is used broadly to mean
ordering or providing any medication,
whether prescription or over-the-counte
Visits with one or more drug mentions
are termed ‘‘drug visits’’ in the survey.
The 1995 and 1996 National
Ambulatory Medical Care Surveys
shared identical survey instruments,
definitions, and procedures. The
resulting 2 years of data have been
combined to provide more reliable
estimates. In most cases, the estimate
percent distributions, and rates present
in this report reflect average annual
estimates based on the combined 1995
and 1996 data. Estimates representing
2-year totals rather than averages are
noted as such in the text.
Because the estimates presented i
this report are based on a sample rath
than on the entire universe of office
visits, they are subject to sampling
variability. The Technical Notes in
Appendix I include an explanation of
sampling errors and guidelines for
judging the precision of the estimates,
well as additional information on the
statistical design of the survey, data
collection and processing, estimation
procedures, etc. Definitions for terms
used in the survey are included in
Appendix II.
Several tables in this report presen
data on rates of office visits. The
population figures used in calculating
these rates are U.S. Bureau of the
Census estimates of the civilian,
noninstitutionalized population of the
United States, averaged for July 1, 199
and July 1, 1996, and have been
adjusted for net underenumeration.
Population estimates are provided in
Appendix I.Results
Patient Characteristics
In 1995 and 1996, an estimated
annual average of 715.8 million visits
were made to nonfederally employed,
office-based physicians in the United
States, yielding a rate of 2.7 visits per
person per year. This rate is not
significantly different from office visit
rates observed since 1975. Persons 7
years and older had the highest visit
rate, 6.1 visits per person (table 1).
Females made 59.4 percent of the
visits and accounted for higher percen
of visits than males in all age categori
except the youngest (under 15 years)
Females also had significantly higher
visit rates than males in each age
category with the exception of the
youngest (under 15 years) and the tw
older groups (65–74 years and 75 yea
and over) (figure 1).
Among males, the visit rate was
lower for those 15–24 years than for
those under 15 years. It increased wit
each successive age group after 15–2
years. Among females, the visit rate
increased with each successive age
group after the age of 24 up to the ag
of 74. There was no difference noted
between the rates for the two oldest
groups (65–74 and 75 years and over
Neither was there a significant
difference noted between the twoFigure 1. Annual rate of office visits by patient’s ayoungest age groups (under 15 years
and 15–24 years).
White persons made 86.2 percent o
all office-based visits, with black
persons and Asians/Pacific Islanders
accounting for 9.9 percent and
3.5 percent, respectively. As seen in
figure 2, the visit rate for the white
population was significantly higher (2.8
visits per person) than the rate for the
black population (2.1 visits per person).
White persons had higher visit rates
than black persons in the age categorie
under 15 years and 15–24 years.
Among white persons, the visit rate
was higher for those under 15 years
compared with those ages 15–24 years
The rate increased with each successiv
age group after 15–24 years.
Among black persons, the visit rate
was not significantly different for those
under 15 years (1.4 visits per person
annually) and 15–24 years (1.3 visits pe
person annually), but increased with
each age group to 65–74 years. The rat
was not significantly different for this
group and for those 75 years and over.
Historically, visit rates to physician
offices for black persons tend to be
lower than for white persons, yet visit
rates to hospital settings for ambulatory
care in the outpatient department and
emergency department tend to be highe
for black persons compared with white
persons (23).
Visit rates also varied according to









Figure 2. Annual rate of office visits by patient’s age and race: United States, 1995–96
Page 4 [ Series 13, No. 142code of residence as shown infigure 3.
Persons who resided in the
highest-income areas ($40,000 or mor
had higher rates of office visits than
persons residing in lower-income area
These results were especially striking
among persons under the age of 18. F
this group, those residing in the
highest-income areas had an average
3.4 visits per year, compared with only
1.7 visits for those in the lowest-incom
areas (less than $20,000). Among
persons 18 and over, rates were
significantly higher (3.2 visits per persoFigure 3. Annual rate of office visits by age group,
in ZIP Code of residence: United States, 1995–96r
f
annually) in median income areas of
$40,000 or more compared with areas
$20,000–$39,000.
Physician Characteristics
Sixty-one percent of all office visits
during 1995–96 were made to primary
care physicians (general and family
practitioners, internists, pediatricians,
and obstetricians/gynecologists)
(figure 4). Figure 5shows annual visit
rates to primary care specialties,
nonsurgical specialties, and surgicalf
according to median household incomef
specialties between 1980 and 1996; the
rate of visits to nonsurgical specialties
increased significantly over this time
period, but no consistent trend was
noted in the other two groups.
One-quarter (25.6 percent) of office
visits were made to general and family
practitioners, who received 69.6 visits
per 100 persons annually (figures 6and
7). Females had a higher rate of visits
than males did to the following
specialties: general and family practice,
internal medicine, ophthalmology,
dermatology, general surgery, and, of
course, obstetrics and gynecology
(figure 8). White persons had
significantly higher rates of visits than
did black persons to general and family
practitioners, pediatricians, and
ophthalmologists, among others (figure 9).
However, no difference was found in the
rates of visits to the specialties of internal
medicine, obstetrics and gynecology, and
general surgery.
Table 2presents statistics on office
visits by patient’s age, sex, and race
according to physician specialty. The
percent of visits made to internists,
ophthalmologists, and cardiologists
increased for each successive age grou
For example, 2.9 percent of the visits by
persons under 15 years were to
internists, compared with 18.9 percent o
those by persons 45–64 years, and
24.0 percent of those by persons 75
years and over. From another
perspective, although persons 65 years
and over accounted for only
24.3 percent of office visits in general,
visits by this age group represented




region—Northeast, Midwest, South, and
West—are shown intables 1and3. The
largest proportion of office visits
occurred in the South (32.2 percent).
The West’s visit rate (3.3 visits per
persons per year) was higher than that
of any other region. No other significant
regional differences were noted for visit
rates in general.
The visit rate to general and family
practitioners was higher in the West,
with 84.3 visits per 100 persons, than in
the Northeast, with 43.8 visits per 100





Figure 4. Percent distribution of office visits by specialty group: United States, 1995–96
Figure 5. Annual rate of office visits by specialty group: United States, 1980–96
Series 13, No. 142 [ Page 5psychiatrists was higher in the
Northeast, with 12.0 visits per 100
persons, compared with as few as 3.4
per 100 in the Midwest. Approximately
8 of every 10 office visits occurred in
urban areas.
An estimated annual average of
674.0 million office visits were made to
doctors of medicine (94.2 percent) and
41.8 million visits were made to doctoof osteopathy (5.8 percent) in 1995 an
1996. Doctors of osteopathy received
15.9 visits per 100 persons per year,
compared with 256.1 visits per 100
persons to doctors of medicine.
Table 4presents data on other
physician characteristics. The majority
of office visits (57.1 percent) were mad
to physicians in group practice, while 4
of every 10 visits were to physicians insolo practice. In contrast, about 7 of
every 10 visits to psychiatrists were
made to solo practitioners, compared
with about 3 of every 10 to orthopedic
surgeons.
Eight of every 10 office visits were
made to physicians who were
participating in prepaid plans such as
health maintenance organizations
(HMO’s), independent practice
associations (IPA’s), and preferred
provider organizations (PPO’s). The
proportion among visits to psychiatrists
was less than two-thirds (65.2 percent),
but was 90 percent or higher at visits to
obstetrician-gynecologists, internists,
pediatricians, dermatologists,
otolaryngologists, and general surgeons
Visit Characteristics
Patient’s Principal Reason for
Visit
The principal reason for visit is the
problem or complaint listed in item 9a
of the PRF. The Reason for Visit
Classification (RVC) (19) is divided into
eight modules or groups of reasons:
symptom; disease; diagnostic/screening
and preventive; treatment; injuries and
adverse effects; test results;
administrative; and other, which
includes complaints not classified
elsewhere, illegible entries, blanks, and
entries of ‘‘none.’’ The symptom module
accounted for more than one-half of all
office visits (54.1 percent), followed by
the diagnostic/screening and preventive
module (17.6 percent) (figure 10).
It should be noted that the RVC is
based upon the patient’s expressed
reason for the visit. The patient’s
terminology determines the coding for
this item. Results may vary accordingly;
for example, the symptom module may
include a significant number of
injury-related visits for those instances
where the patient has described his or
her problem to the physician in
symptomatic terms rather than in terms
denoting an injury.
Data on principal reason for visit
and patient’s age, sex, and race are
shown intables 5and6. More than
one-fifth (22.7 percent) of the visits by






Figure 6. Percent distribution of office visits by physician specialty: United States, 1995–96
Figure 7. Annual rate of office visits by physician specialty: United States, 1995–96
Page 6 [ Series 13, No. 142respiratory symptoms, and 12.6 percent
were made for eye and ear symptoms;
these were relatively higher proportions
than for all other age groups. In contras
16 percent of visits by persons 65–74
years of age and 75 years and over wer
classified in the disease module, higher
than for any other age group, and
denoting care for a previously diagnosed
disease condition, most likely chronic in
nature.
The 25 morbidity-related principal
reasons for visit most frequently
mentioned by patients are shown in
table 7, by patient’s age, sex, and race.
Morbidity-related reasons are those
related to illness and injury, and, for the
purpose of this report, are drawn from th
symptom, disease, and injury and adver
effects modules. Cough, throat symptom
and back symptoms were cited most
often; interestingly, about 5 of every 10e
,
visits for cough and 4 of every 10 visits
for throat symptoms were made by
patients under the age of 15. In contras
visits for back symptoms were made mo
often by patients 25–64 years of age.
Table 8shows the 60 principal
reasons for visit most frequently
mentioned by patients, along with avera
visit duration. General medical
examination was mentioned most
frequently, at 6.8 percent of visits; these
visits had an average duration of 21.1
minutes.
The top 10 principal reasons for vis
most frequently mentioned by patients
according to patient’s age and sex are
shown intable 9. Well-baby examination
accounted for 10.1 percent of visits by
those under 15 years of age. Routine
prenatal examination was cited most
frequently at visits by the 15–24 and




medical exam was the top reason among
visits by those in the older age groups. It
should be noted that estimates that differ
in ranked order may not be significantly
different from each other.
Tables 10–13present statistics on
principal reason for visit and physician
specialty. As might be expected, primary
care specialties were, in general, more
likely to receive visits in the area of
diagnostic, screening, and preventive
services, such as general medical
examination, routine prenatal
examination, and well-baby examination,
compared with other medical and surgical
specialties (table 10).
The distribution of visits across
physician specialty for broad categories of
problems as well as for specific reasons
are shown intables 11and12. For many
specific illness-related problems, visits
were made to either primary care
physicians or other specialists. For
example, although two-thirds of the visits
for depression were made to psychiatrists,
general and family practitioners and
internists received one-quarter of the
total. One-quarter of all visits for chest
pain were to cardiovascular specialists,
yet primary care physicians received an
additional 60.1 percent of the total.
The top 10 reasons for visiting each
of the 13 specialties detailed in this report
are shown intable 13. Among nonprimary
care specialties, certain specific reasons
were seen to dominate the rankings for
each group. For example, 28.6 percent of
visits to psychiatrists were for depression;
23.6 percent of visits to ophthalmologists
were for vision dysfunction; and
14.6 percent of visits to neurologists were
for headache. The diversity of problems
s en by various specialties is illustrated
by the fact that 10 reasons accounted for
only 30.2 percent of the visits to general
and family practitioners, but
three-quarters of all visits to psychiatrists.
Physician’s Principal Diagnosis
Item 11 of the PRF asks the
physician to record the principal diagnosis
or problem associated with the patient’s
most important reason for the current visit
as well as any other significant current
diagnoses. Displayed infigure 11are
office visits by principal diagnosis using




Figure 8. Annual rate of office visits to selected physician specialities by patient’s sex:
United States, 1995–96
Figure 9. Annual rate of office visits to selected physician specialties by patient’s race:
United States, 1995–96
Series 13, No. 142 [ Page 7the ICD–9–CM (20). The supplementary
classification, used for diagnoses not
classifiable to injury or illness (for
example, general medical examination,
routine prenatal examination, and health
supervision of infant or child),
accounted for 16.3 percent of all visits.
Diseases of the respiratory system
(13.5 percent) and diseases of the
nervous system (9.9 percent) were also
among the top broad diagnostic
categories.
Data on principal diagnosis, using
major disease categories, and patient’s
age, sex, and race are shown in
tables 14and15. Among visits by
persons under 15 years, 7.6 percent had
principal diagnoses within the category
of infectious and parasitic diseases, a
higher percent than for any other age
group. Visits by this age group were
also more likely to result in diagnoses
within the respiratory disease category
and the nervous system/sense organ
disease category, compared with other
age groups, with one exception. The
percent of visits with diagnoses within
the category of nervous system/sense
organ diseases was not significantly
different for persons under 15 years and
75 years and over.
Displayed intable 16are office
visits by principal diagnosis using the
major disease categories specified by th
ICD–9–CM in conjunction with more
detailed diagnostic groupings within
each major category. The diagnostic
groupings were developed for use
specifically with NAMCS data. A
complete description of the ICD–9–CM
codes used for each group is included in
the Technical Notes (Appendix I).
Average visit durations are also shown
for each diagnosis group.
Table 17shows a selection of the
most frequently reported principal
diagnoses for 1995 and 1996 for each
age and sex group. The categories
shown in this table are based on the
ICD–9–CM reclassification (shown in
the Technical Notes) that has been
discussed previously. But in this table,
several of the categories have been
combined to better summarize the
ambulatory care visit data. Specifically,
codes for malignant neoplasms have
been aggregated into one group, as hav
ischemic heart disease codes, and code
Figure 10. Percent distribution of office visits by patient’s principal reason for visit:
United States, 1995–96
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Figure 11. Percent distribution of office visits by principal diagnosis: United States,
1995–96for heart disease other than ischemic.
The three most frequent illness
diagnoses were acute upper respiratory
infections (excluding pharyngitis),
essential hypertension, and otitis media.
Routine infant or child health check
was cited most frequently for visits by
persons under 15 years of age. This was
followed by otitis media and acute
respiratory infections. For visits by
persons 15–24 and 25–44 years, normal
pregnancy was the most frequent
diagnosis, followed by general medical
examination. Essential hypertension was
cited most often for the age groups
45–64, 65–74, and 75 years and over.
Tables 18–20present data on visits
by principal diagnosis and physician
specialty. The first two tables use the
major disease categories of the
ICD–9–CM, whiletable 20shows
ranked diagnosis groups for each
physician specialty.
Injury-Related Visits
Data on injury-related visits are
shown intables 21–23. Visits were
considered to be injury related if ‘‘yes’’
was checked in response to the question,
‘‘Is this visit injury related?’’ on the
PRF, or if an injury reason for visit or
injury diagnosis was recorded, or if a
cause of injury was specified on the
form. The results from any one of these
items, each of which measures a unique
aspect of injury, would underestimate
the number of injury-related visits.
There was an annual average of 84.6
million injury-related visits to
office-based physicians in 1995 and
1996, or 11.8 percent of all office visits
(table 21).
The annual rate of injury-related
visits was 32.2 per 100 persons. The
injury visit rate was higher for persons
75 years and over compared with
persons under 15 years and 15–24 years,
but no statistical differences were found
with other age groups. The injury visit
rates for males and females did not
differ by age.
The 25 most frequently mentioned
principal reasons for injury-related visits
are shown intable 22. Back symptoms
(upper and lower), knee symptoms, and















Figure 12. Percent distribution of office visits by injury status, according to physician
specialty: United States, 1995–96
Series 13, No. 142 [ Page 9frequently, together accounting for
one-fifth (20.7 percent) of the total.
The proportion of visits that were
injury related varied by specialty
(figure 12). More than 6 of every 10
visits to orthopedic surgeons were inju
related, in striking contrast to other
physician specialties.
Table 23shows the most frequent
principal diagnoses at injury-related
visits by patient’s age, sex, and race.
The diagnosis groupings here reflect
somewhat broader categories than the
reclassification used intable 16in order
to avoid small cell sizes, and follow the
general headings found in the
ICD–9–CM under the chapter heading
of ‘‘Injury and Poisoning’’ and
‘‘Diseases of the Musculoskeletal
System and Connective Tissue.’’ The
most frequent type of diagnosis at
injury-related visits involved sprains an
strains of joints and adjacent muscles.
Dorsopathies (which include
intervertebral disc disorders and
lumbago), fractures of the upper limb,




For the 1995 and 1996 NAMCS,
item 14 on diagnostic and screening
services was changed from apredominantly open-ended format back
to the check box format used in the
1992 survey. Although this limits
somewhat the diversity of the services
reported, it is thought to increase the
reliability of the reporting for those
services listed on the form.
Tables 24–27present data on
diagnostic and screening services
ordered or performed at office visits by
patient’s age and sex and by physician
specialty. The most frequent service w
blood pressure check, cited at more th
4 of every 10 visits. Pelvic exams were
cited at 12.3 percent of visits by
females, while breast exams were
reported at 10.7 percent of their visits.
About 7 percent of visits overall
included a visual examination, but this
percent rose to 14.1 for visits by perso
75 years of age and over.
Diagnostic and Therapeutic
Procedures
Item 13 on the PRF collected data
on ambulatory surgical procedures
performed at the office visit. Such
procedures could be either diagnostic
therapeutic in nature. It should be note
that the wording of this item was
changed in 1995–96 so that responden
were instructed to record only
ambulatory surgery performed at the
current visit. Previous surveys allowedn
s
s
physicians to record surgery that was
either ordered or performed, which may
have yielded larger estimates. Also,
respondents tended to report surgical
and nonsurgical procedures alike in the
ambulatory surgery item, as well as in
the open-ended responses to the
diagnostic/screening services item.
These responses were not relocated
during data processing. For this reason
it is recommended that any analysis of
procedures take responses from both
items into account.
Procedures, including surgical and
nonsurgical, were reported at
27.3 percent of office visits in 1995–96.
However, the majority of these were
nonsurgical diagnostic and therapeutic
procedures such as electrocardiograms
neurological examinations, general
physical examinations, and ‘‘other
nonoperative measurements and
examinations.’’Table Ashows results
for all procedures, aggregated from the
five write-in procedure fields from item
14 as well as the two write-in procedur
fields from item 13.Tables 28and29




Data on therapeutic and preventive
services, excluding medication therapy,
ordered or provided at physician office
visits were collected in item 15 of the
PRF. Results are shown intables 30and
31. Such services were ordered or
provided at 34.7 percent of visits
overall, with counseling related to diet
(13.2 percent), exercise (9.7 percent),
and weight reduction (4.3 percent)
mentioned most often.
Medication therapy was used more
frequently at office visits compared with
nonmedication therapies such as
counseling and education. As shown in
figure 13, reliance on medication therap
was widespread by physicians, with the
majority of visits to cardiologists,




citing the use of one or more
medications.
l
Table A. Annual number and percent of office visits by selected diagnostic and therapeutic procedures, averaged over a 2-year period:
United States, 1995–96











All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 . . . . . . . . .
Other nonoperative measurements and examinations . . . . . . . . . . . . . . . . . . . . . . . 8939 86,161 12.0 12.0 12.1
Pap smear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9146 16,101 2.2 3.8 . . .
Electrocardiogram . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8952 12,978 1.8 1.6 2.1
Other local excision or destruction of lesion or tissue of skin and subcutaneous tissue . . 8630 9,706 1.4 1.2 1.5
Eye examination, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9509 8,184 1.1 1.2 1.1
Culture of specimen from ear, nose, throat, and larynx . . . . . . . . . . . . . . . . . . . . . . 9032 8,178 1.1 1.0 1.3
Tonometry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8911 5,491 0.8 0.8 0.7
Neurologic examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8913 4,610 0.6 0.6 0.8
General physical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8970 4,034 0.6 0.5 0.6
Vital capacity determination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8937 2,960 0.4 0.4 0.4
Audiometry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9541 2,895 0.4 0.4 0.5
Fetal monitoring, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7534 2,768 0.4 0.7 . . .
Biopsy of skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8611 2,451 0.3 0.3 0.4
Microscopic examination of specimen from lower gastrointestinal tract and stool . . . . . . 9099 2,354 0.3 0.3 0.3
Removal of other therapeutic device . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9789 2,259 0.3 0.3 0.4
Other cardiovascular stress test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8944 1,806 0.3 0.2 0.4
Electromyography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9308 1,754 0.2 0.3 0.2
Hearing examination, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9547 1,701 0.2 0.2 0.3
Culture of specimen from female genital tract . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9142 1,599 0.2 0.2 . . .
Irrigation of ear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9652 1,226 0.2 0.2 0.3
. . . Category not applicable.
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2Based on an estimated 425,415,000 office visits by females.
3Based on an estimated 290,373,000 office visits by males.
Figure 13. Percent distribution of office visits by medication therapy, according to
physician specialty: United States, 1995–96
Page 10 [ Series 13, No. 142As shown intable B, there were an
estimated 954.9 million drug mentions
per year during 1995 and 1996, resulting
from an estimated 458.7 million drug
visits (visits with at least one drug
mention on the PRF). This yields a rate
of 2.1 drug mentions for every drug
visit, or 1.3 drug mentions per visit in
general.
Table Candfigure 13describe
medication therapy by physician
specialty. Overall, more than 6 of every
10 visits involved one or more
medications. For cardiovascular
specialists, about 8 of every 10 visits
did so. Only 3 of every 10 visits to
orthopedic surgeons involved a reported
medication.
Figure 14shows drug mentions by
therapeutic classification. Four
therapeutic classes—cardiovascular-rena
drugs, antimicrobial agents, pain relief
agents, and respiratory tract
drugs—accounted for one-half
(50.1 percent) of all drugs provided or
prescribed at physician office visits











Table B. Annual number and percent distribution of drug visits and drug mentions at office visits by patient’s age, sex, and race, averaged







Percent of total visits
in each category









All visits . . . . . . . . . . . . . . . . 458,696 100.0 64.1 954,925 100.0 2.1
Age
Under 15 years . . . . . . . . . . . 88,483 19.3 65.0 148,396 15.5 1.7
15–24 years . . . . . . . . . . . . . 33,462 7.3 58.0 56,112 5.9 1.7
25–44 years . . . . . . . . . . . . . 110,786 24.2 60.5 205,302 21.5 1.9
45–64 years . . . . . . . . . . . . . 106,972 23.3 64.9 237,797 24.9 2.2
65–74 years . . . . . . . . . . . . . 62,090 13.5 67.3 156,479 16.4 2.5
75 years and over . . . . . . . . . . 56,903 12.4 69.6 150,839 15.8 2.7
Sex
Female . . . . . . . . . . . . . . . . 273,570 59.6 64.3 580,304 60.8 2.1
Male . . . . . . . . . . . . . . . . . . 185,126 40.4 63.8 374,621 39.2 2.0
Race
White . . . . . . . . . . . . . . . . . 393,160 85.7 63.7 818,916 85.8 2.1
Black . . . . . . . . . . . . . . . . . . 47,740 10.4 67.5 100,806 10.6 2.1
Other . . . . . . . . . . . . . . . . . . 17,796 3.9 63.3 35,204 3.7 2.0
NOTE: Numbers may not add to totals because of rounding.
Series 13, No. 142 [ Page 11Tables 32–37display additional data
on the use of medication therapy at
office visits by patient’s age, sex, and
race; by physician specialty; and by
therapeutic classification of drug. The
percent of visits with medication therap
was lower for patients 15 to 24 years o
age compared with those under 15
years, but was not significantly differen
for 15–24 year olds compared with
25–44 year olds. The percent increase
for each successive age group to 65–7
but was not different for the age group
65–74 and 75 years and over.
Tables 38and39 present data on
commonly used generic substances atTable C. Annual number and percent distribution o





All specialties . . . . . . . . . . . . . . . . . . . 458,
General and family practice . . . . . . . . . . . 132,
Internal medicine . . . . . . . . . . . . . . . . . 81,
Pediatrics . . . . . . . . . . . . . . . . . . . . . . 65,
Obstetrics and gynecology . . . . . . . . . . . 28,
Ophthalmology . . . . . . . . . . . . . . . . . . . 21,
Dermatology . . . . . . . . . . . . . . . . . . . . 18,
Psychiatry . . . . . . . . . . . . . . . . . . . . . . 15,
Orthopedic surgery . . . . . . . . . . . . . . . . 11,
Cardiovascular diseases . . . . . . . . . . . . . 11,
Otolaryngology . . . . . . . . . . . . . . . . . . . 9,
Urology . . . . . . . . . . . . . . . . . . . . . . . 6,
General surgery . . . . . . . . . . . . . . . . . . 5,
Neurology . . . . . . . . . . . . . . . . . . . . . . 5,
All other . . . . . . . . . . . . . . . . . . . . . . . 45,
NOTE: Numbers may not add to totals because of rounding.physician office visits. The most
frequently occurring generic substance
in the drugs mentioned at physician
office visits was acetaminophen, used i
3.9 percent of the preparations cited.
This was followed by amoxicillin
(3.7 percent of mentions), ibuprofen
(1.8 percent), and hydrochlorothiazide
(1.7 percent).
Amoxicillin and acetaminophen
were the most frequent substances fou
in the drugs mentioned at office visits
for those under 15 years, 15–24, and
25–44 years. For persons 45–64, the
most frequent substances were






Percent of total visits
in each category
















persons 65–74 they were aspirin and
hydrochlorothiazide; and for 75 years
and over, they were furosemide and
digoxin. Albuterol, an antiasthmatic
drug, was cited at 1.7 percent of the
drug mentions overall, but 4.0 percent o
the drug mentions for those under 15.
Table Dpresents a summary of
services—diagnostic and screening,
ambulatory surgical procedures,
medication, and other therapeutic and
preventive—by patient’s age, sex, race
and physician specialty. The mean
number of services in each category is
shown. There were about 32 services









































Figure 14. Percent distribution of drug mentions at office visits by therapeutic classification
of drug: United states, 1995–96
Page 12 [ Series 13, No. 142overall. Visits by children under 15
years had an average of about 22
services per 10 visits, compared with
services for every 10 visits by those 7
years and over. Most of this difference
was accounted for by the increased
utilization of diagnostic and screening
services and medication therapy at vis
by older age groups compared with
those under 15 years. There was an
average of 56 services recorded at ev
10 cardiology visits, and 46 at every 1
visits to obstetricians and gynecologis
In contrast, about 15 services were
mentioned at every 10 visits to
otolaryngologists, and 17 at every 10
orthopedic surgery visits (figure 15).
Other Visit Characteristics
Referral Status and Prior-Visit Status
Tables 40and41 present data on
patient’s referral status and prior-visit
status according to age, sex, race, an
physician specialty. While more than
one-half (53.4 percent) of the visits by
persons under 15 years of age were b
established patients seeking treatmeny
for continuing problems, 79.0 percent o
visits by persons 75 years and over fe
into this category.
Expected Source of Payment
Data on expected sources of
payment are shown infigure 16and
tables 42and43. This item underwent
substantial revision for the 1995–96
NAMCS. The first part of the new item
concerns type of payment (for example
was the visit part of an insured
fee-for-service arrangement, preferred
provider option, or HMO/other prepaid
plan). Other options that could be
checked were self-pay, no charge, and
‘‘other’’ type of payment. Respondents
were asked to check only one type of
payment. If any of the first three option
were checked, the respondent was the
asked to complete part b of the item,
expected sources of insurance for the
visit. Respondents were asked to chec
all expected sources of insurance that
were applicable.
Office visits were more likely to be
covered under insured, fee-for-service
arrangements (36.6 percent) comparedwith HMO/other prepaid plan visits
(24.4 percent) and preferred provider
option visits (12.5 percent).
Self-payment was reported at 9.6 percen
of visits. Expected sources of payment,
regardless of type of payment, were
most often private insurance
(46.5 percent), Medicare (21.7 percent),
and Medicaid (11.4 percent).
Selected Medical Conditions
Additional diagnostic data on the
patient’s current health status were
collected in item 12 of the PRF.
Physicians were given a list of 10
chronic health conditions and asked to
record whether the patient currently has
any of them, regardless of what was
recorded as the current diagnosis in item
11 of the survey form. The original
intent of this item was to provide data
on chronic conditions, which could be
compared with the diagnoses in item 11
in order to assess possible
underreporting of chronic health
conditions in the NAMCS. Data from
item 12 are shown intables 44and45.
More than one-third (34.5 percent)
of office visits were made by patients
reported to have one or more of the 10
conditions listed on the survey form.
Hypertension and arthritis were checked
most frequently, at 15.6 percent and
10.9 percent of visits, respectively.
Arthritis, obesity, and depression were
more likely to be reported at visits by
females than males. More than one-third
of the visits by persons 65 years and
over mentioned hypertension as a
current condition.
Hypertension, diabetes, and obesity
were reported at higher percents of
visits by black persons than white
persons, either as single conditions or in
various combinations. The combination
of hypertension with diabetes was
reported at 3.9 percent of visits by black
persons compared with 1.9 percent of
visits by white persons (data not
shown). Hypertension was reported in
conjunction with obesity at 2.7 percent
of visits by black persons compared
with 1.8 percent of visits by white
persons. Overall, 3 of every 10 visits by
black persons included a mention of at
least one of these three conditions,











Table D. Mean number of diagnostic and therapeutic services ordered or provided at office visits by patient’s age, sex, and race, and













Number of services per 10 visits
All visits . . . . . . . . . . . . . . . . . . . . . . . 14.1 0.5 11.9 5.8 32.3
Age
Under 15 years . . . . . . . . . . . . . . . . . . 6.8 0.2 9.9 5.4 22.2
15–24 years . . . . . . . . . . . . . . . . . . . . 15.1 0.5 8.9 5.1 29.6
25–44 years . . . . . . . . . . . . . . . . . . . . 16.0 0.5 10.1 6.1 32.6
45–64 years . . . . . . . . . . . . . . . . . . . . 15.8 0.7 12.8 6.5 35.8
65–74 years . . . . . . . . . . . . . . . . . . . . 16.3 0.7 15.0 5.9 37.9
75 years and over . . . . . . . . . . . . . . . . . 15.9 0.7 16.3 4.6 37.5
Sex
Female . . . . . . . . . . . . . . . . . . . . . . . 15.7 0.5 12.2 5.8 34.1
Male . . . . . . . . . . . . . . . . . . . . . . . . . 11.9 0.6 11.6 5.8 29.8
Race
White . . . . . . . . . . . . . . . . . . . . . . . . 13.9 0.6 11.9 5.7 32.1
Black . . . . . . . . . . . . . . . . . . . . . . . . . 16.1 0.3 12.7 5.8 35.0
Other . . . . . . . . . . . . . . . . . . . . . . . . . 14.1 0.5 11.2 6.4 32.1
Physician specialty
General and family practice . . . . . . . . . . . 14.2 0.4 13.6 5.8 34.0
Internal medicine . . . . . . . . . . . . . . . . . 18.9 0.2 16.7 6.8 42.6
Pediatrics . . . . . . . . . . . . . . . . . . . . . . 6.9 0.1 10.7 6.6 24.3
Obstetrics and gynecology . . . . . . . . . . . 32.9 0.5 6.6 6.4 46.4
Ophthalmology . . . . . . . . . . . . . . . . . . . 13.2 0.9 9.2 2.6 25.8
Orthopedic surgery . . . . . . . . . . . . . . . . 7.2 0.5 4.2 5.5 17.4
Dermatology . . . . . . . . . . . . . . . . . . . . 4.0 2.8 10.5 2.9 20.2
Psychiatry . . . . . . . . . . . . . . . . . . . . . . 4.1 0.1 12.2 12.5 28.8
General surgery . . . . . . . . . . . . . . . . . . 10.6 1.2 5.0 3.3 20.1
Otolaryngology . . . . . . . . . . . . . . . . . . . 4.4 1.1 7.9 1.5 14.9
Cardiovascular diseases . . . . . . . . . . . . . 20.3 0.1 24.1 11.4 55.9
Urology . . . . . . . . . . . . . . . . . . . . . . . 15.5 1.5 0.6 2.2 19.8
Neurology . . . . . . . . . . . . . . . . . . . . . . 12.4 0.0 12.4 3.4 28.3
All other . . . . . . . . . . . . . . . . . . . . . . . 14.2 0.7 14.1 5.4 34.5
0.0 Quantity more than zero but less than 0.05.
1Diagnostic and screening services include the following examinations: breast, pelvic, rectal, visual acuity, mental status; the following tests: blood pressure, urinalysis, tuberculin skin test, blood lead
level, cholesterol measure, prostate specific antigen (PSA), HIV serology, other blood test; and the following imaging: x ray, CAT scan (computerized axial tomography), MRI (magnetic resonance
imaging), ultrasound. Up to five additional services could be written in by the respondent; these were coded to the specific ICD–9–CM procedure code. A total of 22 services could be reported per visit.
2Up to two ambulatory surgical procedures could be reported per visit in an item that was separate from diagnostic and screening services. However, it was found that in some cases respondents
reported ambulatory surgery under ‘‘diagnostic and screening services,’’ while some respondents reported nonsurgical procedures under ambulatory surgery. For this reason any analysis should take
results from both items into account.
3As many as six drug mentions could be reported per visit, including all medications provided, prescribed, injected, or administered at the visit, or drugs that the patient was instructed or expected to
continue taking from a prior visit. Medications were defined as prescription and nonprescription preparations, vaccinations, allergy shots, immunizations, and anesthetics.
4Therapeutic and preventive services include the following types of counseling and education: diet, exercise, weight reduction, cholesterol reduction, HIV transmission, injury prevention, tobacco
use/exposure, growth/development, mental health, and ‘‘other.’’ Also included are psychotherapy, corrective lenses, physiotherapy, and ‘‘other therapy.’’ A maximum of 14 services could be coded per
visit.
Series 13, No. 142 [ Page 13white persons. The presence of all thre
conditions was reported at 1.4 percent
visits by black persons compared with
less than 0.6 percent by white persons
Visits are described in terms of the
patient’s cigarette-smoking status in
tables 46and47. Overall, 9.1 percent of
visits were made by cigarette smokers
while 60.5 percent were made by
nonsmokers. At 30.4 percent of visits,
the patient’s cigarette-smoking status
was either unknown or left blank on th
PRF. More than one-quarter of the visi
to cardiologists did not report thef
patient’s smoking status. Among
psychiatrists, one-fifth of the visits wer
made by cigarette smokers.
Providers Seen
Data on providers seen at the offic
visit are shown intables 48and49.
Physicians were in attendance at
96.1 percent of office visits. Medical
assistants (24.8 percent of visits) and
registered nurses (13.5 percent) were
reported less frequently. Visits by whit
persons were more likely to include a
physician (96.4 percent) compared witvisits by black persons (93.9 percent).
Conversely, visits by black persons more
often included services from medical
assistants (30.1 percent) compared with
visits by white persons (23.9 percent).
More than one-third of the visits to
ophthalmologists (38.0 percent) were
attended by a medical assistant.
Visit Disposition and Duration
Data on disposition and duration of
the visit are shown intables 50and51.
At 6 out of every 10 office visits, the
patient was instructed to return at a
of
n n
Figure 15. Mean number of diagnostic and therapeutic services ordered or provided at
office visits by physician specialty: United States, 1995–96
Figure 16. Percent of office visits by expected sources of payment: United States, 1995–96
Page 14 [ Series 13, No. 142specified time. More than one-quarter
the visits included instructions to return
if needed. Less than 1 percent of the
visits resulted in hospital admission
(0.8 percent). More than one dispositio
could be checked per PRF.
Average duration of the visit is
based on the time spent in direct,face-to-face contact between the
physician and the patient. It does not
include visits of ‘‘zero’’ minutes
duration, that is, visits in which the
patient did not meet with the physicia
directly. It should be noted, however,
that in the 1995–96 NAMCS data, the
number of visits with ‘‘zero’’ minutesduration may be overestimated. This
could have occurred because there were
a number of records that indicated that a
physician was seen, but that did not
report a visit duration; the missing
responses for duration were included in
the ‘‘zero’’ minutes category. For the
1997 NAMCS, modifications in the data
editing process should eliminate this
problem.
Based on the available duration
data, more than one-third (37.6 percent)
of the visits lasted for 10 minutes or
less. More than one-half (55.1 percent)
lasted between 11 and 30 minutes.
Tables EandF present data on average
duration of office visits by age, sex,
race, and physician specialty.
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Table E. Annual number and percent distribution of office visits by patient’s age, sex, and race, averaged over a 2-year period, with mean












All visits . . . . . . . . . . . . . . . . . . 715,788 100.0 19.2 0.2
Age
Under 15 years . . . . . . . . . . . . . 136,200 19.0 15.7 0.3
15–24 years . . . . . . . . . . . . . . . 57,682 8.1 18.1 0.3
25–44 years . . . . . . . . . . . . . . . 183,019 25.6 20.1 0.3
45–64 years . . . . . . . . . . . . . . . 164,880 23.0 20.7 0.3
65–74 years . . . . . . . . . . . . . . . 92,212 12.9 20.0 0.4
75 years and over . . . . . . . . . . . . 81,795 11.4 20.3 0.4
Sex
Female . . . . . . . . . . . . . . . . . . 425,415 59.4 19.3 0.3
Male . . . . . . . . . . . . . . . . . . . . 290,373 40.6 19.1 0.3
Race
White . . . . . . . . . . . . . . . . . . . 616,928 86.2 19.4 0.2
Black . . . . . . . . . . . . . . . . . . . . 70,746 9.9 18.1 0.5
Other . . . . . . . . . . . . . . . . . . . . 28,114 3.9 18.8 0.8
1Time spent in face-to-face contact between physician and patient. Does not include visits at which there was no face-to-face contact between physician and patient.
2See Appendix I for discussion of standard errors and precision of NAMCS estimates.
NOTE: Numbers may not add to totals because of rounding.
Table F. Annual number and percent distribution of office visits by physician specialty, averaged over a 2-year period, with mean duration of












All visits . . . . . . . . . . . . . . . . . . . . . . . 715,788 100.0 19.2 0.2
General and family practice . . . . . . . . . . . 183,225 25.6 16.9 0.5
Internal medicine . . . . . . . . . . . . . . . . . 104,431 14.6 18.9 0.5
Pediatrics . . . . . . . . . . . . . . . . . . . . . . 92,888 13.0 15.9 0.5
Obstetrics and gynecology . . . . . . . . . . . 59,515 8.3 17.9 0.6
Ophthalmology . . . . . . . . . . . . . . . . . . . 40,714 5.7 24.8 0.7
Orthopedic surgery . . . . . . . . . . . . . . . . 38,267 5.3 18.8 1.4
Dermatology . . . . . . . . . . . . . . . . . . . . 28,969 4.0 15.4 0.7
Psychiatry . . . . . . . . . . . . . . . . . . . . . . 20,287 2.8 38.9 0.7
General surgery . . . . . . . . . . . . . . . . . . 18,762 2.6 17.4 1.5
Otolaryngology . . . . . . . . . . . . . . . . . . . 18,346 2.6 17.3 1.3
Cardiovascular diseases . . . . . . . . . . . . . 14,705 2.1 24.3 1.4
Urology . . . . . . . . . . . . . . . . . . . . . . . 13,780 1.9 18.2 0.7
Neurology . . . . . . . . . . . . . . . . . . . . . . 8,481 1.2 29.2 0.9
All other . . . . . . . . . . . . . . . . . . . . . . . 73,417 10.3 23.1 0.5
1Time spent in face-to-face contact between physician and patient. Does not include visits at which there was no face-to-face contact between physician and patient.
2See Appendix I for discussion of standard errors and precision of NAMCS estimates.
NOTE: Numbers may not add to totals because of rounding.
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Table 1. Annual number, percent distribution, and rate of office visits by patient’s age, sex, race, and geographic region of visit, averaged










All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 100.0 2.7
Age
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136,200 19.0 2.3
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57,682 8.1 1.6
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183,019 25.6 2.2
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164,880 23.0 3.1
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92,212 12.9 5.0
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81,795 11.4 6.1
Sex and age
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 425,415 59.4 3.2
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66,117 9.2 2.3
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37,979 5.3 2.1
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121,232 16.9 2.9
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97,663 13.6 3.6
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53,753 7.5 5.3
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48,671 6.8 5.9
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290,373 40.6 2.3
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70,082 9.8 2.3
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,703 2.8 1.1
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61,787 8.6 1.5
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67,217 9.4 2.7
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38,459 5.4 4.7
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33,124 4.6 6.5
Race and age
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 616,928 86.2 2.8
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117,341 16.4 2.5
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47,918 6.7 1.7
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153,844 21.5 2.2
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141,356 19.7 3.1
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81,834 11.4 5.1
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74,635 10.4 6.2
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70,746 9.9 2.1
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,155 1.8 1.4
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,891 1.0 1.3
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,882 2.9 2.0
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,197 2.4 3.2
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,269 1.0 4.6
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,353 0.7 5.2
All other races:
Asian/Pacific Islander . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25,376 3.5 2.6
American Indian/Eskimo/Aleut . . . . . . . . . . . . . . . . . . . . . . . . . . 2,738 0.4 1.2
Geographic region
Northeast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142,412 19.9 2.7
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154,807 21.6 2.5
South . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230,373 32.2 2.5
West . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188,195 26.3 3.3
1Based on U.S. Bureau of the Census estimates of the civilian noninstitutionalized population of the United States as of July 1, 1995, and July 1, 1996.
NOTE: Numbers may not add to totals because of rounding.
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diseases Urology Neurology All other
Number of visits in thousands
All visits . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Age
Under 15 years . . . . . . 136,200 28,961 3,900 83,193 * 2,602 3,545 2,396 1,017 733 4,135 * 767 706 3,856
15–24 years . . . . . . . . 57,682 18,276 4,653 5,727 11,220 1,407 3,679 3,880 1,488 1,089 1,197 * 399 584 3,943
25–44 years . . . . . . . . 183,019 50,785 24,979 2,339 34,804 5,735 11,528 7,310 9,288 5,157 4,812 1,139 2,053 2,745 20,345
45–64 years . . . . . . . . 164,880 43,487 31,082 1,056 9,897 8,881 11,772 7,075 6,550 6,034 4,128 4,573 3,793 2,469 24,085
65–74 years . . . . . . . . 92,212 22,842 20,225 * 2,066 10,154 4,490 4,565 1,247 3,357 2,173 4,464 3,685 1,163 11,485
75 years and over . . . . . 81,795 18,874 19,591 * 1,221 11,935 3,252 3,744 698 2,393 1,901 4,308 3,084 814 9,702
Sex
Female . . . . . . . . . . . 425,415 108,000 61,080 45,954 59,461 24,022 19,804 17,006 11,414 11,668 9,530 6,739 3,204 4,960 42,573
Male . . . . . . . . . . . . . 290,373 75,224 43,351 46,934 * 16,692 18,463 11,963 8,874 7,095 8,816 7,966 10,576 3,521 30,844
Race
White . . . . . . . . . . . . 616,928 155,616 85,486 80,858 49,688 37,262 34,277 26,788 18,329 16,318 16,987 13,587 12,361 7,552 61,820
Black . . . . . . . . . . . . . 70,746 19,994 13,821 8,210 7,629 2,509 3,004 1,198 1,525 1,709 873 771 985 586 7,932
Other . . . . . . . . . . . . . 28,114 7,615 5,124 3,821 2,198 943 985 984 433 735 485 348 434 343 3,665
Percent distribution by age, sex, and race
All visits . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Age
Under 15 years . . . . . . 19.0 15.8 3.7 89.6 * 6.4 9.3 8.3 5.0 3.9 22.5 * 5.6 8.3 5.3
15–24 years . . . . . . . . 8.1 10.0 4.5 6.2 18.9 3.5 9.6 13.4 7.3 5.8 6.5 * 2.9 6.9 5.4
25–44 years . . . . . . . . 25.6 27.7 23.9 2.5 58.5 14.1 30.1 25.2 45.8 27.5 26.2 7.7 14.9 32.4 27.7
45–64 years . . . . . . . . 23.0 23.7 29.8 1.1 16.6 21.8 30.8 24.4 32.3 32.2 22.5 31.1 27.5 29.1 32.8
65–74 years . . . . . . . . 12.9 12.5 19.4 * 3.5 24.9 11.7 15.8 6.1 17.9 11.8 30.4 26.7 13.7 15.6
75 years and over . . . . . 11.4 10.3 18.8 * 2.1 29.3 8.5 12.9 3.4 12.8 10.4 29.3 22.4 9.6 13.2
Sex
Female . . . . . . . . . . . 59.4 58.9 58.5 49.5 99.9 59.0 51.8 58.7 56.3 62.2 51.9 45.8 23.3 58.5 58.0
Male . . . . . . . . . . . . . 40.6 41.1 41.5 50.5 * 41.0 48.2 41.3 43.7 37.8 48.1 54.2 76.7 41.5 42.0
Race
White . . . . . . . . . . . . 86.2 84.9 81.9 87.0 83.5 91.5 89.6 92.5 90.3 87.0 92.6 92.4 89.7 89.0 84.2
Black . . . . . . . . . . . . . 9.9 10.9 13.2 8.8 12.8 6.2 7.9 4.1 7.5 9.1 4.8 5.2 7.2 6.9 10.8
Other . . . . . . . . . . . . . 3.9 4.2 4.9 4.1 3.7 2.3 2.6 3.4 2.1 3.9 2.6 2.4 3.2 4.0 5.0


































diseases Urology Neurology All other
Percent distribution by physician specialty
All visits . . . . . . . . . . . 100.0 25.6 14.6 13.0 8.3 5.7 5.3 4.0 2.8 2.6 2.6 2.1 1.9 1.2 10.3
Age
Under 15 years . . . . . . 100.0 21.3 2.9 61.1 * 1.9 2.6 1.8 0.7 0.5 3.0 * 0.6 0.5 2.8
15–24 years . . . . . . . . 100.0 31.7 8.1 9.9 19.5 2.4 6.4 6.7 2.6 1.9 2.1 * 0.7 1.0 6.8
25–44 years . . . . . . . . 100.0 27.7 13.6 1.3 19.0 3.1 6.3 4.0 5.1 2.8 2.6 0.6 1.1 1.5 11.1
45–64 years . . . . . . . . 100.0 26.4 18.9 0.6 6.0 5.4 7.1 4.3 4.0 3.7 2.5 2.8 2.3 1.5 14.6
65–74 years . . . . . . . . 100.0 24.8 21.9 * 2.2 11.0 4.9 5.0 1.4 3.6 2.4 4.8 4.0 1.3 12.5
75 years and over . . . . . 100.0 23.1 24.0 * 1.5 14.6 4.0 4.6 0.9 2.9 2.3 5.3 3.8 1.0 11.9
Sex
Female . . . . . . . . . . . 100.0 25.4 14.4 10.8 14.0 5.6 4.7 4.0 2.7 2.7 2.2 1.6 0.8 1.2 10.0
Male . . . . . . . . . . . . . 100.0 25.9 14.9 16.2 * 5.7 6.4 4.1 3.1 2.4 3.0 2.7 3.6 1.2 10.6
Race
White . . . . . . . . . . . . 100.0 25.2 13.9 13.1 8.1 6.0 5.6 4.3 3.0 2.6 2.8 2.2 2.0 1.2 10.0
Black . . . . . . . . . . . . . 100.0 28.3 19.5 11.6 10.8 3.5 4.2 1.7 2.2 2.4 1.2 1.1 1.4 0.8 11.2
Other . . . . . . . . . . . . . 100.0 27.1 18.2 13.6 7.8 3.4 3.5 3.5 1.5 2.6 1.7 1.2 1.5 1.2 13.0
Number of visits per 100 persons per year1
All visits . . . . . . . . . . . 272.0 69.6 39.7 35.3 22.6 15.5 14.5 11.0 7.7 7.1 7.0 5.6 5.2 3.2 27.9
Age
Under 15 years . . . . . . 229.0 48.7 6.6 139.9 * 4.4 6.0 4.0 1.7 1.2 7.0 * 1.3 1.2 6.5
15–24 years . . . . . . . . 159.0 50.4 12.8 15.8 30.9 3.9 10.1 10.7 4.1 3.0 3.3 * 1.1 1.6 10.9
25–44 years . . . . . . . . 219.8 61.0 30.0 2.8 41.8 6.9 13.8 8.8 11.2 6.2 5.8 1.4 2.5 3.3 24.4
45–64 years . . . . . . . . 314.3 82.9 59.2 2.0 18.9 16.9 22.4 13.5 12.5 11.5 7.9 8.7 7.2 4.7 45.9
65–74 years . . . . . . . . 504.7 125.0 110.7 * 11.3 55.6 24.6 25.0 6.8 18.4 11.9 24.4 20.2 6.4 62.9
75 years and over . . . . . 610.5 140.9 146.2 * 9.1 89.1 24.3 27.9 5.2 17.9 14.2 32.2 23.0 6.1 72.4
Sex
Female . . . . . . . . . . . 315.4 80.1 45.3 34.1 44.1 17.8 14.7 12.6 8.5 8.7 7.1 5.0 2.4 3.7 31.6
Male . . . . . . . . . . . . . 226.3 58.6 33.8 36.6 * 13.0 14.4 9.3 6.9 5.5 6.9 6.2 8.2 2.7 24.0
Race
White . . . . . . . . . . . . 283.5 71.5 39.3 37.2 22.8 17.1 15.8 12.3 8.4 7.5 7.8 6.2 5.7 3.5 28.4
Black . . . . . . . . . . . . . 210.3 59.4 41.1 24.4 22.7 7.5 8.9 3.6 4.5 5.1 2.6 2.3 2.9 1.7 23.6
Other . . . . . . . . . . . . . 235.3 63.7 42.9 32.0 18.4 7.9 8.2 8.2 3.6 6.2 4.1 2.9 3.6 2.9 30.7
* Figure does not meet standard of reliability or precision.
1Based on U.S. Bureau of the Census estimates of the civilian noninstitutionalized population as of July 1, 1995, and July 1, 1996.



































Number of visits in thousands
All visits . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Geographic region
Northeast . . . . . . . . . . . . 142,412 23,174 27,051 18,684 11,331 8,555 7,277 5,810 6,375 3,532 3,725 4,058 2,911 1,869 18,060
Midwest . . . . . . . . . . . . . 154,807 48,747 22,594 15,109 15,040 8,451 9,552 4,644 2,088 4,681 3,775 3,345 3,581 1,443 11,755
South . . . . . . . . . . . . . . 230,373 63,594 26,534 31,007 20,792 12,833 11,488 9,804 7,672 6,126 6,874 3,784 4,823 3,279 21,764
West . . . . . . . . . . . . . . . 188,195 47,709 28,252 28,089 12,352 10,875 9,950 8,711 4,152 4,424 3,973 3,518 2,465 1,890 21,837
Urbanicity
MSA1 . . . . . . . . . . . . . . 588,437 121,227 89,220 85,437 55,358 33,815 32,641 26,231 19,621 14,081 15,899 12,750 11,554 7,475 63,128
Non-MSA1 . . . . . . . . . . . 127,351 61,998 15,210 7,451 4,157 6,899 5,626 2,739 666 4,681 2,447 1,955 2,227 1,006 10,289
Professional identity
Doctor of osteopathy . . . . . 41,759 28,956 2,011 1,631 1,845 805 1,060 1,507 246 440 306 * 482 192 2,218
Doctor of medicine . . . . . . 674,028 154,268 102,420 91,257 57,670 39,909 37,207 27,462 20,041 18,322 18,040 14,646 13,299 8,289 71,198
Percent distribution
All visits . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Geographic region
Northeast . . . . . . . . . . . . 19.9 12.6 25.9 20.1 19.0 21.0 19.0 20.1 31.4 18.8 20.3 27.6 21.1 22.0 24.6
Midwest . . . . . . . . . . . . . 21.6 26.6 21.6 16.3 25.3 20.8 25.0 16.0 10.3 25.0 20.6 22.7 26.0 17.0 16.0
South . . . . . . . . . . . . . . 32.2 34.7 25.4 33.4 34.9 31.5 30.0 33.8 37.8 32.6 37.5 25.7 35.0 38.7 29.6
West . . . . . . . . . . . . . . . 26.3 26.0 27.1 30.2 20.8 26.7 26.0 30.1 20.5 23.6 21.7 23.9 17.9 22.3 29.7
Urbanicity
MSA1 . . . . . . . . . . . . . . 82.2 66.2 85.4 92.0 93.0 83.1 85.3 90.5 96.7 75.1 86.7 86.7 83.8 88.1 86.0
Non-MSA1 . . . . . . . . . . . 17.8 33.8 14.6 8.0 7.0 16.9 14.7 9.5 3.3 24.9 13.3 13.3 16.2 11.9 14.0
Professional identity
Doctor of osteopathy . . . . . 5.8 15.8 1.9 1.8 3.1 2.0 2.8 5.2 1.2 2.3 1.7 * 3.5 2.3 3.0
Doctor of medicine . . . . . . 94.2 84.2 98.1 98.2 96.9 98.0 97.2 94.8 98.8 97.7 98.3 99.6 96.5 97.7 97.0
Number of visits per 100 persons per year2
All visits . . . . . . . . . . . . . 272.0 69.6 39.7 35.3 22.6 15.5 14.5 11.0 7.7 7.1 7.0 5.6 5.2 3.2 27.9
Geographic region
Northeast . . . . . . . . . . . . 269.0 43.8 51.1 35.3 21.4 16.2 13.7 11.0 12.0 6.7 7.0 7.7 5.5 3.5 34.1
Midwest . . . . . . . . . . . . . 251.4 79.2 36.7 24.5 24.4 13.7 15.5 7.5 3.4 7.6 6.1 5.4 5.8 2.3 19.1
South . . . . . . . . . . . . . . 251.0 69.3 28.9 33.8 22.7 14.0 12.5 10.7 8.4 6.7 7.5 4.1 5.3 3.6 23.7
West . . . . . . . . . . . . . . . 332.5 84.3 49.9 49.6 21.8 19.2 17.6 15.4 7.3 7.8 7.0 6.2 4.4 3.3 38.6
Urbanicity
MSA1 . . . . . . . . . . . . . . 279.3 57.5 42.4 40.6 26.3 16.1 15.5 12.5 9.3 6.7 7.5 6.1 5.5 3.5 30.0
Non-MSA1 . . . . . . . . . . . 243.8 118.7 29.1 14.3 8.0 13.2 10.8 5.2 1.3 9.0 4.7 3.7 4.3 1.9 19.7
Professional identity
Doctor of osteopathy . . . . . 15.9 11.0 0.8 0.6 0.7 0.3 0.4 0.6 0.1 0.2 0.1 * 0.2 0.1 0.8
Doctor of medicine . . . . . . 256.1 58.6 38.9 34.7 21.9 15.2 14.1 10.4 7.6 7.0 6.9 5.6 5.1 3.1 27.1
*Figure does not meet standard of reliability or precision.
1MSA is metropolitan statistical area.
2Based on U.S. Bureau of the Census estimates of the civilian noninstitutionalized population of the United States as of July 1, 1995, and July 1, 1996, averaged over the 2-year period.











Table 4. Annual number and percent distribution of office visits by type of practice (solo or group) and prepaid plan participation, according to phys ician specialty, averaged over





















Number of visits in thousands
All visits . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Type of practice
Solo practice . . . . . . . . . . 297,214 84,362 43,387 33,466 25,000 12,681 10,697 17,213 14,718 8,471 6,843 5,376 5,101 2,989 26,909
Group practice . . . . . . . . . 408,569 97,296 57,039 58,245 33,913 27,893 26,589 11,591 5,310 10,042 11,402 9,185 8,357 5,299 46,409
Blank . . . . . . . . . . . . . . . 10,004 1,567 4,004 1,177 602 140 981 165 259 249 100 145 323 193 *
Prepaid plan participation
Physician participates in
prepaid plan1 . . . . . . . . . 605,622 149,027 95,925 87,017 56,863 35,824 33,576 26,215 13,223 17,314 17,782 13,105 12,295 7,626 63,291
Nonparticipant . . . . . . . . . 110,165 34,198 8,506 5,872 2,652 4,889 4,690 2,755 7,064 1,449 564 1,601 1,485 855 10,126
Percent distribution
All visits . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Type of practice
Solo practice . . . . . . . . . . 41.5 46.0 41.5 36.0 42.0 31.1 28.0 59.4 72.5 45.1 37.3 36.6 37.0 35.2 36.7
Group practice . . . . . . . . . 57.1 53.1 54.6 62.7 57.0 68.5 69.5 40.0 26.2 53.5 62.2 62.5 60.6 62.5 63.2
Blank . . . . . . . . . . . . . . . 1.4 0.9 3.8 1.3 1.0 0.3 2.6 0.6 1.3 1.3 0.5 1.0 2.3 2.3 *
Prepaid plan participation
Physician participates in
prepaid plan1 . . . . . . . . . 84.6 81.3 91.9 93.7 95.5 88.0 87.7 90.5 65.2 92.3 96.9 89.1 89.2 89.9 86.2
Nonparticipant . . . . . . . . . 15.4 18.7 8.1 6.3 4.5 12.0 12.3 9.5 34.8 7.7 3.1 10.9 10.8 10.1 13.8
*Figure does not meet standard of reliability or precision.
1Includes participation in health maintenance organization (HMO), independent practice association (IPA), preferred provider organization (PPO), or other prepaid plan.











Table 5. Annual number and percent distribution of office visits by patient’s principal reason for visit, according to patient’s age, sex, and race, a veraged over a 2-year period:
United States, 1995–96













and over Female Male White Black Other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
Symptom module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S001–S999 387,578 85,490 30,145 97,862 87,800 45,606 40,674 225,765 161,813 333,793 37,041 16,743
General symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S001–S099 46,837 13,088 2,075 9,751 10,880 5,448 5,595 26,466 20,371 40,677 4,049 2,112
Symptoms referable to psychological/mental disorders . . . . . . . . . . . . . . S100–S199 20,799 1,527 1,328 7,883 6,573 2,001 1,488 11,680 9,120 18,810 1,460 529
Symptoms referable to the nervous system (excluding sense organs) . . . . S200–S259 19,789 1,669 1,531 5,417 5,810 2,758 2,604 12,624 7,165 16,317 2,331 1,141
Symptoms referable to the cardiovascular/lymphatic system . . . . . . . . . . S260–S299 3,633 * * 759 1,027 631 607 2,289 1,344 3,421 * *
Symptoms referable to the eyes and ears . . . . . . . . . . . . . . . . . . . . . . S300–S399 44,245 17,121 1,799 6,604 6,892 5,531 6,300 24,002 20,243 39,984 2,755 1,507
Symptoms referable to the respiratory system . . . . . . . . . . . . . . . . . . . S400–S499 81,045 30,880 7,166 17,265 12,765 6,976 5,992 45,659 35,386 69,337 7,683 4,025
Symptoms referable to the digestive system . . . . . . . . . . . . . . . . . . . . S500–S639 31,839 6,316 2,551 7,767 7,097 4,326 3,781 18,949 12,890 26,488 3,154 2,197
Symptoms referable to the genitourinary system . . . . . . . . . . . . . . . . . . S640–S829 27,808 1,460 3,260 9,961 6,663 3,530 2,933 20,478 7,330 23,352 3,727 729
Symptoms referable to the skin, hair, and nails . . . . . . . . . . . . . . . . . . S830–S899 38,560 8,148 5,194 9,427 7,553 4,562 3,674 22,238 16,322 33,795 2,955 1,809
Symptoms referable to the musculoskeletal system . . . . . . . . . . . . . . . . S900–S999 73,022 4,811 5,103 23,026 22,541 9,842 7,700 41,380 31,642 61,613 8,784 2,625
Disease module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D001–D999 76,944 7,953 3,332 16,131 20,917 15,009 13,601 42,388 34,556 66,463 7,884 2,597
Diagnostic/screening and preventive module . . . . . . . . . . . . . . . . . . . . . X100–X599 125,632 27,251 13,345 37,052 22,579 13,429 11,976 87,324 38,308 107,465 13,275 4,892
Treatment module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T100–T899 75,339 7,195 4,630 17,903 22,330 12,425 10,856 43,651 31,689 66,264 6,726 2,350
Injuries and adverse effects module . . . . . . . . . . . . . . . . . . . . . . . . . . . J001–J999 20,850 4,317 2,892 6,051 4,242 1,676 1,672 9,933 10,917 18,315 2,094 441
Test results module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R100–R700 10,646 * 713 3,153 2,979 2,252 1,380 6,721 3,925 9,123 1,058 466
Administrative module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A100–A140 7,121 2,348 1,826 2,007 792 * * 2,847 4,275 5,756 1,131 *
Other2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U990–U999 11,677 1,476 799 2,861 3,240 1,733 1,569 6,787 4,890 9,750 1,537 390
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Symptom module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S001–S999 54.1 62.8 52.3 53.5 53.3 49.5 49.7 53.1 55.7 54.1 52.4 59.6
General symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S001–S099 6.5 9.6 3.6 5.3 6.6 5.9 6.8 6.2 7.0 6.6 5.7 7.5
Symptoms referable to psychological/mental disorders . . . . . . . . . . . . . . S100–S199 2.9 1.1 2.3 4.3 4.0 2.2 1.8 2.7 3.1 3.0 2.1 1.9
Symptoms referable to the nervous system (excluding sense organs) . . . . S200–S259 2.8 1.2 2.7 3.0 3.5 3.0 3.2 3.0 2.5 2.6 3.3 4.1
Symptoms referable to the cardiovascular/lymphatic system . . . . . . . . . . S260–S299 0.5 * * 0.4 0.6 0.7 0.7 0.5 0.5 0.6 * *
Symptoms referable to the eyes and ears . . . . . . . . . . . . . . . . . . . . . . S300–S399 6.2 12.6 3.1 3.6 4.2 6.0 7.7 5.6 7.0 6.5 3.9 5.4
Symptoms referable to the respiratory system . . . . . . . . . . . . . . . . . . . S400–S499 11.3 22.7 12.4 9.4 7.7 7.6 7.3 10.7 12.2 11.2 10.9 14.3
Symptoms referable to the digestive system . . . . . . . . . . . . . . . . . . . . S500–S639 4.4 4.6 4.4 4.2 4.3 4.7 4.6 4.5 4.4 4.3 4.5 7.8
Symptoms referable to the genitourinary system . . . . . . . . . . . . . . . . . . S640–S829 3.9 1.1 5.7 5.4 4.0 3.8 3.6 4.8 2.5 3.8 5.3 2.6
Symptoms referable to the skin, hair, and nails . . . . . . . . . . . . . . . . . . S830–S899 5.4 6.0 9.0 5.2 4.6 4.9 4.5 5.2 5.6 5.5 4.2 6.4
Symptoms referable to the musculoskeletal system . . . . . . . . . . . . . . . . S900–S999 10.2 3.5 8.8 12.6 13.7 10.7 9.4 9.7 10.9 10.0 12.4 9.3
Disease module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D001–D999 10.7 5.8 5.8 8.8 12.7 16.3 16.6 10.0 11.9 10.8 11.1 9.2
Diagnostic/screening and preventive module . . . . . . . . . . . . . . . . . . . . . X100–X599 17.6 20.0 23.1 20.2 13.7 14.6 14.6 20.5 13.2 17.4 18.8 17.4
Treatment module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T100–T899 10.5 5.3 8.0 9.8 13.5 13.5 13.3 10.3 10.9 10.7 9.5 8.4
Injuries and adverse effects module . . . . . . . . . . . . . . . . . . . . . . . . . . . J001–J999 2.9 3.2 5.0 3.3 2.6 1.8 2.0 2.3 3.8 3.0 3.0 1.6
Test results module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R100–R700 1.5 * 1.2 1.7 1.8 2.4 1.7 1.6 1.4 1.5 1.5 1.7
Administrative module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A100–A140 1.0 1.7 3.2 1.1 0.5 * * 0.7 1.5 0.9 1.6 *
Other2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U990–U999 1.6 1.1 1.4 1.6 2.0 1.9 1.9 1.6 1.7 1.6 2.2 1.4
*Figure does not meet standard of reliability or precision.
1Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).
2Includes problems and complaints not elsewhere classified, entries of ‘‘none,’’ blanks, and illegible entries.











Table 6. Annual number and percent distribution of office visits by patient’s age, sex, and race, according to patient’s principal reason for visit, a veraged over a 2-year period:
United States, 1995–96
















and over Female Male White Black Other
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 100.0 19.0 8.1 25.6 23.0 12.9 11.4 59.4 40.6 86.2 9.9 3.9
Symptom module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S001–S999 387,578 100.0 22.1 7.8 25.2 22.7 11.8 10.5 58.3 41.7 86.1 9.6 4.3
General symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S001–S099 46,837 100.0 27.9 4.4 20.8 23.2 11.6 11.9 56.5 43.5 86.8 8.6 4.5
Symptoms referable to psychological/mental disorders . . . . . . . . . . . . S100–S199 20,799 100.0 7.3 6.4 37.9 31.6 9.6 7.2 56.2 43.8 90.4 7.0 2.5
Symptoms referable to the nervous system (excluding sense organs) . . S200–S259 19,789 100.0 8.4 7.7 27.4 29.4 13.9 13.2 63.8 36.2 82.5 11.8 5.8
Symptoms referable to the cardiovascular/lymphatic system . . . . . . . . S260–S299 3,633 100.0 * * 20.9 28.3 17.4 16.7 63.0 37.0 94.2 3.9 *
Symptoms referable to the eyes and ears . . . . . . . . . . . . . . . . . . . . S300–S399 44,245 100.0 38.7 4.1 14.9 15.6 12.5 14.2 54.2 45.8 90.4 6.2 3.4
Symptoms referable to the respiratory system . . . . . . . . . . . . . . . . . S400–S499 81,045 100.0 38.1 8.8 21.3 15.8 8.6 7.4 56.3 43.7 85.6 9.5 5.0
Symptoms referable to the digestive system . . . . . . . . . . . . . . . . . . S500–S639 31,839 100.0 19.8 8.0 24.4 22.3 13.6 11.9 59.5 40.5 83.2 9.9 6.9
Symptoms referable to the genitourinary system . . . . . . . . . . . . . . . . S640–S829 27,808 100.0 5.3 11.7 35.8 24.0 12.7 10.5 73.6 26.4 84.0 13.4 2.6
Symptoms referable to the skin, hair, and nails . . . . . . . . . . . . . . . . S830–S899 38,560 100.0 21.1 13.5 24.4 19.6 11.8 9.5 57.7 42.3 87.6 7.7 4.7
Symptoms referable to the musculoskeletal system . . . . . . . . . . . . . . S900–S999 73,022 100.0 6.6 7.0 31.5 30.9 13.5 10.5 56.7 43.3 84.4 12.0 3.6
Disease module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D001–D999 76,944 100.0 10.3 4.3 21.0 27.2 19.5 17.7 55.1 44.9 86.4 10.2 3.4
Diagnostic/screening and preventive module . . . . . . . . . . . . . . . . . . . X100–X599 125,632 100.0 21.7 10.6 29.5 18.0 10.7 9.5 69.5 30.5 85.5 10.6 3.9
Treatment module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T100–T899 75,339 100.0 9.6 6.1 23.8 29.6 16.5 14.4 57.9 42.1 88.0 8.9 3.1
Injuries and adverse effects module . . . . . . . . . . . . . . . . . . . . . . . . . J001–J999 20,850 100.0 20.7 13.9 29.0 20.3 8.0 8.0 47.6 52.4 87.8 10.0 2.1
Test results module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R100–R700 10,646 100.0 * 6.7 29.6 28.0 21.2 13.0 63.1 36.9 85.7 9.9 *
Administrative module . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A100–A140 7,121 100.0 33.0 25.6 28.2 11.1 * * 40.0 60.0 80.8 15.9 3.3
Other2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U990–U999 11,677 100.0 12.6 6.8 24.5 27.7 14.8 13.4 58.1 41.9 83.5 13.2 3.3
* Figure does not meet standard of reliability or precision.
1Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).
2Includes problems and complaints not elsewhere classified, entries of ‘‘none,’’ blanks, and illegible entries.











Table 7. Annual number and percent distribution of office visits for the 25 morbidity-related principal reasons for visit most frequently mentioned by patients, by patient’s age, sex,
and race, averaged over a 2-year period: United States, 1995–96
















and over Female Male White Black
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 100.0 19.0 8.1 25.6 23.0 12.9 11.4 59.4 40.6 86.2 9.9
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 24,215 100.0 47.7 7.6 15.2 13.6 9.0 6.8 55.7 44.3 85.7 9.7
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 17,234 100.0 41.0 16.0 24.9 10.3 5.4 2.5 58.6 41.4 86.1 7.1
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 12,206 100.0 * 7.5 37.4 30.6 11.6 11.3 55.6 44.4 80.6 14.9
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 12,176 100.0 67.4 5.2 14.2 7.9 3.0 * 55.1 44.9 90.8 5.7
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . S545 12,031 100.0 11.6 10.2 31.2 27.3 13.0 6.7 65.8 34.2 80.2 10.8
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S010 11,690 100.0 83.0 * 8.7 4.0 * * 48.6 51.4 86.6 7.7
Skin rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S860 11,119 100.0 36.7 9.0 23.8 16.1 8.6 5.7 57.1 42.9 82.2 11.5
Vision dysfunctions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S305 10,477 100.0 5.5 2.9 13.3 23.4 24.5 30.4 59.6 40.4 91.2 6.3
Nasal congestion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S400 10,282 100.0 49.1 7.3 22.1 12.8 5.2 3.5 54.3 45.7 85.4 7.2
Knee symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S925 9,639 100.0 5.6 8.6 29.2 30.3 15.9 10.4 56.1 43.9 86.6 10.8
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D510 9,494 100.0 * * 13.9 37.9 26.7 21.0 57.7 42.3 77.0 18.3
Headache, pain in head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S210 8,876 100.0 13.3 12.6 36.3 26.4 6.6 4.7 68.9 31.1 79.3 15.1
Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S110 8,590 100.0 *2.8 6.6 41.4 32.7 10.7 5.8 66.1 33.9 92.3 5.5
Head cold, upper respiratory infection (coryza) . . . . . . . . . . . . . . . . . . . . . . S445 8,505 100.0 43.7 6.7 21.0 15.9 6.6 6.2 59.1 40.9 79.7 17.2
Chest pain and related symptoms (not referable to a specific body system) . . . . S050 8,212 100.0 * * 24.5 35.3 19.4 14.8 56.0 44.0 86.9 8.8
Neck symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S900 6,973 100.0 7.9 5.8 40.7 32.9 6.9 5.8 59.9 40.1 82.9 11.4
Shoulder symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S940 6,864 100.0 * 9.0 31.5 32.0 15.3 9.5 50.8 49.2 85.0 10.8
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D205 6,258 100.0 * * 13.9 38.2 28.3 15.3 57.0 43.0 78.4 17.2
Leg symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S920 6,243 100.0 6.2 *4.2 20.3 29.3 15.2 24.9 60.1 39.9 86.0 11.4
Low back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S910 6,009 100.0 * *4.7 44.1 32.4 12.8 *4.5 54.6 45.4 82.1 14.0
Skin lesion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S865 5,697 100.0 12.9 * 17.0 20.8 22.0 24.0 53.1 46.9 89.7 7.6
Other and unspecified symptoms referable to the ears . . . . . . . . . . . . . . . . . S365 5,471 100.0 76.3 * 7.3 6.8 *4.7 * 40.8 59.2 92.1 *
Vertigo-dizziness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S225 5,390 100.0 * * 14.3 35.0 24.6 23.1 62.1 37.9 82.3 10.6
Sinus problems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S410 5,269 100.0 10.0 9.4 45.7 28.2 5.0 * 61.4 38.6 91.0 *
Foot and toe symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S935 5,186 100.0 13.0 * 22.7 29.6 18.7 11.1 58.7 41.3 84.9 12.2
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 437,107 100.0 16.4 9.0 26.9 23.0 12.9 11.9 60.8 39.2 86.6 9.8
*Figure does not meet standard of reliability or precision.
1Estimates for races other than white and black have been omitted because of small sample sizes.
2Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).











Table 8. Annual number and percent of office visits by the 60 principal reasons for visit most frequently mentioned by patients, averaged
over a 2-year period, with mean duration of physician-patient contact and standard error of mean contact duration: United States, 1995–96









All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 . . . 19.2 0.2
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 48,992 6.8 21.1 0.5
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . T800 25,019 3.5 17.6 0.6
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 24,215 3.4 15.5 0.4
Routine prenatal examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . X205 20,839 2.9 15.2 0.5
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 19,556 2.7 15.8 0.4
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 17,234 2.4 14.0 0.4
Well baby examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X105 13,715 1.9 16.9 0.7
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 12,206 1.7 20.6 0.6
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 12,176 1.7 13.7 0.5
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . S545 12,031 1.7 19.8 0.8
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S010 11,690 1.6 14.5 0.6
Skin rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S860 11,119 1.6 14.5 0.4
Vision dysfunctions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S305 10,477 1.5 32.0 2.6
Nasal congestion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S400 10,282 1.4 14.4 0.5
Knee symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S925 9,639 1.3 18.4 0.7
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D510 9,494 1.3 17.9 0.6
Headache, pain in head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S210 8,876 1.2 20.8 0.8
Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S110 8,590 1.2 34.6 1.3
Head cold, upper respiratory infection (coryza) . . . . . . . . . . . . . . . . . S445 8,505 1.2 14.2 0.5
Chest pain and related symptoms (not referable to a specific
body system) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S050 8,212 1.1 21.9 0.6
Blood pressure test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X320 7,415 1.0 15.1 0.5
Neck symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S900 6,973 1.0 22.6 1.1
Shoulder symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S940 6,864 1.0 19.9 0.7
Medication, other and unspecified kinds . . . . . . . . . . . . . . . . . . . . . T115 6,641 0.9 18.8 0.9
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D205 6,258 0.9 18.7 0.9
Leg symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S920 6,243 0.9 20.6 0.8
Low back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S910 6,009 0.8 22.8 1.1
Skin lesion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S865 5,697 0.8 16.4 0.8
Physical examination required for school or employment . . . . . . . . . . . A100 5,598 0.8 17.6 1.0
Other symptoms referable to the ears, not elsewhere classified . . . . . . . S365 5,471 0.8 12.8 0.5
Vertigo-dizziness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S225 5,390 0.8 19.4 0.6
Sinus problems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S410 5,269 0.7 15.8 0.9
Foot and toe symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S935 5,186 0.7 17.9 0.8
Acne or pimples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S830 4,880 0.7 12.8 0.5
For other and unspecified test results . . . . . . . . . . . . . . . . . . . . . . . R700 4,680 0.7 17.3 0.6
Anxiety and nervousness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S100 4,668 0.7 30.6 1.3
Shortness of breath . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S415 4,664 0.7 21.5 0.7
Prophylactic inoculations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X400 4,586 0.6 11.9 0.8
Tiredness, exhaustion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S015 4,471 0.6 22.2 1.0
Hand and finger symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S960 4,294 0.6 18.7 0.9
Other and unspecified diagnostic tests . . . . . . . . . . . . . . . . . . . . . . X370 3,865 0.5 22.8 2.1
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X225 3,575 0.5 18.3 1.1
Counseling, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . T605 3,552 0.5 26.5 1.3
Eye examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X230 3,533 0.5 26.1 2.1
Allergy, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . S090 3,491 0.5 17.5 1.4
Pap smear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X365 3,279 0.5 20.9 1.1
Preoperative visit for specified and unspecified types of surgery . . . . . . T200 3,252 0.5 22.6 0.9
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D410 3,206 0.4 21.2 2.5
Pain and related symptoms, generalized, site unspecified . . . . . . . . . . S060 3,179 0.4 20.7 1.7
Diarrhea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S595 3,103 0.4 18.0 0.7
Abnormal sensations of the eye . . . . . . . . . . . . . . . . . . . . . . . . . . S320 3,080 0.4 21.0 1.8
Arm symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S945 2,924 0.4 20.4 1.0
Other blood test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X315 2,875 0.4 17.2 1.5
Pain, site not referable to a specific body system . . . . . . . . . . . . . . . S055 2,842 0.4 18.9 0.8
Allergy medication . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T100 2,821 0.4 17.6 2.5
Hip symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S915 2,739 0.4 20.1 0.9
Wrist symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S955 2,662 0.4 18.9 1.0
Vomiting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S530 2,648 0.4 17.3 1.2
Discoloration or abnormal pigmentation . . . . . . . . . . . . . . . . . . . . . S835 2,611 0.4 15.6 0.8
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D625 2,537 0.4 17.5 1.0
. . . Category not applicable.
1Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).
2Time spent in face-to-face contact between physician and patient. Does not include visits at which there was no face-to-face contact between physician and patient.
3See Appendix I for discussion of standard errors and precision of NAMCS estimates.
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Table 9. Annual number and percent distribution of office visits by patient’s age, sex, and race and the 10 principal reasons for visit most
frequently mentioned by patients, averaged over a 2-year period: United States, 1995–96
Principal reason for visit,







All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 48,992 6.8
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 25,109 3.5
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 24,215 3.4
Routine prenatal examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X205 20,839 2.9
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 19,556 2.7
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 17,234 2.4
Well baby examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X105 13,715 1.9
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 12,206 1.7
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 12,176 1.7
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . S545 12,031 1.7
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 509,715 71.2
Under 15 years
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136,200 100.0
Well baby examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X105 13,715 10.1
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 11,541 8.5
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 10,344 7.6
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S010 9,701 7.1
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 8,204 6.0
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 7,059 5.2
Nasal congestion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S400 5,046 3.7
Other and unspecified symptoms referable to ears . . . . . . . . . . . . . . . . . . . . . . S365 4,172 3.1
Skin rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S860 4,084 3.0
Head cold, upper respiratory infection (coryza) . . . . . . . . . . . . . . . . . . . . . . . . S445 3,713 2.7
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58,622 43.0
15–24 years
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57,682 100.0
Routine prenatal examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X205 6,704 11.6
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 3,274 5.7
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 2,750 4.8
Acne or pimples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S830 2,365 4.1
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 1,851 3.2
Physical examination required for school or employment . . . . . . . . . . . . . . . . . . A100 1,618 2.8
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 1,342 2.3
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 1,300 2.3
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . S545 1,231 2.1
Headache, pain in head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S210 1,115 1.9
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34,135 59.2
25–44 years
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183,019 100.0
Routine prenatal examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X205 13,950 7.6
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 10,730 5.9
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 5,475 3.0
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 4,566 2.5
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 4,549 2.5
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 4,293 2.3
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . S545 3,754 2.1
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 3,690 2.0
Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S110 3,556 1.9
Headache, pain in head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S210 3,226 1.8
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125,230 68.4
45–64 years
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164,880 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 11,855 7.2
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 7,147 4.3
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 5,235 3.2
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 3,733 2.3
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D510 3,602 2.2
See footnotes at end of table.
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Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 3,305 2.0
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . S545 3,289 2.0
Knee symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S925 2,923 1.8
Chest pain and related symptoms (not referable to a specific body system) . . . . . . S050 2,899 1.8
Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S110 2,806 1.7
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118,085 71.6
65–74 years
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92,212 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 6,809 7.4
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 4,878 5.3
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 3,490 3.8
Vision dysfunctions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S305 2,569 2.8
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D510 2,534 2.7
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 2,173 2.4
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D205 1,769 1.9
Blood pressure test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X320 1,656 1.8
Chest pain and related symptoms (not referable to a specific body system) . . . . . . S050 1,591 1.7
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . S545 1,563 1.7
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63,180 68.5
75 years and over
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81,795 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 5,980 7.3
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 4,824 5.9
Vision dysfunctions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S305 3,189 3.9
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 2,969 3.6
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D510 1,997 2.4
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 1,656 2.0
Shortness of breath . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S415 1,637 2.0
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D410 1,594 1.9
Leg symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S920 1,553 1.9
Blood pressure test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X320 1,471 1.8
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54,924 67.1
Female
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 425,415 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 30,661 7.2
Routine prenatal examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X205 20,839 4.9
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 13,704 3.2
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 13,496 3.2
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 11,787 2.8
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 10,092 2.4
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . S545 7,912 1.9
Well baby examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X105 7,271 1.7
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 6,781 1.6
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 6,703 1.6
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296,169 69.6
Male
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290,373 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 18,331 6.3
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 11,315 3.9
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 10,719 3.7
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 7,769 2.7
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 7,143 2.5
Well baby examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X105 6,444 2.2
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S010 6,003 2.1
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 5,472 1.9
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 5,425 1.9
Skin rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S860 4,773 1.6
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206,979 71.3
See footnotes at end of table.
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Table 9. Annual number and percent distribution of office visits by patient’s age, sex, and race and the 10 principal reasons for visit most
frequently mentioned by patients, averaged over a 2-year period: United States, 1995–96—Con.
Principal reason for visit,







All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 616,928 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 42,425 6.9
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 21,643 3.5
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 20,744 3.4
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 17,851 2.9
Routine prenatal examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X205 17,307 2.8
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 14,841 2.4
Well baby examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X105 12,333 2.0
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 11,051 1.8
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S010 10,125 1.6
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 9,843 1.6
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 438,765 71.1
Black
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70,746 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 5,149 7.3
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 2,771 3.9
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 2,338 3.3
Routine prenatal examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X205 2,205 3.1
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 1,822 2.6
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D510 1,739 2.5
Head cold, upper respiratory infection (coryza) . . . . . . . . . . . . . . . . . . . . . . . . S445 1,465 2.1
Blood pressure test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X320 1,438 2.0
Headache, pain in head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S210 1,341 1.9
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . S545 1,303 1.8
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49,175 69.5
1Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).
NOTE: Numbers may not add to totals because of rounding.
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Table 10. Annual number and percent distribution of office visits by patient’s principal reason for visit, according to physician specialty, averag ed over a 2-year period:
United States, 1995–96























diseases Urology Neurology All other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Symptom module . . . . . . . . . S001–S999 387,578 105,616 56,525 57,876 12,053 16,575 25,085 20,085 12,919 8,226 13,546 6,415 6,960 6,441 39,256
General symptoms . . . . . . . S001–S099 46,837 12,763 9,019 10,104 1,424 360 966 471 384 838 860 2,926 406 529 5,786
Symptoms referable to psychological/
mental disorders . . . . . . . .S100–S199 20,799 3,995 2,340 763 * * * * 11,617 * * * 590 336 652
Symptoms referable to the
nervous system (excluding
sense organs) . . . . . . . . . S200–S259 19,789 6,430 4,378 1,036 * 244 537 * 278 145 967 445 * 3,349 1,823
Symptoms referable to the
cardiovascular/lymphatic
system . . . . . . . . . . . . . .S260–S299 3,633 996 767 * * * – 249 * * * 770 * * *
Symptoms referable to the
eyes and ears . . . . . . . . . S300–S399 44,245 7,360 2,661 10,572 – 15,688 – * * 216 5,895 * – 200 1,440
Symptoms referable to the
respiratory system . . . . . . S400–S499 81,045 29,409 13,994 23,061 * * * 232 * 562 4,806 1,122 * * 7,475
Symptoms referable to the
digestive system . . . . . . . S500–S639 31,839 9,960 6,312 4,619 967 – * * * 1,844 382 210 194 * 6,921
Symptoms referable to the
genitourinary system . . . . . S640–S829 27,808 5,910 2,884 986 8,648 – * * * 1,648 – * 5,520 * 1,847
Symptoms referable to the
skin, hair, and nails . . . . . . S830–S899 38,560 8,131 3,286 4,333 * * 316 18,079 * 1,375 247 * * * 2,029
Symptoms referable to the
musculoskeletal system . . . S900–S999 73,022 20,662 10,884 2,028 * * 23,183 565 253 1,408 277 588 * 1,765 11,020
Disease module . . . . . . . . . . D001–D999 76,944 18,635 16,375 4,860 2,230 7,245 941 4,202 2,433 3,996 1,400 2,224 2,575 1,031 8,797
Diagnostic/screening and preventive
module . . . . . . . . . . . . . . X100–X599 125,632 30,090 15,167 22,424 37,380 7,446 266 1,124 * 1,305 273 1,792 1,398 196 6,580
Treatment module . . . . . . . . . T100–T899 75,339 11,895 9,329 4,011 4,970 6,935 6,165 2,596 3,852 4,041 2,527 3,119 1,885 479 13,534
Injuries and adverse effects
module . . . . . . . . . . . . . . . . J001–J999 20,850 6,617 2,140 2,021 * 820 5,324 474 * 477 383 * * 131 2,154
Test results module . . . . . . . . R100–R700 10,646 2,767 1,899 * 2,193 * * * * 451 * 519 559 * 1,428
Administrative module . . . . . . A100–A140 7,121 4,360 1,041 883 * * * – * * * * * * *
Other2 . . . . . . . . . . . . . . . . U990–U999 11,677 3,244 1,954 661 597 1,384 287 405 656 176 92 532 349 120 1,219
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Symptom module . . . . . . . . . S001–S999 54.1 57.6 54.1 62.3 20.3 40.7 65.6 69.3 63.7 43.8 73.8 43.6 50.5 75.9 53.5
General symptoms . . . . . . . S001–S099 6.5 7.0 8.6 10.9 2.4 0.9 2.5 1.6 1.9 4.5 4.7 19.9 2.9 6.2 7.9
Symptoms referable to psychological/
mental disorders . . . . . . . S100–S199 2.9 2.2 2.2 0.8 * * * * 57.3 * * * 4.3 4.0 0.9
Symptoms referable to the
nervous system (excluding
sense organs) . . . . . . . . . S200–S259 2.8 3.5 4.2 1.1 * 0.6 1.4 * 1.4 0.8 5.3 3.0 * 39.5 2.5
Symptoms referable to the
cardiovascular/lymphatic
system . . . . . . . . . . . . . S260–S299 0.5 0.5 0.7 * * * – 0.9 * * * 5.2 * * *
Symptoms referable to the
eyes and ears . . . . . . . . . S300–S399 6.2 4.0 2.5 11.4 – 38.5 – * * 1.1 32.1 * – 2.4 2.0
Symptoms referable to the
respiratory system . . . . . . S400–S499 11.3 16.1 13.4 24.8 * * * 0.8 * 3.0 26.2 7.6 * * 10.2
Symptoms referable to the











Table 10. Annual number and percent distribution of office visits by patient’s principal reason for visit, according to physician specialty, averag ed over a 2-year period:
United States, 1995–96—Con.























diseases Urology Neurology All other
Symptoms referable to the
genitourinary system . . . . . S640–S829 3.9 3.2 2.8 1.1 14.5 – * * * 8.8 – * 40.1 * 2.5
Symptoms referable to the
skin, hair, and nails . . . . . . S830–S899 5.4 4.4 3.1 4.7 * * 0.8 62.4 * 7.3 1.3 * * * 2.8
Symptoms referable to the
musculoskeletal system . . . S900–S999 10.2 11.3 10.4 2.2 * * 60.6 2.0 1.2 7.5 1.5 4.0 * 20.8 15.0
Disease module . . . . . . . . . . D001–D999 10.7 10.2 15.7 5.2 3.7 17.8 2.5 14.5 12.0 21.3 7.6 15.1 18.7 12.2 12.0
Diagnostic/screening and preventive
module . . . . . . . . . . . . . . X100–X599 17.6 16.4 14.5 24.1 62.8 18.3 0.7 3.9 * 7.0 1.5 12.2 10.1 2.3 9.0
Treatment module . . . . . . . . . T100–T899 10.5 6.5 8.9 4.3 8.4 17.0 16.1 9.0 19.0 21.5 13.8 21.2 13.7 5.6 18.4
Injuries and adverse effects
module . . . . . . . . . . . . . . . J001–J999 2.9 3.6 2.0 2.2 * 2.0 13.9 1.6 * 2.5 2.1 * * 1.5 2.9
Test results module . . . . . . . . R100–R700 1.5 1.5 1.8 * 3.7 * * * * 2.4 * 3.5 4.1 * 1.9
Administrative module . . . . . . A100–A140 1.0 2.4 1.0 1.0 * * * – * * * * * * *
Other2 . . . . . . . . . . . . . . . . U990–U999 1.6 1.8 1.9 0.7 1.0 3.4 0.8 1.4 3.2 0.9 0.5 3.6 2.5 1.4 1.7
– Quantity zero.
* Figure does not meet standard of reliability or precision.
1Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).
2Includes problems and complaints not elsewhere classified, entries of ‘‘none,’’ blanks, and illegible entries.











Table 11. Annual number and percent distribution of office visits by physician specialty, according to patient’s principal reason for visit, averag ed over a 2-year period:
United States, 1995–96
























diseases Urology Neurology All other
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . 715,788 100.0 25.6 14.6 13.0 8.3 5.7 5.3 4.0 2.8 2.6 2.6 2.1 1.9 1.2 10.3
Symptom module . . . . . . S001–S999 387,578 100.0 27.3 14.6 14.9 3.1 4.3 6.5 5.2 3.3 2.1 3.5 1.7 1.8 1.7 10.1
General symptoms . . . . S001–S099 46,837 100.0 27.3 19.3 21.6 3.0 0.8 2.1 1.0 0.8 1.8 1.8 6.2 0.9 1.1 12.4
Symptoms referable to
psychological/mental
disorders . . . . . . . . . S100–S199 20,799 100.0 19.2 11.3 3.7 * * * * 55.9 * * * 2.8 1.6 3.1
Symptoms referable to the nervous
system (excluding sense
organs) . . . . . . . . . . S200–S259 19,789 100.0 32.5 22.1 5.2 * 1.2 2.7 * 1.4 0.7 4.9 2.2 * 16.9 9.2
Symptoms referable to the
cardiovascular/lymphatic
system . . . . . . . . . . S260–S299 3,633 100.0 27.4 21.1 * * * – 6.9 * 2.0 * 21.2 * * *
Symptoms referable to the
eyes and ears . . . . . S300–S399 44,245 100.0 16.6 6.0 23.9 – 35.5 – * * 0.5 13.3 * – 0.5 3.3
Symptoms referable to
the respiratory
system . . . . . . . . . . S400–S499 81,045 100.0 36.3 17.3 28.5 * * * 0.3 * 0.7 5.9 1.4 * * 9.2
Symptoms referable to the
digestive system . . . . S500–S639 31,839 100.0 31.3 19.8 14.5 3.0 – * * * 5.8 1.2 0.7 0.6 * 21.7
Symptoms referable to
the genitourinary
system . . . . . . . . . . S640–S829 27,808 100.0 21.3 10.4 3.5 31.1 – * * * 5.9 – * 19.8 * 6.6
Symptoms referable to
the skin, hair, and
nails . . . . . . . . . . . . S830–S899 38,560 100.0 21.1 8.5 11.2 * * 0.8 46.9 * 3.6 0.6 * * * 5.3
Symptoms referable to
the musculoskeletal
system . . . . . . . . . . S900–S999 73,022 100.0 28.3 14.9 2.8 * * 31.7 0.8 0.3 1.9 0.4 0.8 * 2.4 15.1
Disease module . . . . . . D001–D999 76,944 100.0 24.2 21.3 6.3 2.9 9.4 1.2 5.5 3.2 5.2 1.8 2.9 3.3 1.3 11.4
Diagnostic/screening and
preventive module . . . . . X100–X599 125,632 100.0 24.0 12.1 17.8 29.8 5.9 0.2 0.9 * 1.0 0.2 1.4 1.1 0.2 5.2
Treatment module . . . . . . T100–T899 75,339 100.0 15.8 12.4 5.3 6.6 9.2 8.2 3.4 5.1 5.4 3.4 4.1 2.5 0.6 18.0
Injuries and adverse effects
module . . . . . . . . . . . . J001–J999 20,850 100.0 31.7 10.3 9.7 * 3.9 25.5 2.3 * 2.3 1.8 * * 0.6 10.3
Test results module . . . . R100–R700 10,646 100.0 26.0 17.8 * 20.6 * * * * 4.2 * 4.9 5.3 * 13.4
Administrative module . . . A100–A140 7,121 100.0 61.2 14.6 12.4 * * * – * * * * * * *
Other2 . . . . . . . . . . . . U990–U999 11,677 100.0 27.8 16.7 5.7 5.1 11.9 2.5 3.5 5.6 1.5 0.8 4.6 3.0 1.0 10.4
* Figure does not meet standard of reliability or precision.
– Quantity zero.
1Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).
2Includes problems and complaints not elsewhere classified, entries of ‘‘none,’’ blanks, and illegible entries.











Table 12. Annual number and percent distribution of office visits for the 25 morbidity-related principal reasons for visit most frequently mentione d by patients, by physician
specialty, averaged over a 2-year period: United States, 1995–96





























All visits . . . . . . . . . . . . . . . . . . . 715,788 100.0 25.6 14.6 13.0 8.3 5.7 5.3 4.0 2.8 2.6 2.6 2.1 1.9 1.2 10.3
Cough . . . . . . . . . . . . . . . . S440 24,215 100.0 38.3 18.8 34.1 * – – – * * 1.0 * – * 6.2
Symptoms referable to throat . . S455 17,234 100.0 45.7 13.1 30.7 * – – – – 0.9 5.4 * – * 3.9
Back symptoms . . . . . . . . . . S905 12,206 100.0 40.9 18.8 * * – 16.9 * * 1.8 – * * 2.0 15.5
Earache or ear infection . . . . . S355 12,176 100.0 31.0 5.3 41.6 – * – – – * 16.4 * – * *
Stomach and abdominal pain,
cramps, and spasms . . . . . . S545 12,031 100.0 31.7 23.1 7.7 5.8 – * – * 7.7 – * * * 21.5
Fever . . . . . . . . . . . . . . . . S010 11,690 100.0 24.8 8.5 63.2 * – – – – * * * * – *
Skin rash . . . . . . . . . . . . . . S860 11,119 100.0 28.3 11.6 26.0 * * – 27.7 – * * * * * 4.6
Vision dysfunctions . . . . . . . . S305 10,477 100.0 * * * – 91.6 – – – – * * – 1.4 0.9
Nasal congestion . . . . . . . . . S400 10,282 100.0 22.8 9.4 38.3 – – – * * * 12.9 * – – 15.9
Knee symptoms . . . . . . . . . . S925 9,639 100.0 20.7 9.9 * – – 59.1 * * * – * – * 6.7
Hypertension . . . . . . . . . . . . D510 9,494 100.0 37.8 44.3 * * – – – * 1.3 – 5.2 * * 10.6
Headache, pain in head . . . . . S210 8,876 100.0 38.6 21.1 9.3 0.5 2.5 * * * * 3.7 * – * 7.6
Depression . . . . . . . . . . . . . S110 8,590 100.0 15.2 10.6 * * – – – 67.6 * * * – * 2.2
Head cold, upper respiratory
infection (coryza) . . . . . . . . . S445 8,505 100.0 38.1 21.5 32.2 * – – – * * * * – * 6.0
Chest pain and related
symptoms (not referable to a
specific body system) . . . . . . S050 8,212 100.0 28.4 31.7 * – – * – * * * 25.8 – * 8.8
Neck symptoms . . . . . . . . . . S900 6,973 100.0 31.3 15.3 * * – 14.0 * * * 3.8 * – 7.9 19.8
Shoulder symptoms . . . . . . . . S940 6,864 100.0 28.3 13.4 * * – 43.9 * * * – * * * 9.5
Diabetes mellitus . . . . . . . . . D205 6,258 100.0 42.2 41.6 * – 6.4 – – – * – * * – *
Leg symptoms . . . . . . . . . . . S920 6,243 100.0 27.7 19.7 * – * 14.4 * * 5.6 * 2.9 – 4.3 19.7
Low back symptoms . . . . . . . S910 6,009 100.0 30.6 13.1 – * – 18.0 – * * – * * 3.2 32.0
Skin lesion . . . . . . . . . . . . . S865 5,697 100.0 26.2 12.0 * * * * 29.9 – 10.2 * * * * 8.0
Other and unspecified
symptoms referable to
the ears . . . . . . . . . . . . . . S365 5,471 100.0 15.3 * 58.2 – – – * – * 14.3 – – * *
Vertigo-dizziness . . . . . . . . . S225 5,390 100.0 35.3 29.7 * * * * – * * 10.1 5.8 – 6.3 8.0
Sinus problems . . . . . . . . . . S410 5,269 100.0 48.8 15.3 * * – – * – * 15.4 * – * 8.0
Foot and toe symptoms . . . . . S935 5,186 100.0 31.5 17.0 * * – 30.5 * – 2.7 – * – * 9.3
All other reasons . . . . . . . . . . . . . 437,107 100.0 24.3 13.6 11.0 12.7 5.7 4.1 5.1 3.0 2.7 2.1 1.9 2.8 1.1 10.0
* Figure does not meet standard of reliability or precision.
– Quantity zero.
1Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).











Table 13. Annual number and percent distribution of office visits by physician specialty and the 10 principal reasons for visit most
frequently mentioned by patients, averaged over a 2-year period: United States, 1995–96







All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 48,992 6.8
Progress visit, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 25,019 3.5
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 24,215 3.4
Routine prenatal examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X205 20,839 2.9
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 19,556 2.7
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 17,234 2.4
Well baby examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X105 13,715 1.9
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 12,206 1.7
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 12,176 1.7
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S545 12,031 1.7
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 509,805 71.2
General and family practice
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183,225 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 11,087 6.1
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 9,274 5.1
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 7,879 4.3
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 4,990 2.7
Blood pressure test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X320 4,110 2.2
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S545 3,816 2.1
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 3,778 2.1
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D510 3,588 2.0
Physical examination required for employment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A100 3,472 1.9
Headache, pain in head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S210 3,427 1.9
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127,803 69.8
Internal medicine
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104,431 100.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 9,574 9.2
Progress visit, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 5,477 5.2
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 4,545 4.4
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D510 4,209 4.0
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S545 2,777 2.7
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D205 2,603 2.5
Chest pain and related symptoms (not referable to body system) . . . . . . . . . . . . . . . . . . . . . . . . . S050 2,600 2.5
Blood pressure test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X320 2,390 2.3
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 2,298 2.2
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 2,262 2.2
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65,695 62.9
Pediatrics
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92,888 100.0
Well baby examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X105 11,175 12.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 9,408 10.1
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 8,254 8.9
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S010 7,386 8.0
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 5,286 5.7
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 5,060 5.4
Nasal congestion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S400 3,938 4.2
Other symptoms referable to ears, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . S365 3,185 3.4
Skin rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S860 2,888 3.1
Head cold, upper respiratory infection (coryza) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S445 2,738 2.9
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33,570 36.1
See footnotes at end of table.
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All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59,515 100.0
Routine prenatal examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X205 18,412 30.9
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 10,405 17.5
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X225 3,034 5.1
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 2,077 3.5
For cytology findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R300 1,862 3.1
Pap smear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X365 1,516 2.5
Postpartum examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X215 1,464 2.5
Pelvic symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S775 1,069 1.8
Family planning, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X500 936 1.6
Uterine and vaginal bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S755 831 1.4
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,908 30.1
Ophthalmology
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40,714 100.0
Vision dysfunctions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S305 9,600 23.6
Eye examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X230 3,414 8.4
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 3,115 7.7
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D410 2,881 7.1
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 2,227 5.5
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D415 2,227 5.5
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 2,197 5.4
Abnormal sensations of the eye . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S320 2,167 5.3
Other and unspecified diagnostic tests (including glaucoma test) . . . . . . . . . . . . . . . . . . . . . . . . . X370 1,721 4.2
Abnormal appearance of eyes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S330 1,073 2.6
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,092 24.8
Orthopedic surgery
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38,267 100.0
Knee symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S925 5,701 14.9
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 3,403 8.9
Shoulder symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S940 3,011 7.9
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 2,060 5.4
Hand and finger symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S960 2,039 5.3
Foot and toe symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S935 1,580 4.1
Wrist symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S955 1,566 4.1
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 1,472 3.8
Hip symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S915 1,248 3.3
Ankle symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S930 1,195 3.1
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,992 39.2
Dermatology
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28,969 100.0
Acne or pimples . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S830 4,040 13.9
Skin rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S860 3,076 10.6
Discoloration or pigmentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S835 1,889 6.5
Skin lesion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S865 1,703 5.9
Other symptoms referable to skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S880 1,406 4.9
Cancer, skin and subcutaneous tissues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D110 1,264 4.4
Warts, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S850 1,239 4.3
Symptoms of skin moles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S845 1,213 4.2
Other growths of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S855 1,084 3.7
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 967 3.3
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,086 38.3
See footnotes at end of table.
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All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,287 100.0
Depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S110 5,805 28.6
Anxiety and nervousness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S100 2,160 10.6
Drug dependence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D321 1,683 8.3
Other symptoms relating to psychological and 1,377 6.8
mental disorders, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S165 1,077 5.3
Medication, other and unspecified kinds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T115 815 4.0
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 558 2.8
Behavioral disturbances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S130 509 2.5
Marital problems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T705 370 1.8
Functional psychoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D305 329 1.6
Delusions or hallucinations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S155 315 1.6
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,288 26.1
General surgery
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18,762 100.0
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 2,713 14.5
Hernia of abdominal cavity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D660 973 5.2
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S545 931 5.0
Lump or mass of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S805 925 4.9
Skin lesion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S865 580 3.1
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 459 2.4
Cancer, breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D115 430 2.3
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 425 2.3
Leg symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S920 348 1.9
Symptoms referable to anus-rectum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S605 346 1.8
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,633 56.7
Otolaryngology
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18,346 100.0
Earache or ear infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S355 1,997 10.9
Hearing dysfunctions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S345 1,418 7.7
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 1,373 7.5
Nasal congestion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S400 1,327 7.2
Plugged feeling in ear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S360 1,194 6.5
Symptoms referable to throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S455 938 5.1
Sinus problems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S410 813 4.4
Other symptoms referable to ears, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . S365 783 4.3
Vertigo-dizziness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S225 544 3.0
Allergy, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S090 473 2.6
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,486 40.8
Cardiovascular diseases
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,705 100.0
Chest pain and related symptoms (not referable to specific body system) . . . . . . . . . . . . . . . . . . . S050 2,121 14.4
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 2,109 14.3
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D515 769 5.2
Abnormal pulsations and palpitations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S260 727 4.9
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 723 4.9
Shortness of breath . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S415 680 4.6
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 543 3.7
Other heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D520 500 3.4
Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D510 489 3.3
For other and unspecified test results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R700 329 2.2
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,716 38.9
See footnotes at end of table.
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Table 13. Annual number and percent distribution of office visits by physician specialty and the 10 principal reasons for visit most
frequently mentioned by patients, averaged over a 2-year period: United States, 1995–96—Con.







All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,780 100.0
Other urinary dysfunctions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S660 1,037 7.5
Cancer, urinary and male genital tract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D125 872 6.3
Frequency and urgency of urination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S645 822 6.0
Incontinence of urine (enuresis) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S655 730 5.3
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 692 5.0
Urinary tract disease, except cystitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D705 630 4.6
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 615 4.5
Abnormalities of urine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S640 600 4.4
Psychosexual disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S160 585 4.2
Diseases of the male genital organs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D710 551 4.0
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,646 48.2
Neurology
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,481 100.0
Headache, pain in head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S210 1,239 14.6
Convulsions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S205 687 8.1
Neck symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S900 552 6.5
Disturbances of sensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S220 476 5.6
Progress visit, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 375 4.4
Vertigo-dizziness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S225 342 4.0
Abnormal involuntary movements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S200 316 3.7
Leg symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S920 268 3.2
Migraine headache . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D365 265 3.1
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 245 2.9
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,715 43.8
All other specialties
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73,417 100.0
Progress visit, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .T800 4,865 6.6
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D205 3,839 5.2
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 3,114 4.2
Stomach and abdominal pain, cramps, and spasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S545 2,592 3.5
Low back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S910 1,920 2.6
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 1,887 2.6
Nasal congestion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S400 1,637 2.2
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S440 1,491 2.0
Neck symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S900 1,382 1.9
Leg symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S920 1,232 1.7
All other reasons . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49,457 67.4
1Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).
NOTE: Numbers may not add to totals because of rounding.
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Table 14. Annual number and percent distribution of office visits by principal diagnosis, according to patient’s age, sex, and race, averaged over a 2 -year period: United States,
1995–96













and over Female Male White Black Other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
Infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . 001–139 23,320 10,364 2,331 5,773 2,738 1,394 721 13,330 9,990 19,313 3,062 945
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140–239 24,434 845 851 3,313 7,900 5,939 5,586 12,986 11,448 22,042 1,624 767
Endocrine, nutritional and metabolic diseases, and immunity disorders . . 240–279 28,503 670 864 5,454 10,819 6,547 4,149 17,224 11,280 23,211 4,128 1,164
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290–319 31,732 2,634 2,339 12,965 9,669 2,457 1,669 17,531 14,202 28,573 2,375 784
Diseases of the nervous system and sense organs . . . . . . . . . . . . . . 320–389 71,171 22,261 2,766 11,448 12,339 10,572 11,784 40,130 31,041 63,907 5,070 2,193
Diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . 390–459 54,683 427 394 6,072 17,455 14,531 15,805 29,080 25,603 45,909 6,838 1,936
Diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . 460–519 96,946 36,312 8,607 21,830 15,998 8,246 5,951 53,854 43,092 83,574 8,790 4,582
Diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . . 520–579 27,471 3,446 1,386 7,267 7,589 4,383 3,399 15,715 11,756 23,067 2,585 1,819
Diseases of the genitourinary system . . . . . . . . . . . . . . . . . . . . . . . 580–629 39,793 1,576 3,798 13,240 11,941 5,077 4,160 29,361 10,432 33,764 4,788 1,240
Diseases of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . 680–709 38,604 5,183 5,001 10,049 9,316 5,127 3,928 22,164 16,439 34,255 2,678 1,670
Diseases of the musculoskeletal system and connective tissue . . . . . . . 710–739 51,500 1,993 2,429 14,545 17,632 8,226 6,675 31,319 20,181 44,865 5,318 1,317
Symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . . 780–799 37,094 4,626 2,555 9,353 10,084 5,669 4,808 22,460 14,634 31,249 3,990 1,856
Injury and poisoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 800–999 49,576 8,290 6,350 16,245 11,525 3,688 3,477 24,324 25,252 42,102 5,489 1,985
Supplementary classification . . . . . . . . . . . . . . . . . . . . . . . . . . . . V01–V82 116,490 32,816 15,437 38,120 15,346 7,752 7,020 80,411 36,079 100,774 11,311 4,405
All other diagnoses2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,202 1,943 930 2,513 1,051 548 1,217 5,582 2,620 7,026 948 *
Unknown3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,269 2,814 1,646 4,832 3,476 2,057 1,445 9,945 6,324 13,296 1,751 1,222
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . 001–139 3.3 7.6 4.0 3.2 1.7 1.5 0.9 3.1 3.4 3.1 4.3 3.4
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140–239 3.4 0.6 1.5 1.8 4.8 6.4 6.8 3.1 3.9 3.6 2.3 2.7
Endocrine, nutritional and metabolic diseases, and immunity disorders . . 240–279 4.0 0.5 1.5 3.0 6.6 7.1 5.1 4.0 3.9 3.8 5.8 4.1
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290–319 4.4 1.9 4.1 7.1 5.9 2.7 2.0 4.1 4.9 4.6 3.4 2.8
Diseases of the nervous system and sense organs . . . . . . . . . . . . . . 320–389 9.9 16.3 4.8 6.3 7.5 11.5 14.4 9.4 10.7 10.4 7.2 7.8
Diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . 390–459 7.6 0.3 0.7 3.3 10.6 15.8 19.3 6.8 8.8 7.4 9.7 6.9
Diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . 460–519 13.5 26.7 14.9 11.9 9.7 8.9 7.3 12.7 14.8 13.5 12.4 16.3
Diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . . 520–579 3.8 2.5 2.4 4.0 4.6 4.8 4.2 3.7 4.0 3.7 3.7 6.5
Diseases of the genitourinary system . . . . . . . . . . . . . . . . . . . . . . . 580–629 5.6 1.2 6.6 7.2 7.2 5.5 5.1 6.9 3.6 5.5 6.8 4.4
Diseases of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . 680–709 5.4 3.8 8.7 5.5 5.7 5.6 4.8 5.2 5.7 5.6 3.8 5.9
Diseases of the musculoskeletal system and connective tissue . . . . . . . 710–739 7.2 1.5 4.2 7.9 10.7 8.9 8.2 7.4 7.0 7.3 7.5 4.7
Symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . . 780–799 5.2 3.4 4.4 5.1 6.1 6.1 5.9 5.3 5.0 5.1 5.6 6.6
Injury and poisoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 800–999 6.9 6.1 11.0 8.9 7.0 4.0 4.3 5.7 8.7 6.8 7.8 7.1
Supplementary classification . . . . . . . . . . . . . . . . . . . . . . . . . . . . V01–V82 16.3 24.1 26.8 20.8 9.3 8.4 8.6 18.9 12.4 16.3 16.0 15.7
All other diagnoses2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.1 1.4 1.6 1.4 0.6 0.6 1.5 1.3 0.9 1.1 1.3 *
Unknown3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.3 2.1 2.9 2.6 2.1 2.2 1.8 2.3 2.2 2.2 2.5 4.3
* Figure does not meet standard of reliability or precison.
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2Includes diseases of the blood and blood-forming organs (280–289); complications of pregnancy, childbirth, and the puerperium (630–676); congenital anomalies (740–759); and certain conditions originating in the perinatal period (760–779).
3Includes blank diagnoses, uncodable diagnoses, and illegible diagnoses.











Table 15. Annual number and percent distribution of office visits by patient’s age, sex, and race, according to principal diagnosis, averaged over a 2 -year period: United States,
1995–96
















and over Female Male White Black Other
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 100.0 19.0 8.1 25.6 23.0 12.9 11.4 59.4 40.6 86.2 9.9 3.9
Infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . 001–139 23,320 100.0 44.4 10.0 24.8 11.7 6.0 3.1 57.2 42.8 82.8 13.1 4.1
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140–239 24,434 100.0 3.5 3.5 13.6 32.3 24.3 22.9 53.1 46.9 90.2 6.6 3.1
Endocrine, nutritional and metabolic diseases, and immunity disorders . . 240–279 28,503 100.0 2.4 3.0 19.1 38.0 23.0 14.6 60.4 39.6 81.4 14.5 4.1
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290–319 31,732 100.0 8.3 7.4 40.9 30.5 7.7 5.3 55.2 44.8 90.0 7.5 2.5
Diseases of the nervous system and sense organs . . . . . . . . . . . . . . 320–389 71,171 100.0 31.3 3.9 16.1 17.3 14.9 16.6 56.4 43.6 89.8 7.1 3.1
Diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . 390–459 54,683 100.0 0.8 0.7 11.1 31.9 26.6 28.9 53.2 46.8 84.0 12.5 3.5
Diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . 460–519 96,946 100.0 37.5 8.9 22.5 16.5 8.5 6.1 55.6 44.4 86.2 9.1 4.7
Diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . . 520–579 27,471 100.0 12.5 5.0 26.5 27.6 16.0 12.4 57.2 42.8 84.0 9.4 6.6
Diseases of the genitourinary system . . . . . . . . . . . . . . . . . . . . . . . 580–629 39,793 100.0 4.0 9.5 33.3 30.0 12.8 10.5 73.8 26.2 84.9 12.0 3.1
Diseases of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . 680–709 38,604 100.0 13.4 13.0 26.0 24.1 13.3 10.2 57.4 42.6 88.7 6.9 4.3
Diseases of the musculoskeletal system and connective tissue . . . . . . . 710–739 51,500 100.0 3.9 4.7 28.2 34.2 16.0 13.0 60.8 39.2 87.1 10.3 2.6
Symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . . 780–799 37,094 100.0 12.5 6.9 25.2 27.2 15.3 13.0 60.6 39.4 84.2 10.8 5.0
Injury and poisoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 800–999 49,576 100.0 16.7 12.8 32.8 23.2 7.4 7.0 49.1 50.9 84.9 11.1 4.0
Supplementary classification . . . . . . . . . . . . . . . . . . . . . . . . . . . . V01–V82 116,490 100.0 28.2 13.3 32.7 13.2 6.7 6.0 69.0 31.0 86.5 9.7 3.8
All other diagnoses2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,202 100.0 23.7 11.3 30.6 12.8 6.7 14.8 68.1 31.9 85.7 11.6 *
Unknown3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,269 100.0 17.3 10.1 29.7 21.4 12.6 8.9 61.1 38.9 81.7 10.8 7.5
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2Includes diseases of the blood and blood-forming organs (280–289); complications of pregnancy, childbirth, and the puerperium (630–676); congenital anomalies (740–759); and certain conditions originating in the perinatal period (760–779).
3Includes blank diagnoses, uncodable diagnoses, and illegible diagnoses.











Table 16. Annual number and percent distribution of office visits by principal diagnosis group, according to patient’s sex, averaged over a










duration in minutes2Total Female Male
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 100.0 100.0 100.0 19.2 0.2
Infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23,320 3.3 3.1 3.4 15.5 0.4
Streptococcal sore throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,553 0.4 0.3 0.4 15.2 0.8
HIV infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 626 0.1 * 0.2 24.3 2.5
Viral warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,426 0.5 0.5 0.5 14.8 0.6
Unspecified viral and chlamydial infections . . . . . . . . . . . . . . . . . . . . . . . . 3,357 0.5 0.5 0.4 13.6 0.5
Dermatophytosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,101 0.3 0.3 0.3 13.4 0.9
Candidiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,770 0.2 0.3 0.1 15.5 1.0
Other infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . 9,486 1.3 1.3 1.4 16.4 0.6
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24,434 3.4 3.1 3.9 22.5 1.0
Malignant neoplasm of colon and rectum . . . . . . . . . . . . . . . . . . . . . . . . . 1,796 0.3 0.2 0.3 29.8 6.5
Malignant neoplasm of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,301 0.5 0.4 0.6 23.0 1.8
Malignant neoplasm of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,252 0.5 0.8 * 21.7 1.6
Malignant neoplasm of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,309 0.3 . . . 0.8 17.6 0.8
Malignant neoplasm of lymphatic and hematopoietic tissue . . . . . . . . . . . . . . 2,782 0.4 0.3 0.6 24.8 1.9
Other malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,409 0.6 0.5 0.8 24.2 2.3
Benign neoplasm of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,327 0.3 0.4 0.3 19.7 1.2
Other benign neoplasm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,777 0.4 0.5 0.3 21.6 1.1
Neoplasm of uncertain behavior and unspecified nature . . . . . . . . . . . . . . . . 1,480 0.2 0.1 0.3 20.4 1.3
Endocrine, nutritional and metabolic diseases, and immunity disorders . . . . . . . . 28,503 4.0 4.0 3.9 20.2 0.9
Acquired hypothyroidism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,247 0.3 0.4 0.2 18.8 1.3
Other disorders of the thyroid gland . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,518 0.2 0.3 0.1 19.1 0.9
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,593 2.0 1.9 2.2 20.2 1.4
Disorders of lipoid metabolism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,067 0.6 0.5 0.7 21.2 1.6
Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,696 0.4 0.5 0.2 20.1 1.0
Other endocrine, nutritional and metabolic diseases, and immunity disorders . . . 3,383 0.5 0.5 0.5 20.8 1.2
Diseases of the blood and blood-forming organs . . . . . . . . . . . . . . . . . . . . . . 3,392 0.5 0.5 0.4 20.3 2.6
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,289 0.3 0.4 0.3 21.3 3.8
Other diseases of the blood and blood-forming organs . . . . . . . . . . . . . . . . . 1,102 0.2 0.2 0.1 18.2 1.7
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31,514 4.4 4.1 4.9 32.5 0.9
Schizophrenic disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,627 0.2 0.2 0.3 28.7 2.2
Major depressive disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,931 0.7 0.8 0.5 36.1 2.2
Other psychoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,696 0.4 0.4 0.4 32.2 1.5
Anxiety states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,945 0.6 0.6 0.5 28.6 1.7
Neurotic depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,610 0.4 0.4 0.3 41.1 1.7
Alcohol dependence syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . * * * * * *
Drug dependence and nondependent use of drugs . . . . . . . . . . . . . . . . . . . 2,875 0.4 0.2 0.7 27.8 3.1
Acute reaction to stress and adjustment reaction . . . . . . . . . . . . . . . . . . . . 1,714 0.2 0.3 0.2 39.0 2.1
Depressive disorder, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . 4,780 0.7 0.7 0.6 29.3 1.3
Attention deficit disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,549 0.4 0.1 0.7 27.1 1.5
Other mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,787 0.5 0.4 0.7 33.0 1.9
Diseases of the nervous system and sense organs . . . . . . . . . . . . . . . . . . . . 71,171 9.9 9.4 10.7 20.5 0.6
Migraine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,885 0.4 0.5 0.2 22.8 1.5
Other disorders of the central nervous system . . . . . . . . . . . . . . . . . . . . . . 3,094 0.4 0.4 0.5 22.0 0.9
Carpal tunnel syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,088 0.3 0.4 0.2 21.1 1.1
Other disorders of the nervous system . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,055 0.3 0.3 0.3 23.4 1.2
Retinal detachment and other retinal disorders . . . . . . . . . . . . . . . . . . . . . . 2,744 0.4 0.4 0.3 34.9 4.4
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,253 0.9 0.8 0.9 22.0 1.8
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,034 1.0 1.1 0.8 26.5 2.4
Disorders of refraction and accommodation . . . . . . . . . . . . . . . . . . . . . . . . 4,499 0.6 0.6 0.7 28.1 2.4
Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,774 0.5 0.5 0.5 14.5 0.5
Disorders of eyelids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,072 0.3 0.3 0.3 22.9 1.7
Other disorders of the eye and adnexa . . . . . . . . . . . . . . . . . . . . . . . . . . 6,995 1.0 0.9 1.0 23.3 1.4
Disorders of external ear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,794 0.5 0.5 0.6 15.0 0.6
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . 19,626 2.7 2.2 3.5 13.9 0.4
Other diseases of the ear and mastoid process . . . . . . . . . . . . . . . . . . . . . 4,258 0.6 0.5 0.7 19.9 0.8
See footnotes at end of table.
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Table 16. Annual number and percent distribution of office visits by principal diagnosis group, according to patient’s sex, averaged over a










duration in minutes2Total Female Male
Diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54,683 7.6 6.8 8.8 19.8 0.4
Angina pectoris . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,917 0.3 0.2 0.4 20.4 1.0
Coronary atherosclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,440 0.6 0.5 0.8 21.8 1.1
Other ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,722 0.5 0.3 0.8 22.1 1.5
Cardiac dysrhythmias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,335 0.5 0.4 0.5 22.2 0.8
Congestive heart failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,958 0.4 0.4 0.5 19.1 0.9
Other heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,536 0.5 0.5 0.5 23.4 1.0
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25,129 3.5 3.3 3.8 17.8 0.4
Cerebrovascular disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,350 0.3 0.3 0.4 22.6 1.2
Diseases of the arteries, arterioles, and capillaries . . . . . . . . . . . . . . . . . . . 2,381 0.3 0.3 0.4 21.7 1.1
Hemorrhoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,422 0.2 0.1 0.3 20.2 1.2
Other diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . . 3,493 0.5 0.5 0.5 20.5 1.3
Diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96,946 12.2 12.2 14.4 15.4 0.3
Acute sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,640 0.2 0.3 0.2 15.3 1.3
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,838 1.4 1.3 1.5 14.6 0.6
Acute tonsillitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,422 0.3 0.3 0.4 15.0 1.0
Acute bronchitis and bronchiolitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,059 0.4 0.4 0.4 16.3 1.0
Other acute respiratory infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22,330 3.1 2.9 3.5 13.4 0.4
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,097 1.8 1.9 1.7 15.6 0.4
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,209 1.1 1.1 1.3 16.6 1.1
Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,039 0.4 0.4 0.5 18.1 1.1
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,873 1.5 1.3 1.8 15.2 0.4
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,039 1.3 1.4 1.1 18.1 0.6
Other chronic obstructive pulmonary disease and allied conditions . . . . . . . . . 4,123 0.6 0.4 0.8 18.1 0.7
Other diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . . 9,278 1.3 1.1 1.6 16.1 0.6
Diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27,471 3.8 3.7 4.0 19.1 0.5
Diseases of the teeth and supporting structures . . . . . . . . . . . . . . . . . . . . . 1,110 0.2 0.2 0.1 16.2 1.5
Gastritis and duodenitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,278 0.3 0.3 0.3 19.2 1.5
Esophagitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,006 0.1 0.1 0.1 19.8 1.8
Ulcer of stomach and small intestine . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,540 0.2 0.2 0.2 21.2 1.5
Hernia of abdominal cavity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,718 0.4 0.2 0.6 15.7 0.6
Noninfectious enteritis and colitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,755 0.7 0.7 0.7 19.1 1.5
Diverticula of intestine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,290 0.2 0.2 0.2 19.3 1.6
Constipation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,223 0.2 0.2 0.2 18.7 1.5
Irritable colon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,416 0.2 0.3 * 20.4 1.4
Anal and rectal diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,737 0.2 0.2 0.3 20.6 1.2
Disorders of the gallbladder and biliary tract . . . . . . . . . . . . . . . . . . . . . . . 1,836 0.3 0.3 0.2 18.5 1.2
Gastrointestinal hemorrhage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 433 0.1 * * 24.5 2.8
Other diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . . . 6,128 0.9 0.8 0.9 19.5 0.7
Diseases of the genitourinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39,793 5.6 6.9 3.6 19.6 0.5
Calculus of kidney and ureter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 911 0.1 0.1 0.2 19.0 1.2
Cystitis and other disorders of the bladder . . . . . . . . . . . . . . . . . . . . . . . . 1,880 0.3 0.3 0.2 17.3 1.1
Urinary tract infection, site not specified . . . . . . . . . . . . . . . . . . . . . . . . . . 4,922 0.7 0.9 0.4 16.2 0.7
Other diseases of the urinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,691 0.5 0.4 0.7 18.8 0.6
Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,040 0.4 . . . 1.0 17.2 0.8
Other disorders of male genital organs . . . . . . . . . . . . . . . . . . . . . . . . . . 3,256 0.5 . . . 1.1 18.0 1.1
Disorders of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,595 0.6 1.0 * 20.6 0.8
Inflammatory disorders of female pelvic organs . . . . . . . . . . . . . . . . . . . . . 3,200 0.4 0.8 . . . 20.3 1.0
Noninflammatory disorders of female genital organs . . . . . . . . . . . . . . . . . . 2,172 0.3 0.5 . . . 20.4 1.1
Disorders of menstruation and abnormal bleeding . . . . . . . . . . . . . . . . . . . . 3,514 0.5 0.8 . . . 22.9 2.1
Menopausal and postmenopausal disorders . . . . . . . . . . . . . . . . . . . . . . . 4,336 0.6 1.0 . . . 21.5 1.7
Other disorders of the female genital tract . . . . . . . . . . . . . . . . . . . . . . . . 4,276 0.6 1.0 . . . 21.4 0.9
Complications of pregnancy, childbirth, and the puerperium . . . . . . . . . . . . . . . 1,888 0.3 0.4 . . . 19.9 1.4
See footnotes at end of table.
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duration in minutes2Total Female Male
Diseases of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . . . . . . 38,604 5.4 5.2 5.7 15.4 0.5
Cellulitis and abscess . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,913 0.4 0.4 0.4 18.0 2.1
Other infection of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . 1,902 0.3 0.2 0.3 15.0 0.9
Contact dermatitis and other eczema . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,895 1.0 0.9 1.1 13.3 0.4
Psoriasis and similar disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,812 0.3 0.2 0.3 14.3 0.9
Other inflammatory conditions of skin and subcutaneous tissue . . . . . . . . . . . 4,334 0.6 0.7 0.5 15.8 1.2
Corns, callosities and other hypertrophic and atrophic skin conditions . . . . . . . 2,041 0.3 0.3 0.2 20.8 2.6
Actinic and seborrheic keratosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,288 0.6 0.5 0.8 14.3 0.7
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,085 0.7 0.8 0.6 13.3 0.7
Sebaceous cyst . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,901 0.4 0.3 0.5 16.9 0.7
Urticaria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 789 0.1 0.1 * 23.6 3.4
Other disorders of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . 5,644 0.8 0.8 0.8 15.8 0.5
Diseases of the musculoskeletal system and connective tissue . . . . . . . . . . . . . 51,500 7.2 7.4 7.0 20.3 0.5
Rheumatoid arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,578 0.2 0.3 0.2 22.8 3.3
Osteoarthrosis and allied disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,212 0.9 0.9 0.8 19.1 0.5
Other arthropathies and related disorders . . . . . . . . . . . . . . . . . . . . . . . . . 4,401 0.6 0.7 0.5 19.7 1.1
Derangements and other and unspecified joint disorders . . . . . . . . . . . . . . . 5,341 0.7 0.7 0.8 18.9 0.7
Intervertebral disc disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,291 0.6 0.4 0.9 21.3 1.1
Lumbago . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,526 0.4 0.3 0.4 24.6 2.3
Other dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,033 1.1 1.1 1.2 21.4 0.8
Peripheral enthesopathies and allied disorders . . . . . . . . . . . . . . . . . . . . . . 5,373 0.8 0.7 0.8 18.7 0.7
Synovitis and tenosynovitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,795 0.3 0.3 0.2 17.4 0.8
Myalgia and myositis, unspecified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,980 0.3 0.4 0.1 21.5 1.7
Other rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,592 0.8 0.9 0.6 19.4 0.8
Disorders of bone and cartilage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,389 0.3 0.4 0.3 20.9 1.3
Other diseases of the musculoskeletal system and connective tissue . . . . . . . . 1,988 0.3 0.3 0.2 21.7 1.7
Congenital anomalies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,521 0.4 0.3 0.4 24.9 2.7
Certain conditions originating in the perinatal period . . . . . . . . . . . . . . . . . . . . 402 0.1 * * 15.1 1.5
Symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . . . . . . . . 37,094 5.2 5.3 5.0 20.3 0.4
Syncope and collapse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 452 0.1 * * 24.8 2.8
Convulsions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,547 0.2 0.2 0.3 19.6 1.4
Dizziness and giddiness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,784 0.2 0.3 0.2 18.9 1.0
Pyrexia of unknown origin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 542 0.1 * * 15.6 1.4
Symptoms involving skin and other integumentary tissue . . . . . . . . . . . . . . . 2,869 0.4 0.5 0.3 16.3 0.8
Headache . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,899 0.4 0.4 0.4 21.7 1.1
Epistaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 584 0.1 * * 19.5 1.7
Abnormal heart sounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 733 0.1 0.1 0.1 24.0 1.9
Dyspnea and respiratory abnormalities . . . . . . . . . . . . . . . . . . . . . . . . . . 809 0.1 0.1 0.1 25.1 2.6
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 930 0.1 0.1 0.2 19.4 2.6
Chest pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,025 0.4 0.4 0.4 21.6 1.1
Symptoms involving urinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,938 0.3 0.2 0.3 18.8 0.9
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,748 0.5 0.6 0.4 21.4 1.2
Other symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . . . 15,231 2.1 2.3 1.9 20.4 0.6
Injury and poisoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49,576 6.9 5.7 8.7 19.2 0.6
Fracture of radius and ulna . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,868 0.3 0.2 0.3 20.2 1.5
Fracture of hand and fingers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,061 0.3 0.2 0.4 19.4 1.5
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,204 0.6 0.5 0.7 18.7 1.6
Other fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,566 0.4 0.3 0.5 20.8 1.7
Sprains and strains of wrist and hand . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,109 0.2 0.1 0.2 16.8 2.0
Sprains and strains of knee and leg . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,801 0.3 0.2 0.3 20.4 2.0
Sprains and strains of ankle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,261 0.2 0.1 0.2 14.9 1.4
Sprains and strains of neck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,622 0.5 0.5 0.5 24.7 1.8
Other sprains and strains of back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,131 0.7 0.6 0.9 20.4 1.1
Other sprains and strains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,923 0.5 0.4 0.7 17.4 0.8
Intracranial injury, excluding those with skull fracture . . . . . . . . . . . . . . . . . . 520 0.1 * * 24.6 3.1
Open wound of head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 776 0.1 * 0.2 21.6 2.1
Open wound of hand and fingers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,200 0.2 0.1 0.3 19.2 2.0
See footnotes at end of table.
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Table 16. Annual number and percent distribution of office visits by principal diagnosis group, according to patient’s sex, averaged over a










duration in minutes2Total Female Male
Injury and poisoning—Con.
Other open wound . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,794 0.4 0.3 0.5 17.0 1.0
Superficial injury of cornea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 529 0.1 * 0.1 15.0 1.5
Other superficial injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,358 0.2 0.1 0.3 16.1 1.1
Contusions with intact skin surfaces . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,736 0.5 0.4 0.7 18.6 0.9
Other injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,772 0.8 0.6 1.2 19.0 0.8
Poisonings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 452 0.1 * * 20.8 3.7
Other and unspecified effects of external causes . . . . . . . . . . . . . . . . . . . . 3,764 0.5 0.6 0.5 17.3 1.0
Complications of surgical and medical care, not elsewhere classified . . . . . . . . 1,130 0.2 0.2 0.2 19.4 1.2
Supplementary classification of factors influencing health status and contact with
health services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116,490 16.3 18.9 12.4 17.7 0.4
Potential health hazards related to communicable diseases . . . . . . . . . . . . . . 4,202 0.6 0.6 0.5 14.9 1.3
Potential health hazards related to personal and family history . . . . . . . . . . . . 8,435 1.2 1.1 1.3 17.0 0.8
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22,451 3.1 2.6 3.9 18.1 0.6
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21,625 3.0 5.1 . . . 15.5 0.5
Postpartum care and examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,584 0.2 0.4 . . . 17.6 1.3
Encounter for contraceptive management . . . . . . . . . . . . . . . . . . . . . . . . . 2,230 0.3 0.4 0.2 22.3 1.4
Other encounter related to reproduction . . . . . . . . . . . . . . . . . . . . . . . . . . 353 0.0 0.1 . . . 19.5 2.5
Lens replaced by pseudophakos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,926 0.3 0.3 0.2 15.9 1.2
Artificial opening status and other postsurgical states . . . . . . . . . . . . . . . . . . 5,151 0.7 0.7 0.7 16.4 0.6
Attention to surgical dressing and sutures . . . . . . . . . . . . . . . . . . . . . . . . . 884 0.1 0.1 0.2 – –
Followup examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,993 1.0 1.0 0.9 15.5 0.5
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,355 2.8 3.0 2.6 19.8 0.7
Observation and evaluation for suspected conditions not found . . . . . . . . . . . 3,720 0.5 0.6 0.4 17.2 1.1
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,199 0.6 1.0 . . . 19.5 1.4
Other factors influencing health status and contact with health services . . . . . . 12,382 1.7 1.9 1.5 19.8 1.0
Blank and illegible . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,269 2.3 2.3 2.2 17.2 0.6
* Figure does not meet standard of reliability or precision.
. . . Category not applicable.
– Quantity zero.
0.0 Quantity more than zero but less than 0.05.
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification, (ICD–9–CM) (20).
2Time spent in face-to-face contact between physician and patient. Does not include visits at which there was no face-to-face contact between physician and patient.
NOTE: Numbers may not add to totals because of rounding.
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Table 17. Annual number and percent distribution of office visits by patient’s age, sex, and race and the 15 principal diagnoses most







All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 100.0
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 29,451 4.1
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25,129 3.5
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22,451 3.1
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21,625 3.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,355 2.8
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . 19,626 2.7
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,848 2.5
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,593 2.0
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,097 1.8
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,873 1.5
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,078 1.4
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,838 1.4
Heart disease, excluding ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,829 1.4
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,039 1.3
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,209 1.1
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 473,747 66.2
Under 15 years
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136,200 100.0
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21,849 16.0
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . 16,096 11.8
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 15,566 11.4
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,222 3.8
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,038 3.0
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,598 2.6
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,169 2.3
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,906 2.1
Unspecified viral and chlamydial infections . . . . . . . . . . . . . . . . . . . . . . . . . 2,274 1.7
Streptococcal sore throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,041 1.5
Noninfectious enteritis and colitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,896 1.4
Attention deficit disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,853 1.4
Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,771 1.3
Contact dermatitis and other eczema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,521 1.1
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,317 1.0
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51,083 37.5
15–24 years
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57,682 100.0
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,108 12.3
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,578 6.2
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,529 4.4
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 2,323 4.0
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,303 2.3
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,260 2.2
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,004 1.7
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 981 1.7
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 906 1.6
Inflammatory disorders of female pelvic organs . . . . . . . . . . . . . . . . . . . . . . . 852 1.5
Disorders of menstruation and abnormal bleeding . . . . . . . . . . . . . . . . . . . . . 742 1.3
Encounter for contraceptive management . . . . . . . . . . . . . . . . . . . . . . . . . . 639 1.1
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . 631 1.1
Viral warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 620 1.1
Complications of pregnancy, childbirth, and the puerperium . . . . . . . . . . . . . . . 588 1.0
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32,620 56.6
See footnotes at end of table.
Series 13, No. 142 [ Page 43
Table 17. Annual number and percent distribution of office visits by patient’s age, sex, and race and the 15 principal diagnoses most








All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183,019 100.0
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,351 7.8
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,167 3.9
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 5,547 3.0
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,380 2.4
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,377 1.8
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,839 1.6
Dorsopathies, excluding intervertebral disc disorders and lumbago . . . . . . . . . . . 2,609 1.4
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,437 1.3
Sprains and strains of back, excluding neck . . . . . . . . . . . . . . . . . . . . . . . . . 2,411 1.3
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,339 1.3
Disorders of menstruation and abnormal bleeding . . . . . . . . . . . . . . . . . . . . . 2,154 1.2
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,055 1.1
Major depressive disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,030 1.1
Peripheral enthesopathies and allied disorders . . . . . . . . . . . . . . . . . . . . . . . 2,028 1.1
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,027 1.1
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125,270 68.4
45–64 years
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164,880 100.0
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,970 6.0
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,873 3.6
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,754 3.5
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,536 2.1
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 3,239 2.0
Menopausal and postmenopausal disorders . . . . . . . . . . . . . . . . . . . . . . . . . 3,128 1.9
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,966 1.8
Dorsopathies, excluding intervertebral disc disorders and lumbago . . . . . . . . . . . 2,957 1.8
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,543 1.5
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,205 1.3
Benign and other and unspecified neoplasms . . . . . . . . . . . . . . . . . . . . . . . . 2,027 1.2
Osteoarthrosis and allied disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,990 1.2
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,955 1.2
Heart disease, excluding ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,913 1.2
Peripheral enthesopathies and allied disorders . . . . . . . . . . . . . . . . . . . . . . . 1,907 1.2
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112,915 68.5
65–74 years
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92,212 100.0
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,335 6.9
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,157 5.6
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,042 4.4
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,427 3.7
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,855 3.1
Heart disease, excluding ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,415 2.6
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,977 2.1
Osteoarthrosis and allied disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,762 1.9
COPD and allied disorders, other than bronchitis and asthma2 . . . . . . . . . . . . . 1,607 1.7
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 1,591 1.7
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,288 1.4
Actinic and seborrheic keratosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,273 1.4
Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,226 1.3
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,205 1.3
Followup examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,178 1.3
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54,873 59.5
See footnotes at end of table.
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Table 17. Annual number and percent distribution of office visits by patient’s age, sex, and race and the 15 principal diagnoses most







75 years and over
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81,795 100.0
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,283 6.5
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,836 5.9
Heart disease, excluding ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,554 5.6
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,319 4.1
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,310 4.0
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,789 3.4
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,494 3.0
Osteoarthrosis and allied disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,940 2.4
Other disorders of the eye and adnexa . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,382 1.7
Retinal detachment and other retinal disorders . . . . . . . . . . . . . . . . . . . . . . . 1,280 1.6
COPD and allied disorders, other than bronchitis and asthma2 . . . . . . . . . . . . . 1,272 1.6
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 1,185 1.4
Actinic and seborrheic keratosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,175 1.4
Dorsopathies, excluding intervertebral disc disorders and lumbago . . . . . . . . . . . 1,005 1.2
Lens replaced by pseudophakos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,004 1.2
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44,966 55.0
Female
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 425,415 100.0
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21,625 5.1
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 16,495 3.9
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,123 3.3
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,925 3.0
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,164 2.6
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . 9,420 2.2
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,943 2.1
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,144 1.9
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,090 1.9
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,787 1.4
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,514 1.3
Heart disease, excluding ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,494 1.3
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,341 1.3
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,627 1.1
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,579 1.1
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 274,347 64.5
Male
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290,373 100.0
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 12,956 4.5
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,287 3.9
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,006 3.8
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . 10,206 3.5
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,906 3.1
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,430 2.6
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,503 2.2
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,847 2.0
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,358 1.8
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,953 1.7
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,496 1.5
Heart disease, excluding ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,335 1.5
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,630 1.3
Dorsopathies, excluding intervertebral disc disorders and lumbago . . . . . . . . . . . 3,476 1.2
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,252 1.1
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188,115 64.8
See footnotes at end of table.
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All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 616,928 100.0
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 24,234 3.9
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,656 3.2
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,111 3.1
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18,059 2.9
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,362 2.8
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . 17,275 2.8
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,314 2.6
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,648 1.9
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,177 1.8
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,594 1.6
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,446 1.5
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,779 1.4
Heart disease, excluding ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,759 1.4
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,506 1.2
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,056 1.1
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 410,954 66.6
Black
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70,746 100.0
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,802 6.8
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . 3,313 4.7
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,907 4.1
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,557 3.6
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,426 3.4
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,953 2.8
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . 1,525 2.2
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,097 1.6
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,079 1.5
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 994 1.4
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 965 1.4
Inflammatory disorders of female pelvic organs . . . . . . . . . . . . . . . . . . . . . . . 963 1.4
Heart disease, excluding ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 873 1.2
Sprains and strains of neck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 848 1.2
Sprains and strains of back, excluding neck . . . . . . . . . . . . . . . . . . . . . . . . . 829 1.2
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43,616 61.7
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2COPD is chronic obstructive pulmonary disease.
NOTE: Numbers may not add to totals because of rounding.
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Table 18. Annual number and percent distribution of office visits by principal diagnosis, according to physician specialty, averaged over a 2-year p eriod: United States,
1995–96
























diseases Urology Neurology All other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Infectious and parasitic
diseases . . . . . . . . . . 001–139 23,320 6,218 2,882 7,388 1,417 510 * 2,869 * 240 * * * * 1,488
Neoplasms . . . . . . . . . 140–239 24,434 1,464 2,327 * 1,082 * 182 4,700 – 2,315 531 * 2,219 * 9,047
Endocrine, nutritional and
metabolic diseases, and
immunity disorders . . . .240–279 28,503 11,150 9,062 545 736 1,545 * * * 431 * 441 * * 4,072
Mental disorders . . . . . . 290–319 31,732 6,497 2,848 1,214 * * * – 18,965 * * * 474 668 574
Diseases of the nervous system
and sense organs . . . . 320–389 71,171 10,136 4,289 13,949 * 28,424 1,606 * * 314 6,426 * * 3,043 2,648
Diseases of the
circulatory system . . . . 390–459 54,683 16,972 18,689 * * * * 565 269 1,661 * 9,125 * 484 5,961
Diseases of the
respiratory system . . . . 460–519 96,946 35,506 17,895 26,758 * * * * * 702 6,391 371 * * 8,873
Diseases of the
digestive system . . . . . 520–579 27,471 7,087 5,918 2,608 * * * * – 3,660 507 * * * 7,046
Diseases of the
genitourinary system . . 580–629 39,793 8,798 4,310 921 13,308 – * * * 2,218 – * 7,250 * 2,786
Diseases of the skin and
subcutaneous tissue . . 680–709 38,604 7,639 3,566 2,965 365 365 400 18,383 * 1,677 333 * * * 2,800
Diseases of the musculoskeletal
system and connective
tissue . . . . . . . . . . . . .710–739 51,500 14,115 8,377 978 * * 15,463 * * 596 * 278 * 1,249 9,894
Symptoms, signs, and
ill-defined conditions . . . 780–799 37,094 11,742 8,448 2,970 1,494 * * * * 1,075 1,465 1,659 1,359 1,857 4,391
Injury and poisoning . . . 800–999 49,576 15,147 5,238 3,621 * 1,293 15,784 408 * 1,134 667 * * 454 5,366
Supplementary
classification . . . . . . . V01–V82 116,490 23,589 6,872 25,720 36,360 6,587 3,415 892 331 2,276 1,251 1,769 1,409 231 5,788
All other diagnoses2 . . . . . . . . . 8,202 1,769 1,224 1,060 1,304 * 466 * * * 207 * 209 * 1,409
Unknown3 . . . . . . . . . . . . . . . . 16,269 5,395 2,486 1,678 2,230 1,158 520 381 * 228 198 290 217 116 1,273
Percent distribution
All visits . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Infectious and parasitic
diseases . . . . . . . . . . 001–139 3.3 3.4 2.8 8.0 2.4 1.3 * 9.9 * 1.3 * * * * 2.0
Neoplasms . . . . . . . . . 140–239 3.4 0.8 2.2 * 1.8 * 0.5 16.2 – 12.3 2.9 * 16.1 * 12.3
Endocrine, nutritional and
metabolic diseases, and
immunity disorders . . . .240–279 4.0 6.1 8.7 0.6 1.2 3.8 * * * 2.3 * 3.0 * * 5.5
Mental disorders . . . . . . 290–319 4.4 3.5 2.7 1.3 * * * – 93.5 * * * 3.4 7.9 0.8
Diseases of the nervous system
and sense organs . . . . 320–389 9.9 5.5 4.1 15.0 * 69.8 4.2 * * 1.7 35.0 * * 35.9 3.6
Diseases of the
circulatory system . . . . 390–459 7.6 9.3 17.9 * * * * 2.0 1.3 8.9 * 62.1 * 5.7 8.1
Diseases of the
respiratory system . . . . 460–519 13.5 19.4 17.1 28.8 * * * * * 3.7 34.8 2.5 * * 12.1
Diseases of the
digestive system . . . . . 520–579 3.8 3.9 5.7 2.8 * * * * * 19.5 2.8 * * * 9.6
Diseases of the











Table 18. Annual number and percent distribution of office visits by principal diagnosis, according to physician specialty, averaged over a 2-year p eriod: United States,
1995–96—Con.
























diseases Urology Neurology All other
Diseases of the skin and
subcutaneous tissue . . . 680–709 5.4 4.2 3.4 3.2 0.6 0.9 1.0 63.5 * 8.9 1.8 * * * 3.8
Diseases of the musculoskeletal
system and connective
tissue . . . . . . . . . . . . 710–739 7.2 7.7 8.0 1.1 * * 40.4 * * 3.2 * 1.9 * 14.7 13.5
Symptoms, signs, and
ill-defined conditions . . . 780–799 5.2 6.4 8.1 3.2 2.5 * * * * 5.7 8.0 11.3 9.9 21.9 6.0
Injury and poisoning . . . 800–999 6.9 8.3 5.0 3.9 * 3.2 41.2 1.4 * 6.0 3.6 * * 5.3 7.3
Supplementary
classification . . . . . . . V01–V82 16.3 12.9 6.6 27.7 61.1 16.2 8.9 3.1 1.6 12.1 6.8 12.0 10.2 2.7 7.9
All other diagnoses2 . . . . . . . . . 1.1 1.0 1.2 1.1 2.2 * 1.2 * * * 1.1 * 1.5 * 1.9
Unknown3 . . . . . . . . . . . . . . . . 2.3 2.9 2.4 1.8 3.7 2.8 1.4 1.3 * 1.2 1.1 2.0 1.6 1.4 1.7
– Quantity zero.
* Figure does not meet standard of reliability or precision.
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2Includes diseases of the blood and blood-forming organs (280–289); complications of pregnancy, childbirth, and the puerperium (630–676); congenital anomalies (740–759); and certain conditions originating in the perinatal period (760–779).
3Includes blank diagnoses, uncodable diagnoses, and illegible diagnoses.











Table 19. Annual number and percent distribution of office visits by physician specialty, according to principal diagnosis, averaged over a 2-year p eriod: United States, 1995–96
























diseases Urology Neurology All other
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . 715,788 100.0 25.6 14.6 13.0 8.3 5.7 5.3 4.0 2.8 2.6 2.6 2.1 1.9 1.2 10.3
Infectious and parasitic
diseases . . . . . . . . . . . . . . 001–139 23,320 100.0 26.7 12.4 31.7 6.1 2.2 * 12.3 * 1.0 * * * * 6.4
Neoplasms . . . . . . . . . . . . . 140–239 24,434 100.0 6.0 9.5 * 4.4 * 0.7 19.2 – 9.5 2.2 * 9.1 * 37.0
Endocrine, nutritional and metabolic
diseases and immunity
disorders . . . . . . . . . . . . . . 240–279 28,503 100.0 39.1 31.8 1.9 2.6 5.4 * * * 1.5 * 1.5 * * 14.3
Mental disorders . . . . . . . . . . 290–319 31,732 100.0 20.5 9.0 3.8 * * * – 59.8 * * * 1.5 2.1 1.8
Diseases of the nervous system
and sense organs . . . . . . . . 320–389 71,171 100.0 14.2 6.0 19.6 * 39.9 2.3 * * 0.4 9.0 * * 4.3 3.7
Diseases of the circulatory
system . . . . . . . . . . . . . . . 390–459 54,683 100.0 31.0 34.2 * * * * 1.0 0.5 3.0 * 16.7 * 0.9 10.9
Diseases of the respiratory
system . . . . . . . . . . . . . . . 460–519 96,946 100.0 36.6 18.5 27.6 * * * * * 0.7 6.6 0.4 * * 9.2
Diseases of the digestive
system . . . . . . . . . . . . . . . 520–579 27,471 100.0 25.8 21.5 9.5 * * * * – 13.3 1.8 * * * 25.6
Diseases of the genitourinary
system . . . . . . . . . . . . . . . 580–629 39,793 100.0 22.1 10.8 2.3 33.4 – * * * 5.6 – * 18.2 * 7.0
Diseases of the skin and
subcutaneous tissue . . . . . . 680–709 38,604 100.0 19.8 9.2 7.7 0.9 0.9 1.0 47.6 * 4.3 0.9 * * * 7.3
Diseases of the musculoskeletal
system and connective
tissue . . . . . . . . . . . . . . . . 710–739 51,500 100.0 27.4 16.3 1.9 * * 30.0 * * * * 0.5 * 2.4 19.2
Symptoms, signs, and ill-defined
conditions . . . . . . . . . . . . . 780–799 37,094 100.0 31.7 22.8 8.0 4.0 * * * * 2.9 4.0 4.5 3.7 5.0 11.8
Injury and poisoning . . . . . . . 800–999 49,576 100.0 30.6 10.6 7.3 * 2.6 31.8 0.8 * 2.3 1.3 * * 0.9 10.8
Supplementary classification . . V01–V82 116,490 100.0 20.3 5.9 22.1 31.2 5.7 2.9 0.8 0.3 2.0 1.1 1.5 1.2 0.2 5.0
All other diagnoses2 . . . . . . . . . . . . . 8,202 100.0 21.6 14.9 12.9 15.9 * 5.7 * * 1.2 2.5 * 2.5 * 17.2
Unknown3 . . . . . . . . . . . . . . . . . . . . 16,269 100.0 33.2 15.3 10.3 13.7 7.1 3.2 2.3 * 1.4 1.2 1.8 1.3 0.7 7.8
– Quantity zero.
* Figure does not meet standard of reliability or precision.
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2Includes diseases of the blood and blood-forming organs (280–289); complications of pregnancy, childbirth, and the puerperium (630–676); congenital anomalies (740–759); and certain conditions originating in the perinatal period (760–779).
3Includes blank diagnoses, uncodable diagnoses, and illegible diagnoses.











Table 20. Annual number and percent distribution of office visits by physician specialty and the 10 principal diagnoses most frequently
rendered by physicians, averaged over a 2-year period: United States, 1995–96






General and family practice
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183,225 100.0
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,639 6.9
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,586 5.8
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,170 4.5
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,008 3.3
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,002 2.7
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,875 2.7
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,331 2.4
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,571 1.9
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,239 1.8
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,337 1.3
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122,465 66.8
Internal medicine
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104,431 100.0
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,695 10.2
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,745 4.5
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,388 4.2
Heart disease, excluding ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,481 3.3
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,709 2.6
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,633 2.5
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,356 2.3
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,196 2.1
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,095 2.0
COPD and allied disorders, excluding bronchitis and asthma2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,954 1.9
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67,179 64.3
Pediatrics
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92,888 100.0
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18,945 20.4
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,223 12.1
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,462 11.3
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,268 4.6
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,265 3.5
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,680 2.9
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,430 2.6
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,089 2.2
Unspecified viral and chlamydial infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,871 2.0
Noninfectious enteritis and colitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,538 1.7
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34,117 36.7
Obstetrics and gynecology
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59,515 100.0
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,021 32.0
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,155 8.7
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,344 5.6
Menopausal and postmenopausal disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,181 5.3
Disorders of menstruation and abnormal bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,333 3.9
Noninflammatory disorders of female genital organs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,708 2.9
Inflammatory disorders of female pelvic organs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,696 2.9
Postpartum care and examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,435 2.4
Observation and evaluation for suspected conditions not found . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,236 2.1
Complications of pregnancy, childbirth, and the puerperium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,134 1.9
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,274 32.4
See footnotes at end of table.
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All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40,714 100.0
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,658 16.4
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,151 15.1
Disorders of refraction and accommodation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,460 11.0
Retinal detachment and other retinal disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,669 6.6
Lens replaced by pseudophakos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,926 4.7
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,461 3.6
Disorders of eyelids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,395 3.4
Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,065 2.6
Follow-up examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 903 2.2
Artificial opening status and other postsurgical states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 612 1.5
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,413 32.9
Orthopedic surgery
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38,267 100.0
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,277 8.6
Peripheral enthesopathies and allied disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,736 7.2
Derangements and other and unspecified joint disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,509 6.6
Osteoarthrosis and allied disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,430 6.4
Dislocation of knee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,626 4.2
Fracture of radius and ulna . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,546 4.0
Fracture of hand and fingers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,544 4.0
Intervertebral disc disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,378 3.6
Carpal tunnel syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,149 3.0
Synovitis and tenosynovitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,018 2.7
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,053 49.8
Dermatology
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28,969 100.0
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,185 14.4
Actinic and seborrheic keratosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,721 12.8
Inflammatory conditions of skin and subcutaneous tissue, other than contact dermatitis and psoriasis . . . 2,470 8.5
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,629 9.1
Contact dermatitis and other eczema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,405 8.3
Benign and unspecified neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,071 7.2
Viral warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,576 5.4
Psoriasis and similar disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,348 4.7
Sebaceous cyst . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 727 2.5
Corns, callosities, and other hypertrophic and atrophic skin conditions . . . . . . . . . . . . . . . . . . . . . . 699 2.4
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,138 24.6
Psychiatry
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,287 100.0
Major depressive disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,375 21.6
Schizophrenic disorders and other psychoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,404 16.8
Drug dependence and nondependent use of drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,168 10.7
Other mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,148 10.6
Neurotic depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,010 9.9
Anxiety states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,514 7.5
Depressive reaction, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,287 6.3
Acute reaction to stress and adjustment reaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,133 5.6
Attention deficit disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 806 4.0
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,442 7.1
See footnotes at end of table.
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All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18,762 100.0
Disorders of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,742 9.3
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,630 8.7
Hernia of abdominal cavity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,477 7.9
Disorders of the gallbladder and biliary tract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 964 5.1
Benign and unspecified neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 685 3.7
Artificial opening status and other postsurgical states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 516 2.7
Sebaceous cyst . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 484 2.6
Follow-up examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 475 2.5
Other diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 442 2.4
Hemorrhoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 351 1.9
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,996 53.3
Otolaryngology
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18,346 100.0
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,674 14.6
Other diseases of the ear and mastoid process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,038 11.1
Disorders of external ear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,548 8.4
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,529 8.3
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,481 8.1
Acute respiratory infections, excluding pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 763 4.2
Follow-up examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 421 2.3
Epistaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 287 1.6
Artificial opening status and other postsurgical states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 285 1.6
Other fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 280 1.5
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,040 38.4
Cardiovascular diseases
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,705 100.0
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,516 30.7
Heart disease, other than ischemic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,033 20.6
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,171 8.0
Chest pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 712 4.8
Artificial opening status and other postsurgical states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 438 3.0
Follow-up examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 339 2.3
Observation and evaluation for suspected conditions not found . . . . . . . . . . . . . . . . . . . . . . . . . . . 323 2.2
Abnormal heart sounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 256 1.7
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,916 26.6
Urology
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,780 100.0
Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,107 15.3
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,077 15.1
Other disorders of male genital organs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,408 10.2
Symptoms involving urinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,011 7.3
Cystitis and other disorders of the bladder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 913 6.6
Urinary tract infection, site not specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 569 4.1
Calculus of kidney and ureter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 559 4.1
Encounter for contraceptive management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 327 2.4
Other disorders of the female genital tract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 312 2.3
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,498 32.6
Neurology
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,481 100.0
Migraine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 789 9.3
Convulsions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 657 7.7
Headache . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 489 5.8
Cerebrovascular disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 399 4.7
Carpal tunnel syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 241 2.8
Attention deficit disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 225 2.6
Other rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 199 2.4
Sprains and strains of neck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160 1.9
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,322 62.8
See footnotes at end of table.
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Table 20. Annual number and percent distribution of office visits by physician specialty and the 10 principal diagnoses most frequently
rendered by physicians, averaged over a 2-year period: United States, 1995–96—Con.







All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73,417 100.0
Malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,811 10.6
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,084 2.8
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,013 2.7
Dorsopathies, excluding intervertebral disc disorders and lumbago . . . . . . . . . . . . . . . . . . . . . . . . . 1,974 2.7
Intervertebral disc disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,925 2.6
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,888 2.6
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,817 2.5
Benign and unspecified neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,236 1.7
Noninfectious enteritis and colitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,068 1.5
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 918 1.3
All other diagnoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50,651 69.0
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2COPD is chronic obstructive pulmonary disease.
NOTES: Numbers may not add to totals because of rounding. Some categories may have fewer than 10 diagnoses because only reliable estimates have been included.
Series 13, No. 142 [ Page 53
Table 21. Annual number, percent distribution, and rate of injury-related office visits by patient’s age, sex, and race, averaged over a 2-year









All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84,616 100.0 32.2
Age
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,489 13.6 19.3
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,629 11.4 26.5
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29,598 35.0 35.5
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,895 24.7 39.8
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,975 8.2 38.2
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,030 7.1 45.0
Sex and age
Female . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42,394 50.1 31.4
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,899 5.8 16.9
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,098 4.8 22.7
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,120 16.7 33.4
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,172 13.2 41.2
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,307 5.1 42.6
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,798 4.5 45.7
Male . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42,221 49.9 32.9
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,590 7.8 21.7
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,531 6.5 30.3
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15,478 18.3 37.8
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,723 11.5 38.4
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,667 3.2 32.7
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,232 2.6 43.8
Race and age
White . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72,089 85.2 33.1
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,754 11.5 20.9
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,985 9.4 27.6
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24,525 29.0 35.7
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,872 21.1 39.7
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,334 7.5 39.1
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,620 6.6 46.4
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,209 10.9 27.4
Under 15 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,299 1.5 13.5
15–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,184 1.4 21.6
25–44 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,668 4.3 34.8
45–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,300 2.7 42.4
65–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 492 0.6 31.2
75 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . 265 0.3 26.0
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,318 3.9 27.8
1Based on U.S. Bureau of the Census estimates of the civilian, noninstitutionalized population of the United States as of July 1, 1995, and July 1, 1996.
NOTE: Numbers may not add to totals because of rounding.
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Table 22. Annual number and percent distribution of injury-related office visits by the 25 most frequently mentioned principal reasons for
visit, averaged over a 2-year period: United States, 1995–96






All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84,616 100.0
Back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S905 6,100 7.2
Knee symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S925 4,507 5.3
Neck symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S900 3,654 4.3
Low back symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S910 3,340 3.9
Shoulder symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S940 3,254 3.8
Progress visit, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T800 2,943 3.5
Postoperative visit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T205 2,817 3.3
Hand and finger symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S960 2,118 2.5
Leg symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S920 1,796 2.1
Ankle symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S930 1,596 1.9
Wrist symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S955 1,533 1.8
Foot and toe symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S935 1,531 1.8
Allergy, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S090 1,331 1.6
Arm symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S945 1,195 1.4
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X100 1,165 1.4
Accident, not otherwise specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J810 1,045 1.2
Skin rash . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S860 1,045 1.2
Lacerations and cuts of upper extremity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J225 1,033 1.2
Head, neck, and face injury of other or unspecified type . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J505 1,007 1.2
Fractures and dislocations of arm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J035 979 1.2
Hip symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S915 906 1.1
Injury, multiple or unspecified type . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J570 896 1.1
Elbow symptoms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S950 864 1.0
Headache, pain in head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S210 852 1.0
Pain and related symptoms, generalized, site not specified . . . . . . . . . . . . . . . . . . . . . . . . . . . . S060 822 1.0
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36,283 42.9
1Based on A Reason for Visit Classification for Ambulatory Care (RVC) (19).
NOTE: Numbers may not add to totals because of rounding.
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Table 23. Annual number and percent distribution of injury-related office visits by patient’s age, sex, race, and selected injury diagnoses,
averaged over a 2-year period: United States, 1995–96






All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84,616 100.0
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 16,847 19.9
Dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–724 5,516 6.5
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 5,188 6.1
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 4,204 5.0
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 3,736 4.4
Rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725–729 3,635 4.3
Open wound of upper or lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880–897 2,458 2.9
Dislocations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 830–839 2,414 2.9
Open wound of head, neck, and trunk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 870–879 2,312 2.7
Superficial injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 910–914 1,886 2.2
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36,420 43.0
Under 15 years
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,489 100.0
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 1,814 15.8
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 1,367 11.9
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 798 6.9
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 708 6.2
Superficial injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 910–914 630 5.5
Open wound of head, neck, and trunk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 870–879 562 4.9
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,610 48.8
15–24 years
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,629 100.0
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 2,114 22.0
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 772 8.0
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 537 5.6
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 491 5.1
Dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–724 397 4.1
Dislocations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 830–839 396 4.1
Open wound of upper or lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880–897 387 4.0
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,535 47.1
25–44 years
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29,598 100.0
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 7,238 24.5
Dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–724 2,845 9.6
Rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725–729 1,799 6.1
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 1,171 4.0
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 1,081 3.7
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 1,056 3.6
Dislocations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 830–839 924 3.1
Derangements and other and unspecified joint disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . 717–719 801 2.7
Open wound of upper or lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880–897 756 2.6
Open wound of head, neck, and trunk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 870–879 535 1.8
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,393 38.5
45–64 years
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,895 100.0
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 4,619 22.1
Dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–724 1,911 9.1
Rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725–729 1,090 5.2
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 960 4.6
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 808 3.9
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 796 3.8
Dislocations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 830–839 661 3.2
Derangements and other and unspecified joint disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . 717–719 548 2.6
Arthropathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 710–716 490 2.3
Open wound of head, neck, and trunk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 870–879 477 2.3
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,536 40.6
See footnotes at end of table.
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Table 23. Annual number and percent distribution of injury-related office visits by patient’s age, sex, race, and selected injury diagnoses,
averaged over a 2-year period: United States, 1995–96—Con.






65 years and over
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,005 100.0
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 1,509 11.6
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 943 7.3
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 726 5.6
Open wound of upper or lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880–897 526 4.0
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 468 3.6
Open wound of head, neck, and trunk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 870–879 445 3.4
Fracture of neck and trunk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 805–809 444 3.4
Arthropathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 710–716 411 3.2
Dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–724 363 2.8
Rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725–729 349 2.7
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,822 52.5
Female
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42,394 100.0
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 8,644 20.4
Dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–724 2,589 6.1
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 2,254 5.3
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 2,223 5.2
Rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725–729 2,110 5.0
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 1,841 4.3
Open wound of head, neck, and trunk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 870–879 1,014 2.4
Open wound of upper or lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880–897 973 2.3
Dislocations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 830–839 928 2.2
Derangements and other and unspecified joint disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . 717–719 917 2.2
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18,577 43.8
Male
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42,221 100.0
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 8,203 19.4
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 2,965 7.0
Dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–724 2,926 6.9
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 1,950 4.6
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 1,895 4.5
Rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725–729 1,525 3.6
Dislocations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 830–839 1,486 3.5
Open wound of upper or lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880–897 1,485 3.5
Open wound of head, neck, and trunk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 870–879 1,298 3.1
Superficial injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 910–914 1,159 2.7
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,042 40.4
White
All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72,089 100.0
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 13,308 18.5
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 4,658 6.5
Dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–724 4,620 6.4
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 3,735 5.2
Rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725–729 3,137 4.4
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 3,103 4.3
Dislocations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 830–839 2,175 3.0
Open wound of upper or lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 880–897 2,172 3.0
Open wound of head, neck, and trunk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 870–879 2,079 2.9
Derangements and other and unspecified joint disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . 717–719 1,729 2.4
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31,373 43.5
See footnotes at end of table.
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Table 23. Annual number and percent distribution of injury-related office visits by patient’s age, sex, race, and selected injury diagnoses,
averaged over a 2-year period: United States, 1995–96—Con.







All injury-related visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,209 100.0
Sprains and strains of joints and adjacent muscles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–848 2,550 27.7
Dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–724 744 8.1
Contusion with intact skin surface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924 524 5.7
Fracture of upper limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 810–819 405 4.4
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829 322 3.5
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,663 50.6
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2Estimates for races other than white and black are not shown because of small sample sizes.
NOTE: Numbers may not add to totals because of rounding.
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Table 24. Annual number and percent of office visits by diagnostic and screening services ordered or provided, according to patient’s age,
sex, and race, averaged over a 2-year period: United States, 1995–96
Diagnostic and screening















and over Female Male White Black Other
Number of visits in thousands1
All visits . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
No services . . . . . . . . . . . . . . 208,052 76,369 16,066 45,868 38,256 17,644 13,848 112,027 96,025 182,224 17,399 8,428
Examinations
Breast . . . . . . . . . . . . . . . . . 46,792 1,018 5,066 17,883 13,739 5,282 3,804 45,501 1,291 40,329 4,824 1,639
Pelvic . . . . . . . . . . . . . . . . . 53,305 729 8,369 26,411 12,056 3,646 2,094 52,149 1,156 44,534 6,887 1,884
Rectal . . . . . . . . . . . . . . . . . 32,727 742 1,449 9,514 11,110 5,796 4,116 20,763 11,964 28,706 2,595 1,426
Visual . . . . . . . . . . . . . . . . . 49,099 7,701 2,649 7,747 9,623 9,865 11,515 28,108 20,992 43,830 4,077 1,193
Mental . . . . . . . . . . . . . . . . . 19,242 2,227 1,212 6,221 5,219 2,033 2,330 11,514 7,728 16,978 1,770 494
Other examination . . . . . . . . . . 113,074 22,312 8,879 28,061 23,998 15,148 14,676 66,720 46,353 101,658 8,405 3,011
Tests
Blood pressure . . . . . . . . . . . . 310,547 17,281 26,457 91,151 83,403 48,648 43,608 198,519 112,028 258,990 37,459 14,098
Urinalysis . . . . . . . . . . . . . . . 90,704 9,306 12,008 30,949 19,080 10,785 8,576 61,821 28,883 72,604 12,942 5,158
TB skin test2 . . . . . . . . . . . . . 5,645 3,529 714 838 387 * * 2,726 2,919 4,501 852 *
Blood lead level . . . . . . . . . . . 2,672 1,758 * * * * * 1,273 1,398 1,969 652 *
Cholesterol . . . . . . . . . . . . . . 25,254 432 672 5,134 9,097 6,078 3,841 14,203 11,051 21,164 2,644 1,446
PSA2 . . . . . . . . . . . . . . . . . . 7,298 * * 380 2,760 2,413 1,668 * 7,095 6,295 710 *
HIV serology2 . . . . . . . . . . . . 1,802 * * 1,152 * * * 1,019 783 1,331 * *
Other blood test . . . . . . . . . . . 99,072 9,077 6,415 22,572 27,378 18,491 15,139 61,695 37,377 82,426 12,920 3,726
Other test . . . . . . . . . . . . . . . 71,231 9,648 6,023 21,653 15,795 9,519 8,594 48,333 22,898 61,813 7,060 2,358
Imaging
X ray . . . . . . . . . . . . . . . . . . 54,695 5,857 3,892 13,156 17,366 8,334 6,090 32,856 21,839 47,517 5,681 1,497
CAT scan2 . . . . . . . . . . . . . . 4,281 * *247 1,020 1,447 714 635 2,300 1,981 3,751 398 *
MRI2 . . . . . . . . . . . . . . . . . . 4,393 * 326 1,628 1,506 493 320 2,336 2,057 3,800 527 *
Ultrasound . . . . . . . . . . . . . . 13,957 *307 1,669 5,259 3,086 1,945 1,690 10,448 3,509 11,771 1,618 568
Other imaging . . . . . . . . . . . . 4,320 * * 858 1,335 774 1,033 2,592 1,728 3,728 473 *
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
No services . . . . . . . . . . . . . . 29.1 56.1 27.9 25.1 23.2 19.1 16.9 26.3 33.1 29.5 24.6 30.0
Examinations
Breast . . . . . . . . . . . . . . . . . 6.5 0.7 8.8 9.8 8.3 5.7 4.7 10.7 0.4 6.5 6.8 5.8
Pelvic . . . . . . . . . . . . . . . . . 7.4 0.5 14.5 14.4 7.3 4.0 2.6 12.3 0.4 7.2 9.7 6.7
Rectal . . . . . . . . . . . . . . . . . 4.6 0.5 2.5 5.2 6.7 6.3 5.0 4.9 4.1 4.7 3.7 5.1
Visual . . . . . . . . . . . . . . . . . 6.9 5.7 4.6 4.2 5.8 10.7 14.1 6.6 7.2 7.1 5.8 4.2
Mental . . . . . . . . . . . . . . . . . 2.7 1.6 2.1 3.4 3.2 2.2 2.8 2.7 2.7 2.8 2.5 1.8
Other examination . . . . . . . . . . 15.8 16.4 15.4 15.3 14.6 16.4 17.9 15.7 16.0 16.5 11.9 10.7
Tests
Blood pressure . . . . . . . . . . . . 43.4 12.7 45.9 49.8 50.6 52.8 53.3 46.7 38.6 42.0 52.9 50.1
Urinalysis . . . . . . . . . . . . . . . 12.7 6.8 20.8 16.9 11.6 11.7 10.5 14.5 9.9 11.8 18.3 18.3
TB skin test2 . . . . . . . . . . . . . 0.8 2.6 1.2 0.5 0.2 * * 0.6 1.0 0.7 1.2 *
Blood lead level . . . . . . . . . . . 0.4 1.3 * * * * * 0.3 0.5 0.3 0.9 *
Cholesterol . . . . . . . . . . . . . . 3.5 0.3 1.2 2.8 5.5 6.6 4.7 3.3 3.8 3.4 3.7 5.1
PSA2 . . . . . . . . . . . . . . . . . . 1.0 * * 0.2 1.7 2.6 2.0 * 2.4 1.0 1.0 *
HIV serology2 . . . . . . . . . . . . 0.3 * * 0.6 * * * 0.2 0.3 0.2 * *
Other blood test . . . . . . . . . . . 13.8 6.7 11.1 12.3 16.6 20.1 18.5 14.5 12.9 13.4 18.3 13.3
Other test . . . . . . . . . . . . . . . 10.0 7.1 10.4 11.8 9.6 10.3 10.5 11.4 7.9 10.0 10.0 8.4
Imaging
X ray . . . . . . . . . . . . . . . . . . 7.6 4.3 6.7 7.2 10.5 9.0 7.4 7.7 7.5 7.7 8.0 5.3
CAT scan2 . . . . . . . . . . . . . . 0.6 * *0.4 0.6 0.9 0.8 0.8 0.5 0.7 0.6 0.6 *
MRI2 . . . . . . . . . . . . . . . . . . 0.6 * 0.6 0.9 0.9 0.5 0.4 0.5 0.7 0.6 0.7 *
Ultrasound . . . . . . . . . . . . . . 1.9 *0.2 2.9 2.9 1.9 2.1 2.1 2.5 1.2 1.9 2.3 2.0
Other imaging . . . . . . . . . . . . 0.6 * * 0.5 0.8 0.8 1.3 0.6 0.6 0.6 0.7 *
. . . Category not applicable.
* Figure does not meet standard of precision or reliability.
1Numbers may not add to totals because more than one category may be reported per visit.
2TB is tuberculin; PSA is prostate-specific antigen; HIV is human immunodeficiency virus; CAT is computerized axial tomography; MRI is magnetic resonance imaging.
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diseases Urology Neurology All other
Number of visits in thousands1
All visits . . . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
No services . . . . . . . . . . . . . . . . 208,052 43,448 11,839 54,369 2,827 4,132 16,279 18,840 12,787 6,064 11,606 953 2,487 2,582 19,839
Examinations
Breast . . . . . . . . . . . . . . . . . . . 46,792 7,485 6,610 962 23,963 * * * * 3,547 * 371 * * 3,611
Pelvic . . . . . . . . . . . . . . . . . . . 53,305 8,429 3,485 526 38,192 – * * – 403 * * 733 * 1,296
Rectal . . . . . . . . . . . . . . . . . . . 32,727 6,117 5,982 538 10,973 * * – – 1,293 * 170 3,104 * 4,520
Visual . . . . . . . . . . . . . . . . . . . 49,099 5,023 2,177 4,610 497 34,424 * 398 – 324 * * * 512 867
Mental . . . . . . . . . . . . . . . . . . . 19,242 4,772 3,228 1,429 855 * * * 6,600 * * 312 * 767 1,095
Other examination . . . . . . . . . . . . 113,074 23,907 15,546 13,938 7,297 9,238 8,346 6,812 243 3,679 3,108 2,756 802 1,992 15,409
Tests
Blood pressure . . . . . . . . . . . . . . 310,547 111,069 81,630 11,903 44,815 722 1,251 931 376 4,893 586 12,068 2,126 3,110 35,067
Urinalysis . . . . . . . . . . . . . . . . . 90,704 24,015 14,167 7,231 27,161 * 219 173 * 750 * 610 9,068 * 6,791
TB skin test2 . . . . . . . . . . . . . . . 5,645 1,477 504 3,321 * – – * * * * – * * *
Blood lead level . . . . . . . . . . . . . 2,672 601 * 1,403 * * * * – * – * * * *
Cholesterol . . . . . . . . . . . . . . . . 25,254 7,471 10,680 * 1,221 * * * * 261 * 1,940 * * 3,137
PSA2 . . . . . . . . . . . . . . . . . . . . 7,298 2,073 2,140 * * * – – – * – 227 2,131 * 569
HIV serology2 . . . . . . . . . . . . . . 1,802 468 * – 667 * * * * * * * * * *
Other blood test . . . . . . . . . . . . . 99,072 28,695 28,971 6,872 10,040 * 360 865 656 1,478 370 2,773 694 1,068 15,898
Other test . . . . . . . . . . . . . . . . . 71,231 11,701 9,211 7,303 18,575 6,222 357 2,602 * 729 2,374 5,276 664 1,102 4,985
Imaging
X ray . . . . . . . . . . . . . . . . . . . . 54,695 13,052 9,324 2,624 4,796 * 14,773 * * 1,503 714 831 820 149 5,855
CAT scan2 . . . . . . . . . . . . . . . . 4,281 660 807 * * * 185 * * 219 459 * * 164 1,312
MRI2 . . . . . . . . . . . . . . . . . . . . 4,393 474 328 * * – 1,508 * * * * * * 624 1,156
Ultrasound . . . . . . . . . . . . . . . . 13,957 2,016 2,113 * 4,810 439 * * * 464 * 1,336 766 161 1,546
Other imaging . . . . . . . . . . . . . . 4,320 588 444 * * 1,314 249 * * 179 * 355 * * 628
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
No services . . . . . . . . . . . . . . . . 29.1 23.7 11.3 58.5 4.8 10.1 42.5 65.0 63.0 32.3 63.3 6.5 18.0 30.4 27.0
Examinations
Breast . . . . . . . . . . . . . . . . . . . 6.5 4.1 6.3 1.0 40.3 * * * * 18.9 * 2.5 * * 4.9
Pelvic . . . . . . . . . . . . . . . . . . . 7.4 4.6 3.3 0.6 64.2 – * * – 2.1 * * 5.3 * 1.8
Rectal . . . . . . . . . . . . . . . . . . . 4.6 3.3 5.7 0.6 18.4 * * – – 6.9 * 1.2 22.5 * 6.2
Visual . . . . . . . . . . . . . . . . . . . 6.9 2.7 2.1 5.0 0.8 84.6 * 1.4 – 1.7 * * * 6.0 1.2
Mental . . . . . . . . . . . . . . . . . . . 2.7 2.6 3.1 1.5 1.4 * * * 32.5 * * 2.1 * 9.0 1.5
Other examination . . . . . . . . . . . . 15.8 13.0 14.9 15.0 12.3 22.7 21.8 23.5 1.2 19.6 16.9 18.7 5.8 23.5 21.0






































diseases Urology Neurology All other
Tests
Blood pressure . . . . . . . . . . . . . . 43.4 60.6 78.2 12.8 75.3 1.8 3.3 3.2 1.9 26.1 3.2 82.1 15.4 36.7 47.8
Urinalysis . . . . . . . . . . . . . . . . . 12.7 13.1 13.6 7.8 45.6 * 0.6 0.6 * 4.0 * 4.1 65.8 * 9.2
TB skin test2 . . . . . . . . . . . . . . . 0.8 0.8 0.5 3.6 * – – * * * * – * * *
Blood lead level . . . . . . . . . . . . . 0.4 0.3 * 1.5 * * * * – * – * * * *
Cholesterol . . . . . . . . . . . . . . . . 3.5 4.1 10.2 * 2.1 * * * * 1.4 * 13.2 * * 4.3
PSA2 . . . . . . . . . . . . . . . . . . . . 1.0 1.1 2.0 * * * – – – * – 1.5 15.5 * 0.8
HIV serology2 . . . . . . . . . . . . . . 0.3 0.3 * – 1.1 * * * * * * * * * *
Other blood test . . . . . . . . . . . . . 13.8 15.7 27.7 7.4 16.9 * 0.9 3.0 3.2 7.9 2.0 18.9 5.0 12.6 21.7
Other test . . . . . . . . . . . . . . . . . 10.0 6.4 8.8 7.9 31.2 15.3 0.9 9.0 * 3.9 12.9 35.9 4.8 13.0 6.8
Imaging
X ray . . . . . . . . . . . . . . . . . . . . 7.6 7.1 8.9 2.8 8.1 * 38.6 * * 8.0 3.9 5.7 6.0 1.8 8.0
CAT scan2 . . . . . . . . . . . . . . . . 0.6 0.4 0.8 * * * 0.5 * * 1.2 2.5 * * 1.9 1.8
MRI2 . . . . . . . . . . . . . . . . . . . . 0.6 0.3 0.3 * * – 3.9 * * * * * * 7.4 1.6
Ultrasound . . . . . . . . . . . . . . . . 1.9 1.1 2.0 * 8.1 1.1 * * * 2.5 * 9.1 5.6 1.9 2.1
Other imaging . . . . . . . . . . . . . . 0.6 0.3 0.4 * * 3.2 0.7 * * 1.0 * 2.4 * * 0.9
* Figure does not meet standard of reliability or precision.
– Quantity zero.
. . . Category not applicable.
1Numbers may not add to totals because more than one category may be reported per visit.











Table 26. Annual number and percent distribution of office visits by number of diagnostic and screening services ordered or provided,
according to patient’s age, sex, and race, averaged over a 2-year period: United States, 1995–96
Number of diagnostic
and screening services













and over Female Male White Black Other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
None . . . . . . . . . . . . . . . . . . . . 210,214 76,791 16,301 46,396 38,627 17,900 14,199 113,288 96,927 184,180 17,525 8,510
1 . . . . . . . . . . . . . . . . . . . . . . 255,033 40,037 18,792 64,177 63,079 35,415 33,533 146,649 108,384 221,500 24,369 9,163
2 . . . . . . . . . . . . . . . . . . . . . . 126,207 11,276 10,953 32,644 31,621 20,468 19,244 78,172 48,035 107,315 13,661 5,231
3 . . . . . . . . . . . . . . . . . . . . . . 59,762 4,659 5,289 18,042 14,284 9,144 8,344 38,953 20,809 50,326 6,754 2,682
4 . . . . . . . . . . . . . . . . . . . . . . 30,786 2,029 3,517 10,136 7,154 4,680 3,270 21,687 9,099 24,925 4,417 1,443
5 . . . . . . . . . . . . . . . . . . . . . . 15,017 842 1,419 5,328 4,172 1,934 1,323 11,459 3,559 12,595 1,877 545
6 . . . . . . . . . . . . . . . . . . . . . . 9,690 376 859 3,325 2,797 1,388 946 7,927 1,763 8,409 938 *
7 . . . . . . . . . . . . . . . . . . . . . . 5,511 * 349 2,180 1,659 732 524 4,506 1,005 4,650 771 *
8 or more . . . . . . . . . . . . . . . . . 3,568 * * 791 1,487 552 412 2,775 793 3,028 * *
Percent distribution
All visits . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
None . . . . . . . . . . . . . . . . . . . . 29.4 56.4 28.3 25.4 23.4 19.4 17.4 26.6 33.4 29.9 24.8 30.3
1 . . . . . . . . . . . . . . . . . . . . . . 35.6 29.4 32.6 35.1 38.3 38.4 41.0 34.5 37.3 35.9 34.4 32.6
2 . . . . . . . . . . . . . . . . . . . . . . 17.6 8.3 19.0 17.8 19.2 22.2 23.5 18.4 16.5 17.4 19.3 18.6
3 . . . . . . . . . . . . . . . . . . . . . . 8.3 3.4 9.2 9.9 8.7 9.9 10.2 9.2 7.2 8.2 9.5 9.5
4 . . . . . . . . . . . . . . . . . . . . . . 4.3 1.5 6.1 5.5 4.3 5.1 4.0 5.1 3.1 4.0 6.2 5.1
5 . . . . . . . . . . . . . . . . . . . . . . 2.1 0.6 2.5 2.9 2.5 2.1 1.6 2.7 1.2 2.0 2.7 1.9
6 . . . . . . . . . . . . . . . . . . . . . . 1.4 0.3 1.5 1.8 1.7 1.5 1.2 1.9 0.6 1.4 1.3 *
7 . . . . . . . . . . . . . . . . . . . . . . 0.8 * 0.6 1.2 1.0 0.8 0.6 1.1 0.3 0.8 1.1 *
8 or more . . . . . . . . . . . . . . . . . 0.5 * * 0.4 0.9 0.6 0.5 0.7 0.3 0.5 * *
* Figure does not meet standard of reliability or precision.
NOTE: Numbers may not add to totals because of rounding.
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Table 27. Annual number and percent distribution of office visits by number of diagnostic and screening services ordered or provided, according to ph ysician specialty, averaged
over a 2-year period: United States, 1995–96

























diseases Urology Neurology All other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
None . . . . . . . . . . . . . . . . . . 210,214 43,811 12,070 54,386 2,958 4,149 16,635 19,407 12,793 6,140 11,735 1,028 2,487 2,582 20,034
1 . . . . . . . . . . . . . . . . . . . . 255,033 74,624 40,607 24,332 7,920 24,186 16,796 7,841 6,797 8,498 5,406 5,148 4,973 3,065 24,838
2 . . . . . . . . . . . . . . . . . . . . 126,207 36,845 26,997 7,654 11,362 9,062 4,240 1,412 628 2,517 942 4,275 3,566 1,715 14,992
3 . . . . . . . . . . . . . . . . . . . . 59,762 14,454 11,489 3,755 12,894 2,271 395 247 * 838 208 2,476 1,932 696 8,060
4 . . . . . . . . . . . . . . . . . . . . 30,786 6,730 5,932 1,607 9,742 740 * * * 351 * 1,005 690 275 3,471
5 . . . . . . . . . . . . . . . . . . . . 15,017 2,888 3,042 686 6,097 * * * * 261 * 390 * 82 1,183
6 . . . . . . . . . . . . . . . . . . . . 9,690 1,811 2,185 * 4,608 * * * – * – 159 * * 467
7 . . . . . . . . . . . . . . . . . . . . 5,511 1,234 1,103 * 2,668 * * – – * * * * * *
8 or more . . . . . . . . . . . . . . . 3,568 826 1,007 * 1,266 – – – – * – * – * *
Percent distribution
All visits . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
None . . . . . . . . . . . . . . . . . . 29.4 23.9 11.6 58.5 5.0 10.2 43.5 67.0 63.1 32.7 64.0 7.0 18.0 30.4 27.3
1 . . . . . . . . . . . . . . . . . . . . 35.6 40.7 38.9 26.2 13.3 59.4 43.9 27.1 33.5 45.3 29.5 35.0 36.1 36.1 33.8
2 . . . . . . . . . . . . . . . . . . . . 17.6 20.1 25.9 8.2 19.1 22.3 11.1 4.9 3.1 13.4 5.1 29.1 25.9 20.2 20.4
3 . . . . . . . . . . . . . . . . . . . . 8.3 7.9 11.0 4.0 21.7 5.6 1.0 0.9 * 4.5 1.1 16.8 14.0 8.2 11.0
4 . . . . . . . . . . . . . . . . . . . . 4.3 3.7 5.7 1.7 16.4 1.8 * * * 1.9 * 6.8 5.0 3.2 4.7
5 . . . . . . . . . . . . . . . . . . . . 2.1 1.6 2.9 0.7 10.2 * * * * 1.4 * 2.7 * 1.0 1.6
6 . . . . . . . . . . . . . . . . . . . . 1.4 1.0 2.1 * 7.7 * * * – * – 1.1 * * 0.6
7 . . . . . . . . . . . . . . . . . . . . 0.8 0.7 1.1 * 4.5 * * – – * * * * * *
8 or more . . . . . . . . . . . . . . . 0.5 0.5 1.0 * 2.1 – – – – * – * – * *
– Quantity zero.
* Figure does not meet standard of reliability or precision.











Table 28. Annual number and percent of office visits by diagnostic and therapeutic procedures ordered or performed, according to patient’s age and se x, averaged over a 2-year
period, with corresponding standard errors: United States, 1995–96
Diagnostic or therapeutic





















Number of visits in thousands and corresponding standard error3
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 22,822 193,877 8,914 347,899 11,981 174,006 5,728 425,415 13,625 290,373 9,801
Visits with procedures . . . . . . . . . . . . . . . . . . . . . . . . 195,605 9,119 47,103 3,570 96,843 4,942 51,659 2,514 119,934 5,418 75,671 3,620
Operations on the nervous system . . . . . . . . . . 01–05 476 120 * . . . 320 93 * . . . 253 59 223 80
Operations on the eye . . . . . . . . . . . . . . . . . . 08–16 3,686 703 * . . . 1,549 388 2,019 366 2,229 451 1,457 326
Operations on the ear . . . . . . . . . . . . . . . . . . 18–20 564 95 * . . . 288 69 * . . . 298 68 266 53
Operations on the nose, mouth, and pharynx . . . 21–29 1,174 144 * . . . 655 104 416 80 491 72 683 107
Operations on the cardiovascular system . . . . . . 35–39 768 143 * . . . 481 99 * . . . 455 101 313 90
Operations on the digestive system . . . . . . . . . 42–54 5,035 665 * . . . 3,356 476 1,455 230 3,024 423 2,011 299
Operations on the urinary system . . . . . . . . . . . 55–59 1,688 245 * . . . 667 122 865 139 819 141 869 150
Operations on the male genital organs . . . . . . . . 60–64 938 178 * . . . 535 121 320 93 . . . . . . 938 178
Operations on the female genital organs . . . . . . 65–71 2,999 353 * . . . 2,293 285 * . . . 2,999 353 . . . . . .
Obstetrical procedures . . . . . . . . . . . . . . . . . 72–75 3,323 736 692 198 2,631 640 – . . . 3,323 736 . . . . . .
Operations on the musculoskeletal system . . . . . 76–84 1,935 221 292 69 977 123 665 126 933 147 1,001 151
Operations on the integumentary system . . . . . . 85–86 17,031 1,134 2,670 315 8,588 621 5,773 475 9,351 725 7,680 555
Miscellanous diagnostic and therapeutic
procedures . . . . . . . . . . . . . . . . . . . . . . . . 87–99 189,267 9,870 47,904 3,939 91,875 5,285 49,488 2,674 116,668 6373 72,599 3,839
Other procedures4 . . . . . . . . . . . . . . . . . . . . . . . . . 694 122 * . . . 303 62 341 69 370 86 324 71
Visits without procedures . . . . . . . . . . . . . . . . . . . . . . 520,182 17,154 146,778 7,114 251,056 8,801 122,348 4,403 305,480 10,052 214,702 7,609
Percent of visits and corresponding standard error2
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Visits with procedures . . . . . . . . . . . . . . . . . . . . . . . . 27.3 0.9 24.3 1.4 27.8 1.0 29.7 1.1 28.2 0.9 26.1 0.9
Operations on the nervous system . . . . . . . . . . 01–05 0.1 0.0 * . . . 0.1 0.0 * . . . 0.1 0.0 0.1 0.0
Operations on the eye . . . . . . . . . . . . . . . . . . 08–16 0.5 0.1 * . . . 0.4 0.1 1.2 0.0 0.5 0.1 0.5 0.1
Operations on the ear . . . . . . . . . . . . . . . . . . 18–20 0.1 0.0 * . . . 0.1 0.0 * . . . 0.1 0.0 0.1 0.0
Operations on the nose, mouth, and pharynx . . . 21–29 0.2 0.0 * . . . 0.2 0.0 0.2 0.0 0.1 0.0 0.2 0.0
Operations on the cardiovascular system . . . . . . 35–39 0.1 0.0 * . . . 0.1 0.0 * . . . 0.1 0.0 0.1 0.0
Operations on the digestive system . . . . . . . . . 42–54 0.7 0.1 * . . . 1.0 0.1 0.8 0.1 0.7 0.1 0.7 0.1
Operations on the urinary system . . . . . . . . . . . 55–59 0.2 0.0 * . . . 0.2 0.0 0.5 0.1 0.2 0.0 0.3 0.1
Operations on the male genital organs . . . . . . . . 60–64 0.1 0.0 * . . . 0.2 0.0 0.2 0.1 . . . . . . 0.3 0.1
Operations on the female genital organs . . . . . . 65–71 0.4 0.1 * . . . 0.7 0.1 * . . . 0.7 0.1 . . . . . .
Obstetrical procedures . . . . . . . . . . . . . . . . . 72–75 0.5 0.1 0.4 0.1 0.8 0.2 – . . . 0.8 0.2 . . . . . .
Operations on the musculoskeletal system . . . . . 76–84 0.3 0.0 0.2 0.0 0.3 0.0 0.4 0.1 0.2 0.0 0.3 0.1
Operations on the integumentary system . . . . . . 85–86 2.4 2.0 1.4 0.2 2.5 0.2 3.3 0.3 2.2 0.2 2.6 0.2
Miscellanous diagnostic and therapeutic
procedures . . . . . . . . . . . . . . . . . . . . . . . . 87–99 26.4 1.0 24.7 1.6 26.4 1.1 28.4 1.2 27.4 1.1 25.0 1.0
Other procedures4 . . . . . . . . . . . . . . . . . . . . . . . . . 0.1 0.0 * . . . 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0
Visits without procedures . . . . . . . . . . . . . . . . . . . . . . 72.7 0.9 75.7 1.4 72.2 1.0 70.3 1.1 71.8 0.9 73.9 0.9
* Figure does not meet standard of reliability or precision.
– Quantity zero.
0.0 Quantity is greater than zero but less than 0.05.
. . . Category not applicable.
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2Estimates relating to ambulatory procedures are presented with specific standard errors calculated using SUDAAN software (25).
3Numbers may not add to totals because up to seven procedures could be coded per visit. There were an estimated 229.6 million write-in procedures mentioned overall. Included here are responses to both the ambulatory surgery item on the Patient
Record form (up to two procedures could be reported) and the diagnostic/screening services item (up to five procedures could be reported in the ‘‘other-specify’’ categories).
4Includes operations on the endocrine system (ICD–9–CM codes 06–07), operations on the respiratory system (ICD–9–CM codes 30–34), operations on the hemic and lymphatic system (ICD–9–CM codes 40–41), and obstetrical procedures (ICD–9–CM
codes 72–75).











Table 29. Annual number and percent of office visits by diagnostic and therapeutic procedures ordered or performed, according to
physician specialty group, averaged over a 2-year period, with corresponding standard errors: United States, 1995–96
Diagnostic or therapeutic

















Number of visits in thousands and corresponding standard error4
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 22,822 436,703 17,845 147,257 6,509 131,828 6,484
Visits with procedures . . . . . . . . . . . . . . . . . . . . . . . 195,605 9,119 107,901 6,720 46,775 2,708 40,929 2,960
Operations on the nervous system . . . . . . . . . 01–05 476 120 * . . . *334 115 * . . .
Operations on the eye . . . . . . . . . . . . . . . . . 08–16 3,686 703 * . . . 3,592 701 * . . .
Operations on the ear . . . . . . . . . . . . . . . . . 18–20 564 95 * . . . 366 65 * . . .
Operations on the nose, mouth, and pharynx . . 21–29 1,174 144 * . . . 937 125 * . . .
Operations on the cardiovascular system . . . . . 35–39 768 143 * . . . * . . . 420 107
Operations on the digestive system . . . . . . . . 42–54 5,035 665 1,742 301 1,092 269 2,202 481
Operations on the urinary system . . . . . . . . . . 55–59 1,688 245 * . . . 1,438 215 * 107
Operations on the male genital organs . . . . . . . 60–64 938 178 * . . . 625 129 * . . .
Operations on the female genital organs . . . . . 65–71 2,999 353 2,817 339 * . . . * . . .
Obstetrical procedures . . . . . . . . . . . . . . . . 72–75 3,323 736 3,309 736 – . . . * . . .
Operations on the musculoskeletal system . . . . 76–84 1,935 221 456 87 1,215 156 * . . .
Operations on the integumentary system . . . . . 85–86 17,031 1,134 4,859 481 2,487 276 9,685 973
Miscellanous diagnostic and therapeutic
procedures . . . . . . . . . . . . . . . . . . . . . . . 87–99 189,267 9,870 107,735 7,059 44,318 3,062 37,214 3,540
Other procedures5 . . . . . . . . . . . . . . . . . . . . . . . . 694 122 * . . . 431 73 * . . .
Visits without procedures . . . . . . . . . . . . . . . . . . . . . 520,182 17,154 328,801 14,319 100,482 4,924 90,899 5,419
Percent of visits and corresponding standard error4
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Visits with procedures . . . . . . . . . . . . . . . . . . . . . . . 27.3 0.9 24.7 1.2 31.8 1.3 31.0 1.9
Operations on the nervous system . . . . . . . . . 01–05 0.1 0.0 * . . . *0.2 0.1 * . . .
Operations on the eye . . . . . . . . . . . . . . . . . 08–16 0.5 0.1 * . . . 2.4 0.4 * . . .
Operations on the ear . . . . . . . . . . . . . . . . . 18–20 0.1 0.0 * . . . 0.2 0.0 * . . .
Operations on the nose, mouth, and pharynx . . 21–29 0.2 0.0 * . . . 0.6 0.1 * . . .
Operations on the cardiovascular system . . . . . 35–39 0.1 0.0 * . . . * 0.0 0.3 0.1
Operations on the digestive system . . . . . . . . 42–54 0.7 0.1 0.4 0.1 0.7 0.2 1.7 0.4
Operations on the urinary system . . . . . . . . . . 55–59 0.2 0.0 * . . . 1.0 0.1 * . . .
Operations on the male genital organs . . . . . . . 60–64 0.1 0.0 * . . . 0.4 0.1 * . . .
Operations on the female genital organs . . . . . 65–71 0.4 0.1 0.7 0.1 * 0.0 * . . .
Obstetrical procedures . . . . . . . . . . . . . . . . 72–75 0.5 0.1 0.8 0.2 – . . . * . . .
Operations on the musculoskeletal system . . . . 76–84 0.3 0.0 0.1 0.0 0.8 0.1 * . . .
Operations on the integumentary system . . . . . 85–86 2.4 0.2 1.1 0.1 1.7 0.2 7.3 0.7
Miscellanous diagnostic and therapeutic
procedures . . . . . . . . . . . . . . . . . . . . . . . 87–99 26.4 0.1 24.7 1.3 30.1 1.3 28.2 2.4
Other procedures5 . . . . . . . . . . . . . . . . . . . . . . . . 0.1 0.0 0.0 0.0 0.3 0.1 * . . .
Visits without procedures . . . . . . . . . . . . . . . . . . . . . 72.7 0.9 75.3 1.2 68.2 1.3 69.0 1.9
* Figure does not meet standard of reliability or precision.
– Quantity zero.
0.0 Quantity is greater than zero but less than 0.05.
. . . Category not applicable.
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
2A list of the specialties used to define each group is included in Appendix I.
3Estimates relating to ambulatory procedures are presented with specific standard errors calculated using SUDAAN software (25).
4Numbers may not add to totals because up to seven procedures could be coded per visit. There were an estimated 229.6 million write-in procedures mentioned overall. Included here are responses
to both the ambulatory surgery item on the Patient Record form (up to two procedures could be reported) and the diagnostic/screening services item (up to five procedures could be reported in the
‘‘other-specify’’ categories).
5Includes operations on the endocrine system (ICD–9–CM codes 06–07), operations on the respiratory system (ICD–9–CM codes 30–34), operations on the hemic and lymphatic system (ICD–9–CM
codes 40–41), and obstetrical procedures (ICD–9–CM codes 72–75).
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Table 30. Annual number and percent of office visits by therapeutic and preventive services ordered or provided, according to patient’s age, sex, and race, averaged over a 2-year
period: United States, 1995–96
Therapeutic and
preventive services













and over Female Male White Black Other
Number of visits in thousands1
All visits . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
No services . . . . . . . . . . . . . . . . 467,724 95,314 39,140 114,371 101,600 60,305 56,995 277,541 190,184 404,220 46,357 17,147
Counseling/education
Diet . . . . . . . . . . . . . . . . . . . . . 94,687 17,336 5,631 21,762 25,095 14,711 10,152 57,893 36,793 79,598 9,650 5,439
Exercise . . . . . . . . . . . . . . . . . . 69,395 4,472 5,001 20,074 21,823 10,941 7,085 41,839 27,556 59,948 6,515 2,933
Weight reduction . . . . . . . . . . . . 30,534 722 1,342 8,375 12,019 5,292 2,783 19,389 11,145 25,730 3,824 980
Growth/development . . . . . . . . . . 27,200 22,051 2,099 2,619 * * * 14,727 12,473 23,076 2,892 1,232
Mental health . . . . . . . . . . . . . . . 21,388 2,782 1,632 7,954 5,689 1,911 1,420 12,823 8,565 19,113 1,636 639
Tobacco use/exposure . . . . . . . . . 20,518 3,463 1,760 6,408 5,874 2,283 732 11,285 9,233 17,218 2,689 611
Cholesterol reduction . . . . . . . . . . 18,519 366 * 3,372 6,469 5,174 2,800 9,787 8,732 15,859 1,585 1,075
Injury prevention . . . . . . . . . . . . . 17,860 8,755 1,173 3,159 2,081 1,105 1,586 9,109 8,751 15,708 1,326 825
HIV transmission2 . . . . . . . . . . . . 2,708 * 895 1,342 * * * 1,648 1,060 1,877 730 *
Other counseling . . . . . . . . . . . . 54,781 8,593 5,476 16,622 12,059 6,331 5,701 34,617 20,165 47,435 5,446 1,900
Other therapy
Physiotherapy . . . . . . . . . . . . . . 18,974 1,346 1,881 6,579 5,825 1,863 1,481 10,374 8,601 15,321 2,531 1,123
Psychotherapy . . . . . . . . . . . . . . 17,571 788 1,247 7,389 6,068 1,330 750 10,389 7,182 16,177 1,152 242
Corrective lenses . . . . . . . . . . . . 6,029 743 252 1,144 1,439 1,184 1,267 3,556 2,473 5,504 332 *
Other therapy . . . . . . . . . . . . . . 13,450 1,852 929 3,970 3,038 1,688 1,975 7,388 6,062 11,687 1,061 702
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
No services . . . . . . . . . . . . . . . . 65.3 70.0 67.9 62.5 61.6 65.4 69.7 65.2 65.5 65.5 65.5 61.0
Counseling/education
Diet . . . . . . . . . . . . . . . . . . . . . 13.2 12.7 9.8 11.9 15.2 16.0 12.4 13.6 12.7 12.9 13.6 19.3
Exercise . . . . . . . . . . . . . . . . . . 9.7 3.3 8.7 11.0 13.2 11.9 8.7 9.8 9.5 9.7 9.2 10.4
Weight reduction . . . . . . . . . . . . 4.3 0.5 2.3 4.6 7.3 5.7 3.4 4.6 3.8 4.2 5.4 3.5
Growth/development . . . . . . . . . . 3.8 16.2 3.6 1.4 * * * 3.5 4.3 3.7 4.1 4.4
Mental health . . . . . . . . . . . . . . . 3.0 2.0 2.8 4.3 3.5 2.1 1.7 3.0 2.9 3.1 2.3 2.3
Tobacco use/exposure . . . . . . . . . 2.9 2.5 3.1 3.5 3.6 2.5 0.9 2.7 3.2 2.8 3.8 2.2
Cholesterol reduction . . . . . . . . . . 2.6 0.3 * 1.8 3.9 5.6 3.4 2.3 3.0 2.6 2.2 3.8
Injury prevention . . . . . . . . . . . . . 2.5 6.4 2.0 1.7 1.3 1.2 1.9 2.1 3.0 2.5 1.9 2.9
HIV transmission2 . . . . . . . . . . . . 0.4 * 1.6 0.7 * * * 0.4 0.4 0.3 1.0 *
Other counseling . . . . . . . . . . . . 7.7 6.3 9.5 9.1 7.3 6.9 7.0 8.1 6.9 7.7 7.7 6.8
Other therapy
Physiotherapy . . . . . . . . . . . . . . 2.7 1.0 3.3 3.6 3.5 2.0 1.8 2.4 3.0 2.5 3.6 4.0
Psychotherapy . . . . . . . . . . . . . . 2.5 0.6 2.2 4.0 3.7 1.4 0.9 2.4 2.5 2.6 1.6 0.9
Corrective lenses . . . . . . . . . . . . 0.8 0.5 0.4 0.6 0.9 1.3 1.5 0.8 0.9 0.9 0.5 *
Other therapy . . . . . . . . . . . . . . 1.9 1.4 1.6 2.2 1.8 1.8 2.4 1.7 2.1 1.9 1.5 2.5
* Figure does not meet standard of reliability or precision.
. . . Category not applicable.
1Numbers may exceed totals because more than one category may be reported per visit.






































diseases Urology Neurology All other
Number of visits in thousands1
All visits . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
No services . . . . . . . . . . . . . . 467,724 123,734 64,674 61,392 36,428 30,929 21,859 21,373 4,132 14,265 15,949 7,304 11,301 6,442 47,942
Counseling/education
Diet . . . . . . . . . . . . . . . . . . . 94,687 28,109 21,330 15,029 9,808 * 539 753 740 1,733 307 4,950 833 384 9,908
Exercise . . . . . . . . . . . . . . . . 69,395 20,637 15,151 3,994 7,544 * 6,904 329 901 928 * 4,017 322 583 7,843
Weight reduction . . . . . . . . . . 30,534 11,479 7,893 568 2,452 * 646 * 461 389 * 2,374 168 147 3,770
Growth/development . . . . . . . . 27,200 3,546 474 19,253 2,910 * * * 256 * * * – * 302
Mental health . . . . . . . . . . . . . 21,388 5,254 2,787 2,138 845 * * * 8,584 * * 226 * 159 1,167
Tobacco use/exposure . . . . . . . 20,518 6,507 4,485 3,353 1,771 * * * 396 329 353 834 * 180 1,838
Cholesterol reduction . . . . . . . . 18,519 6,318 6,539 322 676 * * * * 184 * 2,817 * * 1,464
Injury prevention . . . . . . . . . . . 17,860 4,380 1,643 7,846 447 * 1,858 * * 194 * 231 * 143 812
HIV transmission2 . . . . . . . . . . 2,708 810 360 376 649 – * * * * * * * – *
Other . . . . . . . . . . . . . . . . . . 54,781 9,444 6,094 6,396 9,857 3,085 2,056 6,178 702 1,682 1,361 869 1,217 501 5,339
Other therapy
Physiotherapy . . . . . . . . . . . . 18,974 5,297 1,559 * * * 7,097 * * 214 * * * 440 3,486
Psychotherapy . . . . . . . . . . . . 17,571 2,471 1,097 * * * * * 12,360 * – * * * 703
Corrective lenses . . . . . . . . . . 6,029 * – * – 5,670 – – * – – * – – *
Other . . . . . . . . . . . . . . . . . . 13,450 2,414 1,099 1,439 735 882 1,450 568 525 345 354 235 305 192 2,907
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
No services . . . . . . . . . . . . . . 65.3 67.5 61.9 66.1 61.2 76.0 57.1 73.8 20.4 76.0 86.9 49.7 82.0 76.0 65.3
Counseling/education
Diet . . . . . . . . . . . . . . . . . . . 13.2 15.3 20.4 16.2 16.5 * 1.4 2.6 3.6 9.2 1.7 33.7 6.0 4.5 13.5
Exercise . . . . . . . . . . . . . . . . 9.7 11.3 14.5 4.3 12.7 * 18.0 1.1 4.4 4.9 * 27.3 2.3 6.9 10.7
Weight reduction . . . . . . . . . . 4.3 6.3 7.6 0.6 4.1 * 1.7 * 2.3 2.1 * 16.1 1.2 1.7 5.1
Growth/development . . . . . . . . 3.8 1.9 * 20.7 4.9 * * * 1.3 * * * – * 0.4
Mental health . . . . . . . . . . . . . 3.0 2.9 2.7 2.3 1.4 * * * 42.3 * * 1.5 * 1.9 1.6
Tobacco use/exposure . . . . . . . 2.9 3.6 4.3 3.6 3.0 * * * 1.9 1.8 1.9 5.7 * 2.1 2.5
Cholesterol reduction . . . . . . . . 2.6 3.4 6.3 * 1.1 * * * * 1.0 * 19.2 * * 2.0
Injury prevention . . . . . . . . . . . 2.5 2.4 1.6 8.4 0.8 * 4.9 * * 1.0 * 1.6 * 1.7 1.1
HIV transmission2 . . . . . . . . . . 0.4 0.4 * * 1.1 – * * * * * * * – *
Other . . . . . . . . . . . . . . . . . . 7.7 5.2 5.8 6.9 16.6 7.6 5.4 21.3 3.5 9.0 7.4 5.9 8.8 5.9 7.3
Other therapy
Physiotherapy . . . . . . . . . . . . 2.7 2.9 1.5 * * * 18.5 * * 1.1 * * * 5.2 4.7
Psychotherapy . . . . . . . . . . . . 2.5 1.3 1.1 * * * * * 60.9 * – * * * 1.0
Corrective lenses . . . . . . . . . . 0.8 * – * – 13.9 – – * – – * – – *
Other . . . . . . . . . . . . . . . . . . 1.9 1.3 1.1 1.5 1.2 2.2 3.8 2.0 2.6 1.8 1.9 1.6 2.2 2.3 4.0
– Quantity zero.
* Figure does not meet standard of precision or reliability.
. . . Category not applicable.
1Numbers may exceed totals because more than one category may be reported per visit.











Table 32. Annual number and percent distribution of office visits by medication therapy and number of medications provided or prescribed, according to patient’s age, sex, and














and over Female Male White Black Other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
Medication therapy
provided or prescribed
Yes . . . . . . . . . . . . . . . . . . . . . . . . . . 458,696 88,483 33,462 110,786 106,972 62,090 56,903 273,570 185,126 393,160 47,740 17,796
No . . . . . . . . . . . . . . . . . . . . . . . . . . 257,091 47,717 24,220 72,233 57,908 30,121 24,892 151,844 105,247 223,768 23,006 10,318
Number of medications
None . . . . . . . . . . . . . . . . . . . . . . . . . 257,091 47,717 24,220 72,233 57,908 30,121 24,892 151,844 105,247 223,768 23,006 10,318
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . 207,748 48,260 18,535 55,418 44,235 21,988 19,312 121,201 86,548 178,925 20,599 8,225
2 . . . . . . . . . . . . . . . . . . . . . . . . . . . 127,371 25,658 9,748 32,548 29,683 16,318 13,417 75,547 51,824 108,148 14,001 5,222
3 . . . . . . . . . . . . . . . . . . . . . . . . . . . 58,668 10,736 3,329 12,747 14,608 8,842 8,406 35,811 22,857 50,235 6,214 2,220
4 . . . . . . . . . . . . . . . . . . . . . . . . . . . 29,204 2,878 1,331 5,837 8,100 5,422 5,637 18,062 11,142 24,699 3,205 1,300
5 . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,616 605 347 2,218 4,105 3,482 3,858 9,368 5,248 12,731 1,584 *
6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 21,089 * * 2,018 6,241 6,039 6,273 13,581 7,508 18,424 2,137 529
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Medication therapy
provided or prescribed
Yes . . . . . . . . . . . . . . . . . . . . . . . . . . 64.1 65.0 58.0 60.5 64.9 67.3 69.6 64.3 63.8 63.7 67.5 63.3
No . . . . . . . . . . . . . . . . . . . . . . . . . . 35.9 35.0 42.0 39.5 35.1 32.7 30.4 35.7 36.2 36.3 32.5 36.7
Number of medications
None . . . . . . . . . . . . . . . . . . . . . . . . . 35.9 35.0 42.0 39.5 35.1 32.7 30.4 35.7 36.2 36.3 32.5 36.7
1 . . . . . . . . . . . . . . . . . . . . . . . . . . . 29.0 35.4 32.1 30.3 26.8 23.8 23.6 28.5 29.8 29.0 29.1 29.3
2 . . . . . . . . . . . . . . . . . . . . . . . . . . . 17.8 18.8 16.9 17.8 18.0 17.7 16.4 17.8 17.8 17.5 19.8 18.6
3 . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.2 7.9 5.8 7.0 8.9 9.6 10.3 8.4 7.9 8.1 8.8 7.9
4 . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.1 2.1 2.3 3.2 4.9 5.9 6.9 4.2 3.8 4.0 4.5 4.6
5 . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.0 0.4 0.6 1.2 2.5 3.8 4.7 2.2 1.8 2.1 2.2 *
6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.9 * * 1.1 3.8 6.5 7.7 3.2 2.6 3.0 3.0 1.9
* Figure does not meet standard of reliability or precision.











Table 33. Annual number and percent distribution of office visits by medication therapy and number of medications provided or prescribed, according to physician specialty,
























diseases Urology Neurology All other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Medication therapy
provided or prescribed
Yes . . . . . . . . . . . . . . . . . . . 458,696 132,483 81,230 65,281 28,542 21,340 11,768 18,464 15,184 5,510 9,549 11,723 6,238 5,398 45,986
No . . . . . . . . . . . . . . . . . . . 257,091 50,741 23,201 27,607 30,973 19,374 26,499 10,506 5,103 13,252 8,796 2,983 7,542 3,083 27,430
Number of medications
provided or prescribed
None . . . . . . . . . . . . . . . . . . 257,091 50,741 23,201 27,607 30,973 19,374 26,499 10,506 5,103 13,252 8,796 2,983 7,542 3,083 27,430
1 . . . . . . . . . . . . . . . . . . . . 207,748 56,099 29,184 35,276 19,358 9,701 8,201 8,648 7,936 3,026 5,429 1,730 4,664 2,428 16,068
2 . . . . . . . . . . . . . . . . . . . . 127,371 39,747 22,841 18,104 6,531 6,158 2,439 5,887 3,993 1,297 2,730 2,774 964 1,200 12,706
3 . . . . . . . . . . . . . . . . . . . . 58,668 17,595 11,916 8,798 1,536 3,374 708 2,525 2,021 568 890 1,718 315 755 5,951
4 . . . . . . . . . . . . . . . . . . . . 29,204 9,415 6,688 2,343 763 992 267 906 700 283 317 1,829 * 459 4,128
5 . . . . . . . . . . . . . . . . . . . . 14,616 3,943 4,020 * * 539 * 335 272 * * 1,386 * 259 2,684
6 . . . . . . . . . . . . . . . . . . . . 21,089 5,685 6,583 * * 577 * * 262 214 * 2,285 * 298 4,449
Percent distribution
All visits . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Medication therapy
provided or prescribed
Yes . . . . . . . . . . . . . . . . . . . 64.1 72.3 77.8 70.3 48.0 52.4 30.8 63.7 74.8 29.4 52.1 79.7 45.3 63.6 62.6
No . . . . . . . . . . . . . . . . . . . 35.9 27.7 22.2 29.7 52.0 47.6 69.2 36.3 25.2 70.6 47.9 20.3 54.7 36.4 37.4
Number of medications
provided or prescribed
None . . . . . . . . . . . . . . . . . . 35.9 27.7 22.2 29.7 52.0 47.6 69.2 36.3 25.2 70.6 47.9 20.3 54.7 36.4 37.4
1 . . . . . . . . . . . . . . . . . . . . 29.0 30.6 27.9 38.0 32.5 23.8 21.4 29.9 39.1 16.1 29.6 11.8 33.8 28.6 21.9
2 . . . . . . . . . . . . . . . . . . . . 17.8 21.7 21.9 19.5 11.0 15.1 6.4 20.3 19.7 6.9 14.9 18.9 7.0 14.1 17.3
3 . . . . . . . . . . . . . . . . . . . . 8.2 9.6 11.4 9.5 2.6 8.3 1.8 8.7 10.0 3.0 4.9 11.7 2.3 8.9 8.1
4 . . . . . . . . . . . . . . . . . . . . 4.1 5.1 6.4 2.5 1.3 2.4 0.7 3.1 3.4 1.5 1.7 12.4 * 5.4 5.6
5 . . . . . . . . . . . . . . . . . . . . 2.0 2.2 3.8 * * 1.3 * 1.2 1.3 * * 9.4 * 3.1 3.7
6 . . . . . . . . . . . . . . . . . . . . 2.9 3.1 6.3 * * 1.4 * * 1.3 1.1 * 15.5 * 3.5 6.1
* Figure does not meet standard of reliability or precision.











Table 34. Annual number and percent distribution of drug mentions at office visits by therapeutic classification, according to patient’s age, sex, an d race, averaged over a 2-year














and over Female Male White Black Other
Number of mentions in thousands
All mentions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 954,925 148,396 56,112 205,302 237,797 156,479 150,839 580,304 374,621 818,916 100,806 35,204
Cardiovascular-renal drugs . . . . . . . . . . . . . . . . . . . . . . . . . 138,401 1,156 789 11,190 39,145 40,013 46,108 79,157 59,244 117,606 17,258 3,537
Antimicrobial agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126,018 45,689 12,944 31,651 19,296 8,960 7,479 70,697 55,322 107,265 13,577 5,176
Drugs used for pain relief . . . . . . . . . . . . . . . . . . . . . . . . . . 113,259 11,610 5,792 31,158 31,831 17,003 15,865 65,456 47,803 96,016 13,201 4,042
Respiratory tract drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100,600 28,799 8,195 23,440 20,968 11,104 8,095 59,120 41,481 85,224 10,387 4,989
Hormones and agents affecting hormonal mechanisms . . . . . . . . 88,797 2,901 4,424 17,934 32,824 17,381 13,332 66,726 22,071 77,373 9,200 2,224
Central nervous system . . . . . . . . . . . . . . . . . . . . . . . . . . . 69,175 3,607 3,286 24,296 22,406 8,403 7,176 45,609 23,567 61,461 5,992 1,722
Skin/mucous membrane . . . . . . . . . . . . . . . . . . . . . . . . . . . 57,883 10,287 7,280 15,816 12,329 7,238 4,934 35,380 22,503 49,000 6,142 2,741
Metabolic/nutrient agents . . . . . . . . . . . . . . . . . . . . . . . . . . 49,198 3,395 3,805 10,338 11,229 10,695 9,734 34,098 15,099 42,585 4,883 1,729
Gastrointestinal agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43,381 1,971 1,689 9,573 12,888 8,653 8,608 26,708 16,673 36,820 4,421 2,140
Immunologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36,139 26,147 1,217 1,926 2,502 2,307 2,039 18,807 17,332 31,642 3,142 1,355
Ophthalmics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33,758 3,566 1,026 3,953 6,201 8,320 10,693 19,989 13,768 30,393 2,713 652
Neurologic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22,769 *510 1,258 8,760 7,228 2,681 2,333 13,251 9,518 19,664 2,475 631
Hematologic agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,350 * 914 2,378 3,439 3,705 5,342 10,309 6,040 14,157 1,783 *
Oncolytics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,391 * * 911 2,986 2,125 2,095 4,642 3,749 7,269 891 *
Contrast media/radiopharmaceuticals . . . . . . . . . . . . . . . . . . . 7,953 2,148 *686 2,037 2,117 *612 *353 4,604 3,349 6,903 *384 666
Other2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15,977 1,975 880 3,582 4,068 2,823 2,648 9,582 6,396 13,745 1,496 736
Unclassified, miscellaneous . . . . . . . . . . . . . . . . . . . . . . . . . 26,876 3,907 1,809 6,357 6,339 4,456 4,006 16,169 10,707 21,792 2,861 2,223
Percent distribution
All mentions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Cardiovascular-renal drugs . . . . . . . . . . . . . . . . . . . . . . . . . 14.5 0.8 1.4 5.5 16.5 25.6 30.6 13.6 15.8 14.4 17.1 10.0
Antimicrobial agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13.2 30.8 23.1 15.4 8.1 5.7 5.0 12.2 14.8 13.1 13.5 14.7
Drugs used for pain relief . . . . . . . . . . . . . . . . . . . . . . . . . . 11.9 7.8 10.3 15.2 13.4 10.9 10.5 11.3 12.8 11.7 13.1 11.5
Respiratory tract drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.5 19.4 14.6 11.4 8.8 7.1 5.4 10.2 11.1 10.4 10.3 14.2
Hormones and agents affecting hormonal mechanisms . . . . . . . . 9.3 2.0 7.9 8.7 13.8 11.1 8.8 11.5 5.9 9.4 9.1 6.3
Central nervous system . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.2 2.4 5.9 11.8 9.4 5.4 4.8 7.9 6.3 7.5 5.9 4.9
Skin/mucous membrane . . . . . . . . . . . . . . . . . . . . . . . . . . . 6.1 6.9 13.0 7.7 5.2 4.6 3.3 6.1 6.0 6.0 6.1 7.8
Metabolic/nutrient agents . . . . . . . . . . . . . . . . . . . . . . . . . . 5.2 2.3 6.8 5.0 4.7 6.8 6.5 5.9 4.0 5.2 4.8 4.9
Gastrointestinal agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.5 1.3 3.0 4.7 5.4 5.5 5.7 4.6 4.5 4.5 4.4 6.1
Immunologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.8 17.6 2.2 0.9 1.1 1.5 1.4 3.2 4.6 3.9 3.1 3.9
Ophthalmics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.5 2.4 1.8 1.9 2.6 5.3 7.1 3.4 3.7 3.7 2.7 1.9
Neurologic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.4 *0.3 2.2 4.3 3.0 1.7 1.5 2.3 2.5 2.4 2.5 1.8
Hematologic agents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.7 * 1.6 1.2 1.4 2.4 3.5 1.8 1.6 1.7 1.8 *
Oncolytics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.9 * * 0.4 1.3 1.4 1.4 0.8 1.0 0.9 0.9 *
Contrast media/radiopharmaceuticals . . . . . . . . . . . . . . . . . . . 0.8 1.4 *1.2 1.0 0.9 *0.4 *0.2 0.8 0.9 0.8 *0.4 1.9
Other2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.7 1.3 1.6 1.7 1.7 1.8 1.8 1.7 1.7 1.7 1.5 2.1
Unclassified, miscellaneous . . . . . . . . . . . . . . . . . . . . . . . . . 2.8 2.6 3.2 3.1 2.7 2.8 2.7 2.8 2.9 2.7 2.8 6.3
* Figure does not meet standard of reliability or precision.
1Therapeutic classification is based on the standard drug classification used in the National Drug Code Directory, 1995 edition (22).
2Includes anesthetic drugs, otologics, antiparasitics, antidotes, and homeopathic products.











Table 35. Annual number and percent distribution of drug mentions at office visits by patient’s age, sex, and race, according to therapeutic classific ation, averaged over a 2-year

















and over Female Male White Black Other
Percent distribution
All mentions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 954,925 100.0 15.5 5.9 21.5 24.9 16.4 15.8 60.8 39.2 85.8 10.6 3.7
Cardiovascular-renal drugs . . . . . . . . . . . . . . . . . . . . . 138,401 100.0 0.8 0.6 8.1 28.3 28.9 33.3 57.2 42.8 85.0 12.5 2.6
Antimicrobial agents . . . . . . . . . . . . . . . . . . . . . . . . . 126,018 100.0 36.3 10.3 25.1 15.3 7.1 5.9 56.1 43.9 85.1 10.8 4.1
Drugs used for pain relief . . . . . . . . . . . . . . . . . . . . . . 113,259 100.0 10.3 5.1 27.5 28.1 15.0 14.0 57.8 42.2 84.8 11.7 3.6
Respiratory tract drugs . . . . . . . . . . . . . . . . . . . . . . . . 100,600 100.0 28.6 8.1 23.3 20.8 11.0 8.0 58.8 41.2 84.7 10.3 5.0
Hormones and agents affecting hormonal mechanisms . . . . 88,797 100.0 3.3 5.0 20.2 37.0 19.6 15.0 75.1 24.9 87.1 10.4 2.5
Central nervous system . . . . . . . . . . . . . . . . . . . . . . . 69,175 100.0 5.2 4.8 35.1 32.4 12.1 10.4 65.9 34.1 88.8 8.7 2.5
Skin/mucous membrane . . . . . . . . . . . . . . . . . . . . . . . 57,883 100.0 17.8 12.6 27.3 21.3 12.5 8.5 61.1 38.9 84.7 10.6 4.7
Metabolic/nutrient agents . . . . . . . . . . . . . . . . . . . . . . 49,198 100.0 6.9 7.7 21.0 22.8 21.7 19.8 69.3 30.7 86.6 9.9 3.5
Gastrointestinal agents . . . . . . . . . . . . . . . . . . . . . . . . 43,381 100.0 4.5 3.9 22.1 29.7 19.9 19.8 61.6 38.4 84.9 10.2 4.9
Immunologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36,139 100.0 72.4 3.4 5.3 6.9 6.4 5.6 52.0 48.0 87.6 8.7 3.8
Ophthalmics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33,758 100.0 10.6 3.0 11.7 18.4 24.6 31.7 59.2 40.8 90.0 8.0 1.9
Neurologic drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . 22,769 100.0 *2.2 5.5 38.5 31.7 11.8 10.2 58.2 41.8 86.4 10.9 2.8
Hematologic agents . . . . . . . . . . . . . . . . . . . . . . . . . . 16,350 100.0 * 5.6 14.5 21.0 22.7 32.7 63.1 36.9 86.6 10.9 *
Oncolytics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,391 100.0 * * 10.9 35.6 25.3 25.0 55.3 44.7 86.6 10.6 *
Contrast media/radiopharmaceuticals . . . . . . . . . . . . . . . 7,953 100.0 27.0 *8.6 25.6 26.6 *7.7 *4.4 57.9 42.1 86.8 *4.8 8.4
Other2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15,977 100.0 12.4 5.5 22.4 25.5 17.7 16.6 60.0 40.0 86.0 9.4 4.6
Unclassified, miscellaneous . . . . . . . . . . . . . . . . . . . . . 26,876 100.0 14.5 6.7 23.7 23.6 16.6 14.9 60.2 39.8 81.1 10.6 8.3
* Figure does not meet standard of reliability or precision.
1Therapeutic classification is based on the standard drug classification used in the National Drug Code Directory, 1995 edition (22).
2Includes anesthetic drugs, otologics, antiparasitics, antidotes, and homeopathic products.




































diseases Urology Neurology All other
Number of drug mentions in thousands
All mentions . . . . . . . . . . . . . . . . . . 954,925 279,861 196,956 111,281 41,959 42,261 17,126 34,273 27,718 10,347 15,808 40,389 8,979 12,009 115,959
Cardiovascular-renal drugs . . . . . . . . . 138,401 42,941 47,395 677 1,314 2,507 576 219 807 1,628 333 19,895 1,883 1,436 16,791
Antimicrobial agents . . . . . . . . . . . . . 126,018 44,470 19,201 33,651 3,522 1,109 580 5,773 * 1,724 3,963 457 2,636 246 8,523
Drugs used for pain relief . . . . . . . . . . 113,259 38,710 24,243 8,401 2,016 1,499 9,331 238 2,462 1,510 652 5,214 753 2,812 15,417
Respiratory tract drugs . . . . . . . . . . . . 100,600 34,363 21,063 21,456 751 1,581 198 659 491 700 4,972 829 * 243 13,175
Hormones and related agents . . . . . . . 88,797 25,212 21,633 2,800 15,625 1,841 1,755 1,425 438 1,042 869 2,872 843 662 11,781
Central nervous system . . . . . . . . . . . 69,175 20,875 12,246 2,179 1,137 349 459 645 19,225 612 192 1,297 334 2,161 7,465
Skin/mucous membrane . . . . . . . . . . . 57,883 11,322 6,553 6,229 2,531 686 1,843 20,868 211 629 1,897 195 224 * 4,626
Metabolic and nutrient agents . . . . . . . 49,198 12,442 10,302 2,674 9,722 834 181 227 213 401 295 4,567 153 349 6,837
Gastrointestinal agents . . . . . . . . . . . . 43,381 13,387 12,824 1,607 486 504 251 * 177 839 159 1,525 453 405 10,701
Immunologics . . . . . . . . . . . . . . . . . 36,139 7,709 2,972 22,656 * * * * * * 254 * * * 1,941
Ophthalmics . . . . . . . . . . . . . . . . . . 33,758 1,597 1,161 1,906 * 27,313 * * * * 313 * * * 998
Neurologic drugs . . . . . . . . . . . . . . . 22,769 7,803 4,243 * * * 649 * 3,073 205 * 352 * 2,766 2,791
Hematologic agents . . . . . . . . . . . . . . 16,350 3,677 4,512 * 2,092 * * * * 204 * 1,936 * 351 2,738
Oncolytics . . . . . . . . . . . . . . . . . . . . 8,391 *523 1,069 * * * * 313 * 146 * * 549 * 5,258
Contrast media/radiopharmaceuticals . . . 7,953 1,573 *559 2,192 10 842 – * * * 594 * – * 2,000
Other2 . . . . . . . . . . . . . . . . . . . . . . 15,977 4,418 2,439 1,277 583 930 697 1,689 183 319 615 *176 153 203 2,296
Unclassified/miscellaneous . . . . . . . . . 26,876 8,839 4,542 2,732 1,617 1,772 443 1,822 223 232 564 759 505 205 2,621
Percent distribution
All mentions . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Cardiovascular-renal drugs . . . . . . . . . 14.5 15.3 24.1 0.6 3.1 5.9 3.4 0.6 2.9 15.7 2.1 49.3 21.0 12.0 14.5
Antimicrobial agents . . . . . . . . . . . . . 13.2 15.9 9.7 30.2 8.4 2.6 3.4 16.8 0.0 16.7 25.1 1.1 29.4 2.0 7.4
Drugs used for pain relief . . . . . . . . . . 11.9 13.8 12.3 7.5 4.8 3.5 54.5 0.7 8.9 14.6 4.1 12.9 8.4 23.4 13.3
Respiratory tract drugs . . . . . . . . . . . . 10.5 12.3 10.7 19.3 1.8 3.7 1.2 1.9 1.8 6.8 31.5 2.1 * 2.0 11.4
Hormones and related agents . . . . . . . 9.3 9.0 11.0 2.5 37.2 4.4 10.2 4.2 1.6 10.1 5.5 7.1 9.4 5.5 10.2
Central nervous system . . . . . . . . . . . 7.2 7.5 6.2 2.0 2.7 0.8 2.7 1.9 69.4 5.9 1.2 3.2 3.7 18.0 6.4
Skin/mucous membrane . . . . . . . . . . . 6.1 4.0 3.3 5.6 6.0 1.6 10.8 60.9 0.8 6.1 12.0 0.5 2.5 * 4.0
Metabolic and nutrient agents . . . . . . . 5.2 4.4 5.2 2.4 23.2 2.0 1.1 0.7 0.8 3.9 1.9 11.3 1.7 2.9 5.9
Gastrointestinal agents . . . . . . . . . . . . 4.5 4.8 6.5 1.4 1.2 1.2 1.5 * 0.6 8.1 1.0 3.8 5.0 3.4 9.2
Immunologics . . . . . . . . . . . . . . . . . 3.8 2.8 1.5 20.4 * * :* * * * 1.6 * * * 1.7
Ophthalmics . . . . . . . . . . . . . . . . . . 3.5 0.6 0.6 1.7 * 64.6 * * * * 2.0 * * * 0.9
Neurologic drugs . . . . . . . . . . . . . . . 2.4 2.8 2.2 * * * 3.8 * 11.1 2.0 * 0.9 * 23.0 2.4
Hematologic agents . . . . . . . . . . . . . . 1.7 1.3 2.3 * 5.0 * * * * 2.0 * 4.8 * 2.9 2.4
Oncolytics . . . . . . . . . . . . . . . . . . . . 0.9 *0.2 0.5 * * * * 0.9 * 1.4 * * 6.1 * 4.5
Contrast media/radiopharmaceuticals . . . 0.8 0.6 *0.3 2.0 * 2.0 – * * * 3.8 * – * 1.7
Other2 . . . . . . . . . . . . . . . . . . . . . . 1.7 1.6 1.2 1.1 1.4 2.2 4.1 4.9 0.7 3.1 3.9 *0.4 1.7 1.7 2.0
Unclassified/miscellaneous . . . . . . . . . 2.8 3.2 2.3 2.5 3.9 4.2 2.6 5.3 0.8 2.2 3.6 1.9 5.6 1.7 2.3
* Figure does not meet standard of reliability or precision.
– Quantity zero.
0.0 Quantity more than zero but less 0.05.
1Therapeutic classification is based on the standard drug classification used in the National Drug Code Directory, 1995 edition (22).
2Includes anesthetic drugs, otologics, antiparasitics, antidotes, and homeopathic products.





































diseases Urology Neurology All other
Percent distribution
All mentions . . . . . . . . . . . . . . . . . . 954,925 100.0 29.3 20.6 11.7 4.4 4.4 1.8 3.6 2.9 1.1 1.7 4.2 0.9 1.3 12.1
Cardiovascular-renal drugs . . . . . . . . . 138,401 100.0 31.0 34.2 0.5 0.9 1.8 0.4 0.2 0.6 1.2 0.2 14.4 1.4 1.0 12.1
Antimicrobial agents . . . . . . . . . . . . . 126,018 100.0 35.3 15.2 26.7 2.8 0.9 0.5 4.6 * 1.4 3.1 0.4 2.1 0.2 6.8
Drugs used for pain relief . . . . . . . . . . 113,259 100.0 34.2 21.4 7.4 1.8 1.3 8.2 0.2 2.2 1.3 0.6 4.6 0.7 2.5 13.6
Respiratory tract drugs . . . . . . . . . . . . 100,600 100.0 34.2 20.9 21.3 0.7 1.6 0.2 0.7 0.5 0.7 4.9 0.8 * 0.2 13.1
Hormones and related agents . . . . . . . 88,797 100.0 28.4 24.4 3.2 17.6 2.1 2.0 1.6 0.5 1.2 1.0 3.2 0.9 0.7 13.3
Central nervous system . . . . . . . . . . . 69,175 100.0 30.2 17.7 3.2 1.6 0.5 0.7 0.9 27.8 0.9 0.3 1.9 0.5 3.1 10.8
Skin/mucous membrane . . . . . . . . . . . 57,883 100.0 19.6 11.3 10.8 4.4 1.2 3.2 36.1 0.4 1.1 3.3 0.3 0.4 * 8.0
Metabolic and nutrient agents . . . . . . . 49,198 100.0 25.3 20.9 5.4 19.8 1.7 0.4 0.5 0.4 0.8 0.6 9.3 0.3 0.7 13.9
Gastrointestinal agents . . . . . . . . . . . . 43,381 100.0 30.9 29.6 3.7 1.1 1.2 0.6 * 0.4 1.9 0.4 3.5 1.0 0.9 24.7
Immunologics . . . . . . . . . . . . . . . . . 36,139 100.0 21.3 8.2 62.7 * * * * * * 0.7 * * * 5.4
Ophthalmics . . . . . . . . . . . . . . . . . . 33,758 100.0 4.7 3.4 5.6 * 80.9 * * * * 0.9 * * * 3.0
Neurologic drugs . . . . . . . . . . . . . . . 22,769 100.0 34.3 18.6 * * * 2.9 * 13.5 0.9 * 1.5 * 12.1 12.3
Hematologic agents . . . . . . . . . . . . . . 16,350 100.0 22.5 27.6 * 12.8 * * * * 1.2 * 11.8 * 2.1 16.7
Oncolytics . . . . . . . . . . . . . . . . . . . . 8,391 100.0 *6.2 12.7 * * * * 3.7 * 1.7 * * 6.5 * 62.7
Contrast media/radiopharmaceuticals . . . 7,953 100.0 19.8 *7.0 27.6 * 10.6 – * * * 7.5 * – * 25.1
Other2 . . . . . . . . . . . . . . . . . . . . . . 15,977 100.0 27.7 15.3 8.0 3.6 5.8 4.4 10.6 1.1 2.0 3.8 *1.1 1.0 1.3 14.4
Unclassified/miscellaneous . . . . . . . . . 26,876 100.0 32.9 16.9 10.2 6.0 6.6 1.6 6.8 0.8 0.9 2.1 2.8 1.9 0.8 9.8
* Figure does not meet standard of reliability or precision.
– Quantity zero.
1Therapeutic classification is based on the standard drug classification used in the National Drug Code Directory, 1995 edition (22).
2Includes anesthetic drugs, otologics, antiparasitics, antidotes, and homeopathic products.











Table 38. Annual number of occurrences and percent of drug mentions for the 10 generic substances most frequently used at office visits,
according to patient’s age, sex, and race, averaged over a 2-year period: United States, 1995–96







All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,148,725 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37,144 3.9
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35,405 3.7
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,167 1.8
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,374 1.7
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,299 1.7
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,087 1.7
Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,973 1.5
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,981 1.4
Guaifenesin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,601 1.3
Phenylephrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,496 1.2
Under 15 years
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201,309 . . .
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21,674 14.6
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,659 5.2
Polio vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,970 4.0
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,888 4.0
Hepatitis B vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,728 3.2
Diphtheria Pertussis Tetanus vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,178 2.8
Erythromycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,057 2.7
Phenylephrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,943 2.7
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,491 2.4
Trimethoprim . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,427 2.3
15–24 years
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76,081 . . .
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,882 5.1
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,399 4.3
Ergocalciferol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,978 3.5
Vitamin A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,950 3.5
Pyridoxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,934 3.4
Riboflavin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,917 3.4
Thiamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,907 3.4
Estradiol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,704 3.0
Erythromycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,662 3.0
Cephalexin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,452 2.6
25–44 years
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 262,524 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,257 5.5
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,865 2.9
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,313 2.6
Pyridoxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,492 2.2
Hydrocodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,477 2.2
Riboflavin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,435 2.2
Thiamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,410 2.1
Vitamin A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,402 2.1
Ergocalciferol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,379 2.1
Guaifenesin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,089 2.0
See footnotes at end of table.
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Table 38. Annual number of occurrences and percent of drug mentions for the 10 generic substances most frequently used at office visits,
according to patient’s age, sex, and race, averaged over a 2-year period: United States, 1995–96—Con.







All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 268,911 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,787 3.7
Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,931 3.3
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,921 2.1
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,629 1.9
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,318 1.8
Medroxyprogesterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,065 1.7
Levothyroxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,289 1.4
Naproxen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,997 1.3
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,960 1.2
Atenolol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,894 1.2
65–74 years
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172,949 . . .
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,908 3.1
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,490 2.9
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,574 2.3
Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,365 2.2
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,362 2.1
Digoxin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,942 1.9
Levothyroxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,750 1.8
Potassium replacement solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,510 1.6
Diltiazem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,445 1.6
Glyburide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,229 1.4
75 years and over
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166,944 . . .
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,754 3.8
Digoxin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,561 3.7
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,156 3.4
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,086 3.4
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,682 2.4
Potassium replacement solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,297 2.2
Levothyroxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,871 1.9
Warfarin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,700 1.8
Diltiazem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,656 1.8
Nifedipine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,546 1.7
Female
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 708,723 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21,989 3.8
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19,347 3.3
Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,741 2.4
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,556 2.0
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9,575 1.7
Levothyroxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,898 1.5
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,789 1.5
Estradiol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,395 1.4
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,972 1.4
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,751 1.3
See footnotes at end of table.
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Table 38. Annual number of occurrences and percent of drug mentions for the 10 generic substances most frequently used at office visits,
according to patient’s age, sex, and race, averaged over a 2-year period: United States, 1995–96—Con.







All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 440,002 . . .
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,058 4.3
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15,155 4.0
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,327 2.2
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,592 2.0
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7,298 1.9
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,230 1.4
Guaifenesin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,104 1.4
Hydrocodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,919 1.3
Erythromycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,830 1.3
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,818 1.3
White
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 984,825 100.0
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31,234 3.8
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30,291 3.7
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,830 1.8
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,891 1.7
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,720 1.7
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,328 1.6
Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,737 1.6
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,091 1.4
Guaifenesin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,750 1.3
Phenylephrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,108 1.2
Black3
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120,527 100.0
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,333 4.3
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,629 3.6
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,548 2.5
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,445 2.4
Nifedipine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,903 1.9
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,728 1.7
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,661 1.6
Insulin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,508 1.5
Pseudoephedrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,376 1.4
Potassium replacement solutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,371 1.4
. . . Category not applicable.
1Frequency of mention combines single-ingredient agents with mentions of the agent as an ingredient in a combination drug.
2Denominators on which percents in each category are based can be found in table B.
3Estimates for races other than white and black are not shown because of small sample sizes.
Page 76 [ Series 13, No. 142
Table 39. Annual number of occurrences and percent of drug mentions for the 10 generic substances used most frequently at office visits,
according to physician specialty, averaged over a 2-year period: United States, 1995–96






All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,148,725 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37,144 3.9
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35,405 3.7
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17,167 1.8
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,374 1.7
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,299 1.7
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,087 1.7
Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,973 1.5
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,981 1.4
Guaifenesin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,601 1.3
Phenylephrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,496 1.2
General and family practice
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 334,469 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,009 4.6
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,655 4.5
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,593 2.4
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,446 2.3
Guaifenesin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,550 2.0
Codeine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,463 1.6
Pseudoephedrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,408 1.6
Cephalexin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,209 1.5
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,121 1.5
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,114 1.5
Internal medicine
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223,063 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6,455 3.3
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,820 3.0
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,873 2.5
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,436 2.3
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,132 2.1
Digoxin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,515 1.8
Levothyroxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,512 1.8
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,507 1.8
Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,365 1.7
Lisinopril . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,198 1.6
Pediatrics
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152,056 . . .
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15,188 13.6
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,189 4.7
Polio vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,117 4.6
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,065 4.6
Hepatitis B vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,427 4.0
Diphtheria Pertussis Tetanus vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,196 2.9
Erythromycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,006 2.7
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,694 2.4
Ttrimethoprim . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,648 2.4
Haemophilus B vaccine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,569 2.3
Obstetrics and gynecology
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72,652 . . .
Vitamin A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,508 13.1
Ergocalciferol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,497 13.1
Pyridoxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,471 13.0
Riboflavin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,467 13.0
Thiamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,457 13.0
Estradiol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,031 12.0
Estrogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,306 10.3
Medroxyprogesterone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,618 8.6
Multivitamins general . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,789 6.6
Iron preparations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,765 4.2
See footnotes at end of table.
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Table 39. Annual number of occurrences and percent of drug mentions for the 10 generic substances used most frequently at office visits,
according to physician specialty, averaged over a 2-year period: United States, 1995–96—Con.






All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49,399 . . .
Proparacaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,481 8.2
Fluorescein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,883 6.8
Prednisolone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,778 6.6
Timolol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,644 6.3
Dexamethasone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,605 6.2
Tropicamide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,209 5.2
Phenylephrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,195 5.2
Tobramycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,195 5.2
Pilocarpine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,247 3.0
Betaxolol HCL3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,009 2.4
Cardiovascular diseases
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42,441 . . .
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,870 9.6
Digoxin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,293 5.7
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,107 5.2
Nitroglycerin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,860 4.6
Diltiazem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,498 3.7
Metoprolol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,417 3.5
Warfarin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,417 3.5
Potassium replacement solution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,341 3.3
Atenolol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,139 2.8
Enalapril . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,079 2.7
Dermatology
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38,137 . . .
Tretinoin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,104 6.1
Lidocaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,767 5.2
Triamcinolone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,682 4.9
Erythromycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,501 4.4
Benzoyl peroxide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,374 4.0
Clindamycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,184 3.5
Hydrocortisone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,010 2.9
Bacitracin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 972 2.8
Tetracycline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 836 2.4
Ketoconazole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 827 2.4
Psychiatry
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28,298 . . .
Fluoxetine hydrochloride . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,758 9.9
Methadone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,067 7.5
Sertraline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,748 6.3
Paroxetine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,342 4.8
Alprazolam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,279 4.6
Lithium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,097 4.0
Conazepam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,063 3.8
Trazodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 883 3.2
Lorazepam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 866 3.1
Methylphenidate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 719 2.6
Otolaryngology
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,750 . . .
Beclomethasone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,064 6.7
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,060 6.7
Guaifenesin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,040 6.6
Polymyxin B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 752 4.8
Neomycin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 749 4.7
Hydrocortisone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 749 4.7
Loratadine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 702 4.4
Phenylpropanolamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 564 3.6
Phenylephrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 519 3.3
Pseudoephedrine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 515 3.3
See footnotes at end of table.
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Table 39. Annual number of occurrences and percent of drug mentions for the 10 generic substances used most frequently at office visits,
according to physician specialty, averaged over a 2-year period: United States, 1995–96—Con.






All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,267 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,012 17.6
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,443 8.4
Hydrocodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,198 7.0
Naproxen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,159 6.8
Lidocaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 822 4.8
Propoxyphene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 765 4.5
Nabumetone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 633 3.7
Cortisone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 594 3.5
Codeine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 545 3.2
Methylprednisolone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 531 3.1
Neurology
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14,292 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 751 6.3
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 461 3.8
Carbamazepine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 419 3.5
Phenytoin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 392 3.3
Amitriptyline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 331 2.8
Sumatriptan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 325 2.7
Carbidopa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 322 2.7
Levodopa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 319 2.7
Caffeine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 307 2.6
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296 2.5
General surgery
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,904 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 606 5.9
Lidocaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315 3.0
Cephalexin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 282 2.7
Levothyroxine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227 2.2
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 225 2.2
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 216 2.1
Hydrocodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 211 2.0
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200 1.9
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197 1.9
Ciprofloxacin HCL3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194 1.9
Urology
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10,170 . . .
Ciprofloxacin HCL3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 536 6.0
Trimethoprim . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 506 5.6
Nitrofurantoin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 492 5.5
Ofloxacin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 474 5.3
Sulfamethoxazole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 457 5.1
Terazosin HCL3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 378 4.2
Oxybutynin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 344 3.8
Hyoscyamine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 316 3.5
Leuprolide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296 3.3
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 277 3.1
All other
All occurrences . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130,828 . . .
Acetaminophen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,545 4.8
Prednisone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,205 2.8
Albuterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,874 2.5
Hydrochlorothiazide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,115 1.8
Furosemide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,095 1.8
Aspirin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,911 1.6
Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,817 1.6
Amoxicillin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,751 1.5
Hydrocodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,740 1.5
Triamcinolone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,689 1.5
. . . Category not applicable.
1Frequency of mention combines single-ingredient agents with mentions of the agent as an ingredient in a combination drug.
2Denominators on which percents in each category are based can be found in table C.
3HCL is hydrochloric acid.
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Table 40. Annual number and percent distribution of office visits by patient’s referral status and prior-visit status, according to patient’s age, s ex, and race, averaged over a 2-year
period: United States, 1995–96













and over Female Male White Black Other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
New patient . . . . . . . . . . . . . . . . . . . 100,029 17,194 11,101 32,012 23,186 9,395 7,141 55,990 44,038 84,521 10,967 4,540
Old patient . . . . . . . . . . . . . . . . . . . . 615,759 119,006 46,581 151,007 141,694 82,817 74,654 369,424 246,335 532,407 59,778 23,573
New problem . . . . . . . . . . . . . . . . . 143,633 46,241 12,764 34,981 27,374 12,254 10,019 84,590 59,042 124,406 14,400 4,827
Old problem . . . . . . . . . . . . . . . . . . 472,126 72,765 33,817 116,026 114,320 70,562 64,636 284,834 187,292 408,001 45,378 18,747
Referred for this visit . . . . . . . . . . . . . . . 110,758 11,460 7,955 30,544 31,734 16,288 12,778 63,946 46,812 97,236 9,443 4,080
New patient . . . . . . . . . . . . . . . . . . . 38,963 4,571 3,136 10,995 11,273 5,104 3,885 22,730 16,233 34,393 3,366 1,204
Old patient . . . . . . . . . . . . . . . . . . . . 71,795 6,889 4,819 19,549 20,461 11,183 8,893 41,216 30,579 62,843 6,077 2,876
New problem . . . . . . . . . . . . . . . . . 8,755 1,098 516 2,632 2,236 1,252 1,022 5,182 3,573 7,636 781 338
Old problem . . . . . . . . . . . . . . . . . . 63,040 5,791 4,303 16,917 18,225 9,931 7,871 36,034 27,005 55,207 5,295 2,538
Not referred for this visit . . . . . . . . . . . . . 605,029 124,739 49,727 152,476 133,146 75,924 69,017 361,468 243,561 519,693 61,303 24,034
New patient . . . . . . . . . . . . . . . . . . . 61,065 12,623 7,966 21,017 11,913 4,291 3,256 33,260 27,805 50,128 7,601 3,336
Old patient . . . . . . . . . . . . . . . . . . . . 543,964 112,117 41,761 131,459 121,233 71,633 65,761 328,208 215,756 469,564 53,702 20,698
New problem . . . . . . . . . . . . . . . . . 134,877 45,143 12,248 32,349 25,138 11,002 8,997 79,408 55,469 116,770 13,619 4,489
Old problem . . . . . . . . . . . . . . . . . . 409,087 66,974 29,513 99,109 96,095 60,631 56,764 248,800 160,287 352,795 40,083 16,209
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
New patient . . . . . . . . . . . . . . . . . . . 14.0 12.6 19.2 17.5 14.1 10.2 8.7 13.2 15.2 13.7 15.5 16.1
Old patient . . . . . . . . . . . . . . . . . . . . 86.0 87.4 80.8 82.5 85.9 89.8 91.3 86.8 84.8 86.3 84.5 83.9
New problem . . . . . . . . . . . . . . . . . 20.1 34.0 22.1 19.1 16.6 13.3 12.2 19.9 20.3 20.2 20.4 17.2
Old problem . . . . . . . . . . . . . . . . . . 66.0 53.4 58.6 63.4 69.3 76.5 79.0 67.0 64.5 66.1 64.1 66.7
Referred for this visit . . . . . . . . . . . . . . . 15.5 8.4 13.8 16.7 19.2 17.7 15.6 15.0 16.1 15.8 13.3 14.5
New patient . . . . . . . . . . . . . . . . . . . 5.4 3.4 5.4 6.0 6.8 5.5 4.7 5.3 5.6 5.6 4.8 4.3
Old patient . . . . . . . . . . . . . . . . . . . . 10.0 5.1 8.4 10.7 12.4 12.1 10.9 9.7 10.5 10.2 8.6 10.2
New problem . . . . . . . . . . . . . . . . . 1.2 0.8 0.9 1.4 1.4 1.4 1.2 1.2 1.2 1.2 1.1 1.2
Old problem . . . . . . . . . . . . . . . . . . 8.8 4.3 7.5 9.2 11.1 10.8 9.6 8.5 9.3 8.9 7.5 9.0
Not referred for this visit . . . . . . . . . . . . . 84.5 91.6 86.2 83.3 80.8 82.3 84.4 85.0 83.9 84.2 86.7 85.5
New patient . . . . . . . . . . . . . . . . . . . 8.5 9.3 13.8 11.5 7.2 4.7 4.0 7.8 9.6 8.1 10.7 11.9
Old patient . . . . . . . . . . . . . . . . . . . . 76.0 82.3 72.4 71.8 73.5 77.7 80.4 77.2 74.3 76.1 75.9 73.6
New problem . . . . . . . . . . . . . . . . . 18.8 33.1 21.2 17.7 15.2 11.9 11.0 18.7 19.1 18.9 19.2 16.0
Old problem . . . . . . . . . . . . . . . . . . 57.2 49.2 51.2 54.2 58.3 65.8 69.4 58.5 55.2 57.2 56.7 57.7





































diseases Urology Neurology All other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
New patient . . . . . . . . . . . . . . 100,029 21,324 9,196 8,060 6,921 6,831 10,115 6,548 1,936 4,513 4,911 2,217 2,637 2,364 12,456
Old patient . . . . . . . . . . . . . . . 615,759 161,901 95,235 84,829 52,594 33,883 28,152 22,421 18,351 14,250 13,434 12,488 11,143 6,117 60,960
New problem . . . . . . . . . . . . 143,633 52,363 25,463 34,358 8,658 2,782 2,944 3,062 367 2,551 1,459 839 554 341 7,892
Old problem . . . . . . . . . . . . . 472,126 109,538 69,772 50,470 43,936 31,101 25,208 19,359 17,984 11,699 11,976 11,649 10,589 5,777 53,069
Referred for this visit . . . . . . . . . . 110,758 6,172 5,732 4,040 7,310 8,096 14,805 6,895 5,121 7,828 6,857 4,827 5,744 4,753 22,579
New patient . . . . . . . . . . . . . . 38,963 1,553 1,728 1,061 2,257 3,011 5,848 3,010 878 3,458 3,084 1,760 1,826 1,952 7,536
Old patient . . . . . . . . . . . . . . . 71,795 4,619 4,004 2,979 5,052 5,084 8,957 3,886 4,243 4,370 3,773 3,067 3,918 2,800 15,043
New problem . . . . . . . . . . . . 8,755 1,592 948 723 917 545 843 393 * 644 342 192 222 158 1,179
Old problem . . . . . . . . . . . . . 63,040 3,027 3,056 2,255 4,135 4,540 8,114 3,492 4,188 3,726 3,431 2,875 3,696 2,642 13,864
Not referred for this visit . . . . . . . . 605,029 177,052 98,699 88,848 52,206 32,618 23,462 22,074 15,166 10,935 11,489 9,879 8,036 3,728 50,837
New patient . . . . . . . . . . . . . . 61,065 19,771 7,468 6,998 4,664 3,819 4,267 3,539 1,058 1,055 1,827 457 811 411 4,920
Old patient . . . . . . . . . . . . . . . 543,964 157,282 91,231 81,850 47,542 28,799 19,196 18,535 14,108 9,880 9,662 9,421 7,225 3,317 45,917
New problem . . . . . . . . . . . . 134,877 50,771 24,515 33,635 7,741 2,237 2,101 2,669 * 1,907 1,117 647 332 182 6,712
Old problem . . . . . . . . . . . . . 409,087 106,511 66,716 48,215 39,800 26,562 17,094 15,867 13,797 7,973 8,545 8,775 6,893 3,135 39,205
Percent distribution
All visits . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
New patient . . . . . . . . . . . . . . 14.0 11.6 8.8 8.7 11.6 16.8 26.4 22.6 9.5 24.1 26.8 15.1 19.1 27.9 17.0
Old patient . . . . . . . . . . . . . . . 86.0 88.4 91.2 91.3 88.4 83.2 73.6 77.4 90.5 75.9 73.2 84.9 80.9 72.1 83.0
New problem . . . . . . . . . . . . 20.1 28.6 24.4 37.0 14.5 6.8 7.7 10.6 1.8 13.6 8.0 5.7 4.0 4.0 10.7
Old problem . . . . . . . . . . . . . 66.0 59.8 66.8 54.3 73.8 76.4 65.9 66.8 88.6 62.4 65.3 79.2 76.8 68.1 72.3
Referred for this visit . . . . . . . . . . 15.5 3.4 5.5 4.3 12.3 19.9 38.7 23.8 25.2 41.7 37.4 32.8 41.7 56.0 30.8
New patient . . . . . . . . . . . . . . 5.4 0.8 1.7 1.1 3.8 7.4 15.3 10.4 4.3 18.4 16.8 12.0 13.3 23.0 10.3
Old patient . . . . . . . . . . . . . . . 10.0 2.5 3.8 3.2 8.5 12.5 23.4 13.4 20.9 23.3 20.6 20.9 28.4 33.0 20.5
New problem . . . . . . . . . . . . 1.2 0.9 0.9 0.8 1.5 1.3 2.2 1.4 * 3.4 1.9 1.3 1.6 1.9 1.6
Old problem . . . . . . . . . . . . . 8.8 1.7 2.9 2.4 6.9 11.2 21.2 12.1 20.6 19.9 18.7 19.5 26.8 31.2 18.9
Not referred for this visit . . . . . . . . 84.5 96.6 94.5 95.7 87.7 80.1 61.3 76.2 74.8 58.3 62.6 67.2 58.3 44.0 69.2
New patient . . . . . . . . . . . . . . 8.5 10.8 7.2 7.5 7.8 9.4 11.1 12.2 5.2 5.6 10.0 3.1 5.9 4.8 6.7
Old patient . . . . . . . . . . . . . . . 76.0 85.8 87.4 88.1 79.9 70.7 50.2 64.0 69.5 52.7 52.7 64.1 52.4 39.1 62.5
New problem . . . . . . . . . . . . 18.8 27.7 23.5 36.2 13.0 5.5 5.5 9.2 * 10.2 6.1 4.4 2.4 2.1 9.1
Old problem . . . . . . . . . . . . . 57.2 58.1 63.9 51.9 66.9 65.2 44.7 54.8 68.0 42.5 46.6 59.7 50.0 37.0 53.4
* Figure does not meet standard of reliabilty or precision.











Table 42. Annual number and percent of office visits by type of payment and expected sources of insurance, according to patient’s age, sex, and race, av eraged over over a 2-year
period: United States, 1995–96
Type of payment and















and over Female Male White Black
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746
Insurance3 . . . . . . . . . . . . . . . . . . . . . 618,277 118,187 46,303 149,935 138,525 87,391 77,933 369,047 249,229 532,891 61,788
Insured, fee-for-service . . . . . . . . . . . . 261,930 36,971 18,410 53,953 59,489 48,421 44,685 153,945 107,984 231,502 21,067
Private insurance . . . . . . . . . . . . . . 150,841 22,575 10,557 35,521 42,461 21,277 18,450 89,152 61,689 136,013 9,647
Medicare . . . . . . . . . . . . . . . . . . . 94,191 393 * 2,518 6,384 42,342 42,320 54,272 39,919 86,367 6,067
Medicaid . . . . . . . . . . . . . . . . . . . . 35,523 10,930 4,995 7,678 5,240 3,597 3,084 23,379 12,144 27,304 5,983
Worker’s compensation . . . . . . . . . . . 8,581 * 751 4,568 2,951 *239 * 3,243 5,338 7,443 919
Other . . . . . . . . . . . . . . . . . . . . . . 15,329 1,805 1,314 3,674 4,370 2,350 1,817 8,802 6,528 13,276 1,294
Unknown . . . . . . . . . . . . . . . . . . . 6,677 1,709 805 1,931 1,771 335 * 3,618 3,058 6,101 *290
HMO/other prepaid4 . . . . . . . . . . . . . . 174,510 42,340 14,853 50,465 39,554 15,456 11,842 105,533 68,977 142,741 23,029
Private insurance . . . . . . . . . . . . . . 87,905 21,777 7,533 28,182 20,790 5,414 4,209 53,538 34,367 73,802 10,156
Medicare . . . . . . . . . . . . . . . . . . . 16,375 * * 715 1,544 7,223 6,526 10,032 6,343 13,466 2,231
Medicaid . . . . . . . . . . . . . . . . . . . . 16,742 6,833 2,255 3,687 2,268 1,052 647 10,996 5,746 9,981 5,997
Worker’s compensation . . . . . . . . . . . 757 – * 368 *307 – * 387 370 610 *
Other . . . . . . . . . . . . . . . . . . . . . . 34,759 8,195 3,196 11,602 7,661 2,635 1,471 20,784 13,976 29,593 3,502
Unknown . . . . . . . . . . . . . . . . . . . 26,372 5,681 1,755 6,635 8,006 2,428 1,866 15,145 11,227 22,017 2,315
Preferred provider option . . . . . . . . . . . 89,118 21,818 6,664 26,722 22,580 6,471 4,864 54,974 34,144 79,387 6,965
Private insurance . . . . . . . . . . . . . . 63,310 16,397 4,789 19,709 17,089 3,129 2,198 39,086 24,225 56,709 4,427
Medicare . . . . . . . . . . . . . . . . . . . 10,101 * * 381 789 4,816 3,993 5,880 4,221 8,852 1,194
Medicaid . . . . . . . . . . . . . . . . . . . . 3,274 1,097 * 565 613 344 383 2,150 1,125 2,180 981
Worker’s compensation . . . . . . . . . . . 512 – * *314 * * – * 336 442 *
Other . . . . . . . . . . . . . . . . . . . . . . 11,972 3,169 953 4,112 2,899 584 *255 7,499 4,473 11,071 572
Unknown . . . . . . . . . . . . . . . . . . . 5,535 1,189 619 1,912 1,621 * * 3,772 1,762 5,073 *
Type of payment unspecified, but source of
insurance listed . . . . . . . . . . . . . . . . 92,719 17,058 6,375 18,796 16,902 17,042 16,543 54,595 38,124 79,262 10,726
Private insurance . . . . . . . . . . . . . . 30,991 3,941 2,119 8,150 7,715 4,678 4,390 18,114 12,877 28,520 1,943
Medicare . . . . . . . . . . . . . . . . . . . 34,733 * * 1,205 2,820 14,982 15,279 21,201 13,532 31,254 2,664
Medicaid . . . . . . . . . . . . . . . . . . . . 25,728 11,104 2,774 4,402 3,276 1,961 2,212 16,025 9,703 18,826 5,678
Worker’s compensation . . . . . . . . . . . 5,376 * 402 2,941 1,849 * * 2,169 3,207 4,338 843
Other . . . . . . . . . . . . . . . . . . . . . . 6,822 581 678 1,946 1,866 1,033 718 3,775 3,047 5,989 603
Unknown . . . . . . . . . . . . . . . . . . . 3,861 1,257 * 925 916 * * 2,304 1,558 3,569 *
Self-pay . . . . . . . . . . . . . . . . . . . . . . . 69,045 13,727 8,465 23,740 18,918 2,316 1,879 40,121 28,924 60,501 5,816
No charge . . . . . . . . . . . . . . . . . . . . . . 7,944 799.469 732 2,393 2,217 959 843 4,658 3,286 6,867 544
Other . . . . . . . . . . . . . . . . . . . . . . . . . 10,221 1,849 1,279 3,744 2,668 441 242 5,068 5,153 7,646 1,721
No answer5 . . . . . . . . . . . . . . . . . . . . . 10,301 1,637 902 3,208 2,551 1,105 897 6,520 3,781 9,022 877











Table 42. Annual number and percent of office visits by type of payment and expected sources of insurance, according to patient’s age, sex, and race, av eraged over over a 2-year
period: United States, 1995–96—Con.
Type of payment and















and over Female Male White Black
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Insurance3 . . . . . . . . . . . . . . . . . . . . . 86.4 86.8 80.3 81.9 84.0 94.8 95.3 86.7 85.8 86.4 87.3
Insured, fee-for-service . . . . . . . . . . . . 36.6 27.1 31.9 29.5 36.1 52.5 54.6 36.2 37.2 37.5 29.8
Private insurance . . . . . . . . . . . . . . 21.1 16.6 18.3 19.4 25.8 23.1 22.6 21.0 21.2 22.0 13.6
Medicare . . . . . . . . . . . . . . . . . . . 13.2 0.3 * 1.4 3.9 45.9 51.7 12.8 13.7 14.0 8.6
Medicaid . . . . . . . . . . . . . . . . . . . . 5.0 8.0 8.7 4.2 3.2 3.9 3.8 5.5 4.2 4.4 8.5
Worker’s Compensation . . . . . . . . . . 1.2 * 1.3 2.5 1.8 *0.3 * 0.8 1.8 1.2 1.3
Other . . . . . . . . . . . . . . . . . . . . . . 2.1 1.3 2.3 2.0 2.7 2.5 2.2 2.1 2.2 2.2 1.8
Unknown . . . . . . . . . . . . . . . . . . . 0.9 1.3 1.4 1.1 1.1 0.4 * 0.9 1.1 1.0 *0.4
HMO/other prepaid4 . . . . . . . . . . . . . . 24.4 31.1 25.8 27.6 24.0 16.8 14.5 24.8 23.8 23.1 32.6
Private insurance . . . . . . . . . . . . . . 12.3 16.0 13.1 15.4 12.6 5.9 5.1 12.6 11.8 12.0 14.4
Medicare . . . . . . . . . . . . . . . . . . . 2.3 * * 0.4 0.9 7.8 8.0 2.4 2.2 2.2 3.2
Medicaid . . . . . . . . . . . . . . . . . . . . 2.3 5.0 3.9 2.0 1.4 1.1 0.8 2.6 2.0 1.6 8.5
Worker’s Compensation . . . . . . . . . . 0.1 – * 0.2 *0.2 – * 0.1 0.1 0.1 *
Other . . . . . . . . . . . . . . . . . . . . . . 4.9 6.0 5.5 6.3 4.6 2.9 1.8 4.9 4.8 4.8 5.0
Unknown . . . . . . . . . . . . . . . . . . . 3.7 4.2 3.0 3.6 4.9 2.6 2.3 3.6 3.9 3.6 3.3
Preferred provider option . . . . . . . . . . . 12.5 16.0 11.6 14.6 13.7 7.0 5.9 12.9 11.8 12.9 9.8
Private insurance . . . . . . . . . . . . . . 8.8 12.0 8.3 10.8 10.4 3.4 2.7 9.2 8.3 9.2 6.3
Medicare . . . . . . . . . . . . . . . . . . . 1.4 * * 0.2 0.5 5.2 4.9 1.4 1.5 1.4 1.7
Medicaid . . . . . . . . . . . . . . . . . . . . 0.5 0.8 * 0.3 0.4 0.4 0.5 0.5 0.4 0.4 1.4
Worker’s Compensation . . . . . . . . . . 0.1 – * *0.2 * * – * 0.1 0.1 *
Other . . . . . . . . . . . . . . . . . . . . . . 1.7 2.3 1.7 2.2 1.8 0.6 *0.3 1.8 1.5 1.8 0.8
Unknown . . . . . . . . . . . . . . . . . . . 0.8 0.9 1.1 1.0 1.0 * * 0.9 0.6 0.8 *
Type of payment unspecified, but source of
insurance listed . . . . . . . . . . . . . . . . 13.0 12.5 11.1 10.3 10.3 18.5 20.2 12.8 13.1 12.8 15.2
Private insurance . . . . . . . . . . . . . . . . . 4.3 2.9 3.7 4.5 4.7 5.1 5.4 4.3 4.4 4.6 2.7
Medicare . . . . . . . . . . . . . . . . . . . . . 4.9 * * 0.7 1.7 16.2 18.7 5.0 4.7 5.1 3.8
Medicaid . . . . . . . . . . . . . . . . . . . . . 3.6 8.2 4.8 2.4 2.0 2.1 2.7 3.8 3.3 3.1 8.0
Worker’s Compensation . . . . . . . . . . . . 0.8 * 0.7 1.6 1.1 * * 0.5 1.1 0.7 1.2
Other . . . . . . . . . . . . . . . . . . . . . . . 1.0 0.4 1.2 1.1 1.1 1.1 0.9 0.9 1.0 1.0 0.9
Unknown . . . . . . . . . . . . . . . . . . . . . 0.5 0.9 * 0.5 0.6 * * 0.5 0.5 0.6 *
Self-pay . . . . . . . . . . . . . . . . . . . . . . . 9.6 10.1 14.7 13.0 11.5 2.5 2.3 9.4 10.0 9.8 8.2
No charge . . . . . . . . . . . . . . . . . . . . . . 1.1 0.6 1.3 1.3 1.3 1.0 1.0 1.1 1.1 1.1 0.8
Other . . . . . . . . . . . . . . . . . . . . . . . . . 1.4 1.4 2.2 2.0 1.6 0.5 0.3 1.2 1.8 1.2 2.4
No answer5 . . . . . . . . . . . . . . . . . . . . . 1.4 1.2 1.6 1.8 1.5 1.2 1.1 1.5 1.3 1.5 1.2
* Figure does not meet standard of reliability or precision.
1Estimates for races other than white and black are not shown because of small sample sizes.
2Only one type of payment (preferred provider option, insured fee-for-service, HMO/other prepaid, self-pay, no charge, or other) was coded for each visit. These figures may not always add to totals because of rounding. For payment types of preferred
provider option, insured fee-for-service, and HMO/other prepaid, respondents were also asked to check all of the applicable expected sources of insurance (private, Medicare, Medicaid, Worker’s Compensation, or other sources). As a result, expected
sources of insurance will not add to totals because more than one source could be reported per visit.
3Includes insured, fee-for-service; HMO/other prepaid; preferred provider option; and unspecified type of payment but source of insurance listed.
4HMO is health maintenance organization.











Table 43. Annual number and percent of office visits by type of payment and expected sources of insurance, according to physician specialty, averaged over a 2-year period:
United States, 1995–96
Type of payment and























diseases Urology Neurology All other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Insurance2
Insured, fee-for-service . . . . . . . 261,930 66,187 38,022 22,094 19,510 18,373 17,822 8,724 6,533 8,399 6,372 9,011 6,792 3,730 30,360
Private insurance . . . . . . . . . 150,841 33,580 19,632 15,285 13,811 10,079 9,760 5,685 4,016 5,273 4,065 5,443 4,330 2,066 17,815
Medicare . . . . . . . . . . . . . . 94,191 21,358 19,994 * 1,766 12,129 5,042 3,295 1,382 3,192 2,061 5,872 4,248 1,263 12,414
Medicaid . . . . . . . . . . . . . . . 35,523 14,892 3,159 4,511 2,933 1,525 967 445 1,122 875 698 586 477 421 2,911
Worker’s compensation . . . . . . 8,581 1,150 * * – * 3,452 * 218 187 * * * 317 2,604
Other . . . . . . . . . . . . . . . . . 15,329 3,608 2,694 938 1,009 1,065 1,182 700 292 492 454 546 438 339 1,571
Unknown . . . . . . . . . . . . . . 6,677 1,917 957 1,268 835 * 290 * 253 131 * * * * 343
HMO/other prepaid3 . . . . . . . . . 174,510 40,738 34,160 31,614 17,828 7,107 7,455 6,538 2,454 3,543 3,520 2,231 2,701 1,945 12,676
Private insurance . . . . . . . . . 87,905 20,821 14,898 16,074 10,243 3,516 3,821 3,515 1,191 1,921 1,596 1,129 1,021 867 7,292
Medicare . . . . . . . . . . . . . . 16,375 3,291 4,843 * 434 2,046 468 814 487 535 198 687 493 186 1,607
Medicaid . . . . . . . . . . . . . . . 16,742 5,436 1,875 4,872 2,371 326 * * 597 152 171 * * 178 494
Worker’s compensation . . . . . . 757 * * – – * 319 * * * * * – * *
Other . . . . . . . . . . . . . . . . . 34,759 7,232 6,480 6,716 3,998 1,406 2,223 1,808 117 450 1,015 378 637 517 1,781
Unknown . . . . . . . . . . . . . . 26,372 5,686 7,958 3,813 1,045 1,127 1,016 795 279 730 615 326 669 311 2,002
Preferred provider option . . . . . . 89,118 17,183 9,594 16,440 10,371 3,214 4,802 6,265 2,003 2,215 3,138 1,112 1,492 831 10,457
Private insurance . . . . . . . . . 63,310 12,277 6,313 12,595 7,703 2,239 3,428 4,252 1,708 1,582 1,940 669 928 522 7,154
Medicare . . . . . . . . . . . . . . 10,101 2,221 1,666 * * 762 510 1,230 * 436 458 305 269 98 1,776
Medicaid . . . . . . . . . . . . . . . 3,274 685 * 737 * * * * * * * * * * 692
Worker’s compensation . . . . . . 512 * * – – * 272 – – * * – – * *
Other . . . . . . . . . . . . . . . . . 11,972 1,960 1,487 2,250 1,614 353 602 910 94 270 573 198 297 151 1,211
Unknown . . . . . . . . . . . . . . 5,535 1,198 581 852 802 235 234 302 103 124 223 58 155 67 601
Type of payment unspecified, but
source of insurance listed . . . . . 92,719 28,872 14,094 11,549 4,867 5,999 4,696 2,091 2,800 2,182 2,373 1,479 1,895 1,141 8,678
Private insurance . . . . . . . . . 30,991 8,755 5,325 2,130 2,243 2,826 1,540 968 885 756 1,145 518 606 286 3,007
Medicare . . . . . . . . . . . . . . 34,733 11,512 8,293 * 588 3,589 1,028 1,019 745 977 970 1,078 1,151 387 3,274
Medicaid . . . . . . . . . . . . . . . 25,728 8,094 2,298 7,845 1,735 1,082 377 211 1,204 361 426 262 268 281 1,284
Worker’s compensation . . . . . . 5,376 1,204 * * – * 1,709 * * 125 * * * 141 1,573
Other . . . . . . . . . . . . . . . . . 6,822 2,508 542 * * 513 354 251 * 305 132 * 200 184 1,004
Unknown . . . . . . . . . . . . . . 3,861 891 556 1,142 * 313 * * * * * * * * *
Self-pay . . . . . . . . . . . . . . . . . . 69,045 23,638 5,638 8,849 4,112 3,795 1,676 4,573 5,754 1,120 1,533 558 615 376 6,811
No charge . . . . . . . . . . . . . . . . . 7,944 1,044 * * 808 1,442 227 378 328 974 536 * * * 1,465
Other . . . . . . . . . . . . . . . . . . . . 10,221 3,387 1,529 1,133 * 370 758 223 173 204 170 * * 267 1,400
No answer4 . . . . . . . . . . . . . . . . 10,301 2,177 1,134 926 1,586 414 829 177 242 127 703 210 * 151 1,570











Table 43. Annual number and percent of office visits by type of payment and expected sources of insurance, according to physician specialty, averaged over a 2-year period:
United States, 1995–96—Con.
Type of payment and























diseases Urology Neurology All other
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Insurance2
Insured, fee-for-service . . . . . . . 36.6 36.1 36.4 23.8 32.8 45.1 46.6 30.1 32.2 44.8 34.7 61.3 49.3 44.0 41.4
Private insurance . . . . . . . . . 21.1 18.3 18.8 16.5 23.2 24.8 25.5 19.6 19.8 28.1 22.2 37.0 31.4 24.4 24.3
Medicare . . . . . . . . . . . . . . 13.2 11.7 19.1 * 3.0 29.8 13.2 11.4 6.8 17.0 11.2 39.9 30.8 14.9 16.9
Medicaid . . . . . . . . . . . . . . . 5.0 8.1 3.0 4.9 4.9 3.7 2.5 1.5 5.5 4.7 3.8 4.0 3.5 5.0 4.0
Worker’s compensation . . . . . . 1.2 0.6 * * – * 9.0 * 1.1 1.0 * * * 3.7 3.5
Other . . . . . . . . . . . . . . . . . 2.1 2.0 2.6 1.0 1.7 2.6 3.1 2.4 1.4 2.6 2.5 3.7 3.2 4.0 2.1
Unknown . . . . . . . . . . . . . . 0.9 1.0 0.9 1.4 1.4 * 0.8 * 1.2 0.7 * * * * 0.5
HMO/other prepaid3 . . . . . . . . . 24.4 22.2 32.7 34.0 30.0 17.5 19.5 22.6 12.1 18.9 19.2 15.2 19.6 22.9 17.3
Private insurance . . . . . . . . . 12.3 11.4 14.3 17.3 17.2 8.6 10.0 12.1 5.9 10.2 8.7 7.7 7.4 10.2 9.9
Medicare . . . . . . . . . . . . . . 2.3 1.8 4.6 * 0.7 5.0 1.2 2.8 2.4 2.9 1.1 4.7 3.6 2.2 2.2
Medicaid . . . . . . . . . . . . . . . 2.3 3.0 1.8 5.2 4.0 0.8 0.0 0.0 2.9 0.8 0.9 * * 2.1 0.7
Worker’s compensation . . . . . . 0.1 * * – – * 0.8 – – * * * – * *
Other . . . . . . . . . . . . . . . . . 4.9 3.9 6.2 7.2 6.7 3.5 5.8 6.2 0.6 2.4 5.5 2.6 4.6 6.1 2.4
Unknown . . . . . . . . . . . . . . 3.7 3.1 7.6 4.1 1.8 2.8 2.7 2.7 1.4 3.9 3.4 2.2 4.9 3.7 2.7
Preferred provider option . . . . . . 12.5 9.4 9.2 17.7 17.4 7.9 12.5 21.6 9.9 11.8 17.1 7.6 10.8 9.8 14.2
Private insurance . . . . . . . . . 8.8 6.7 6.0 13.6 12.9 5.5 9.0 14.7 8.4 8.4 10.6 4.6 6.7 6.2 9.7
Medicare . . . . . . . . . . . . . . 1.4 1.2 1.6 * * 1.9 1.3 4.2 * 2.3 2.5 2.1 2.0 1.2 2.4
Medicaid . . . . . . . . . . . . . . . 0.5 0.4 * 0.8 * * * * * * * * * * 0.9
Worker’s compensation . . . . . . 0.1 * * – – * 0.7 – – * * – – * *
Other . . . . . . . . . . . . . . . . . 1.7 1.1 1.4 2.4 2.7 0.9 1.6 3.1 0.5 1.4 3.1 1.3 2.2 1.8 1.6
Unknown . . . . . . . . . . . . . . 0.8 0.7 0.6 0.9 1.3 0.6 0.6 1.0 0.5 0.7 1.2 0.4 1.1 0.8 0.8
Type of payment unspecified, but
source of insurance listed . . . . . 13.0 15.8 13.5 12.4 8.2 14.7 12.3 7.2 13.8 11.6 12.9 10.1 13.8 13.5 11.8
Private insurance . . . . . . . . .
Medicare . . . . . . . . . . . . . . 4.3 4.8 5.1 2.3 3.8 6.9 4.0 3.3 4.4 4.0 6.2 3.5 4.4 3.4 4.1
Medicaid . . . . . . . . . . . . . . . 4.9 6.3 7.9 * 1.0 8.8 2.7 3.5 3.7 5.2 5.3 7.3 8.4 4.6 4.5
Worker’s compensation . . . . . . 3.6 4.4 2.2 8.4 2.9 2.7 1.0 0.7 5.9 1.9 2.3 1.8 1.9 3.3 1.7
Other . . . . . . . . . . . . . . . . . 0.8 0.7 * * – * 4.5 * * 0.7 * * * 1.7 2.1
Unknown . . . . . . . . . . . . . . 1.0 1.4 0.5 * * 1.3 0.9 0.9 * 1.6 0.7 * 1.5 2.2 1.4
Self-pay . . . . . . . . . . . . . . . . . . 9.6 12.9 5.4 9.5 6.9 9.3 4.4 15.8 28.4 6.0 8.4 3.8 4.5 4.4 9.3
No charge . . . . . . . . . . . . . . . . . 1.1 0.6 * * 1.4 3.5 0.6 1.3 1.6 5.2 2.9 * * * 2.0
Other . . . . . . . . . . . . . . . . . . . . 1.4 1.8 1.5 1.2 * 0.9 2.0 0.8 0.9 1.1 0.9 * * 3.1 1.9
No answer4 . . . . . . . . . . . . . . . . 1.4 1.2 1.1 1.0 2.7 1.0 2.2 0.6 1.2 0.7 3.8 1.4 * 1.8 2.1
* Figure does not meet standard of reliability or precision.
– Quantity zero.
. . . Category not applicable.
0.0 Quantity more than zero but less than 0.05.
1Only one type of payment (preferred provider option, insured, fee-for-service, HMO/other prepaid, self-pay, no charge, or other) was coded for each visit. These figures may not always add to totals because of rounding. For payment types of preferred
provider option, insured, fee-for-service, and HMO/other prepaid, respondents were also asked to check all of the applicable expected sources of insurance (private, Medicare, Medicaid, Worker’s Compensation, or other sources). As a result, expected
sources of insurance will not add to totals because more than one source could be reported per visit.
2Includes insured, fee-for-service; HMO/other prepaid; preferred provider option; and unspecified type of payment but source of insurance listed.
3HMO is health maintenance organization.




























and over Female Male White Black Other
Number of visits in thousands1
Total . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
Hypertension . . . . . . . . . . . . . . . . . . . . 112,014 498 688 11,427 37,823 31,479 30,099 66,357 45,657 92,571 15,281 4,162
Arthritis . . . . . . . . . . . . . . . . . . . . . . . 78,053 610 378 6,106 20,599 22,704 27,656 51,274 26,780 68,981 7,338 1,734
Obesity . . . . . . . . . . . . . . . . . . . . . . . 48,866 1,462 2,651 14,775 18,442 7,362 4,174 34,797 14,069 40,856 6,608 1,403
Diabetes . . . . . . . . . . . . . . . . . . . . . . . 43,092 494 598 5,096 15,029 12,608 9,267 24,098 18,993 34,735 6,743 1,613
Depression . . . . . . . . . . . . . . . . . . . . . 38,822 644 1,712 13,327 13,917 4,949 4,273 26,355 12,467 35,102 2,801 919
Atherosclerosis . . . . . . . . . . . . . . . . . . 29,674 * * 658 5,882 9,750 13,094 14,300 15,373 27,421 1,460 793
COPD2 . . . . . . . . . . . . . . . . . . . . . . . 22,090 * * 1,334 5,816 7,226 7,408 10,877 11,213 19,975 1,364 752
Hyperactivity/ADD3 . . . . . . . . . . . . . . . . 5,094 2,811 432 811 520 * * 1,645 3,449 4,584 428 *
Chronic renal failure . . . . . . . . . . . . . . . 3,789 * * 489 1,052 1,066 1,074 1,912 1,877 3,069 612 *
HIV/AIDS4 . . . . . . . . . . . . . . . . . . . . . 1,769 * * 1,152 509 * * 339 1,430 1,422 * *
None of the above . . . . . . . . . . . . . . . . 468,792 130,271 51,703 140,345 86,540 34,059 25,875 276,682 192,110 405,242 43,630 19,920
Percent of visits
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hypertension . . . . . . . . . . . . . . . . . . . . 15.6 0.4 1.2 6.2 22.9 34.1 36.8 15.6 15.7 15.0 21.6 14.8
Arthritis . . . . . . . . . . . . . . . . . . . . . . . 10.9 0.4 0.7 3.3 12.5 24.6 33.8 12.1 9.2 11.2 10.4 6.2
Obesity . . . . . . . . . . . . . . . . . . . . . . . 6.8 1.1 4.6 8.1 11.2 8.0 5.1 8.2 4.8 6.6 9.3 5.0
Diabetes . . . . . . . . . . . . . . . . . . . . . . . 6.0 0.4 1.0 2.8 9.1 13.7 11.3 5.7 6.5 5.6 9.5 5.7
Depression . . . . . . . . . . . . . . . . . . . . . 5.4 0.5 3.0 7.3 8.4 5.4 5.2 6.2 4.3 5.7 4.0 3.3
Atherosclerosis . . . . . . . . . . . . . . . . . . 4.1 * * 0.4 3.6 10.6 16.0 3.4 5.3 4.4 2.1 2.8
COPD2 . . . . . . . . . . . . . . . . . . . . . . . 3.1 * * 0.7 3.5 7.8 9.1 2.6 3.9 3.2 1.9 2.7
Hyperactivity/ADD3 . . . . . . . . . . . . . . . . 0.7 2.1 0.7 0.4 0.3 * * 0.4 1.2 0.7 0.6 *
Chronic renal failure . . . . . . . . . . . . . . . 0.5 * * 0.3 0.6 1.2 1.3 0.4 0.6 0.5 0.9 *
HIV/AIDS4 . . . . . . . . . . . . . . . . . . . . . 0.2 * * 0.6 0.3 * * 0.1 0.5 0.2 * *
None of the above . . . . . . . . . . . . . . . . 65.5 95.6 89.6 76.7 52.5 36.9 31.6 65.0 66.2 65.7 61.7 70.9
* Figure does not meet standard of reliability or precision.
. . . Category not applicable.
1Numbers may not add to totals because more than one category could be reported per visit.
2COPD is chronic obstructive pulmonary disease.
3ADD is attention deficit disorder.



































diseases Urology Neurology All other
Number of visits in thousands1
All visits . . . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Hypertension . . . . . . . . . . . . . . . 112,014 34,769 31,818 697 2,751 8,657 2,743 2,623 1,191 2,886 1,418 6,083 2,272 1,136 12,970
Arthritis . . . . . . . . . . . . . . . . . . 78,053 23,871 17,553 * 1,335 6,105 7,881 1,813 1,195 1,900 1,038 2,295 1,710 831 10,458
Obesity . . . . . . . . . . . . . . . . . . 48,866 16,669 11,436 920 3,884 1,027 1,760 817 1,506 1,313 483 1,656 718 553 6,124
Diabetes . . . . . . . . . . . . . . . . . . 43,092 12,757 11,121 * 1,071 5,034 1,193 707 391 1,189 433 2,029 1,026 441 5,569
Depression . . . . . . . . . . . . . . . . 38,822 10,521 7,360 * 1,217 729 574 417 10,734 550 259 774 396 877 3,871
Atherosclerosis . . . . . . . . . . . . . 29,674 7,166 7,929 * * 1,633 548 660 280 822 429 4,786 938 305 3,905
COPD2 . . . . . . . . . . . . . . . . . . 22,090 7,080 7,205 * * 880 305 334 172 512 221 1,038 455 168 3,493
Hyperactivity/ADD3 . . . . . . . . . . . 5,094 1,513 * 1,465 * * * * 1,013 * * * * 262 *
Chronic renal failure . . . . . . . . . . 3,789 700 969 * * * * * * 116 * 156 * * 1,240
HIV/AIDS4 . . . . . . . . . . . . . . . . 1,769 * 649 * * * * * * * * * * * 451
None of the above . . . . . . . . . . . 468,792 111,784 45,916 89,251 50,889 24,015 26,871 23,539 7,661 12,560 15,406 3,851 8,842 5,336 42,873
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hypertension . . . . . . . . . . . . . . . 15.6 19.0 30.5 0.8 4.6 21.3 7.2 9.1 5.9 15.4 7.7 41.4 16.5 13.4 17.7
Arthritis . . . . . . . . . . . . . . . . . . 10.9 13.0 16.8 * 2.2 15.0 20.6 6.3 5.9 10.1 5.7 15.6 12.4 9.8 14.2
Obesity . . . . . . . . . . . . . . . . . . 6.8 9.1 11.0 1.0 6.5 2.5 4.6 2.8 7.4 7.0 2.6 11.3 5.2 6.5 8.3
Diabetes . . . . . . . . . . . . . . . . . . 6.0 7.0 10.6 * 1.8 12.4 3.1 2.4 1.9 6.3 2.4 13.8 7.4 5.2 7.6
Depression . . . . . . . . . . . . . . . . 5.4 5.7 7.0 * 2.0 1.8 1.5 1.4 52.9 2.9 1.4 5.3 2.9 10.3 5.3
Atherosclerosis . . . . . . . . . . . . . 4.1 3.9 7.6 * * 4.0 1.4 2.3 1.4 4.4 2.3 32.5 6.8 3.6 5.3
COPD2 . . . . . . . . . . . . . . . . . . 3.1 3.9 6.9 * * 2.2 0.8 1.2 0.8 2.7 1.2 7.1 3.3 2.0 4.8
Hyperactivity/ADD3 . . . . . . . . . . . 0.7 0.8 * 1.6 * * * * 5.0 * * * * 3.1 *
Chronic renal failure . . . . . . . . . . 0.5 0.4 0.9 * * * * * * 0.6 * 1.1 * * 1.7
HIV/AIDS4 . . . . . . . . . . . . . . . . 0.2 * 0.6 * * * * * * * * * * * 0.6
None of the above . . . . . . . . . . . 65.5 61.0 44.0 96.1 85.5 59.0 70.2 81.3 37.8 66.9 84.0 26.2 64.2 62.9 58.4
* Figure does not meet standard of reliability or precision.
. . . Category not applicable.
1Numbers may not add to totals because more than one category could be reported per visit.
2COPD is chronic obstructive pulmonary disease.
3ADD is attention deficit disorder.











Table 46. Annual number and percent distribution of office visits by patient’s cigarette-smoking status, according to patient’s age, sex, and race, averaged over a 2-year period:
United States, 1995–96















and over Female Male White Black Other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
Yes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65,250 * 5,007 26,880 22,311 7,303 3,500 36,879 28,370 56,053 7,398 1,798
No . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 433,132 129,189 31,649 88,978 81,522 52,251 49,543 258,691 174,442 373,010 40,421 19,702
Unknown . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217,406 6,763 21,025 67,162 61,046 32,658 28,752 129,844 87,561 187,865 22,927 6,613
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Yes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9.1 * 8.7 14.7 13.5 7.9 4.3 8.7 9.8 9.1 10.5 6.4
No . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60.5 94.9 54.9 48.6 49.4 56.7 60.6 60.8 60.1 60.5 57.1 70.1
Unknown . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30.4 5.0 36.5 36.7 37.0 35.4 35.2 30.5 30.2 30.5 32.4 23.5
* Figure does not meet standard of reliability or precision.
NOTE: Numbers may not add to totals because of rounding.
Table 47. Annual number and percent distribution of office visits by patient’s cigarette-smoking status, according to physician specialty, averag ed over a 2-year period: United
States, 1995–96























diseases Urology Neurology All other
Number of visits in thousands
All visits . . . . . . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Yes . . . . . . . . . . . . . . . . . . . . . . . . 65,250 20,670 10,665 558 6,002 2,121 3,932 1,179 4,374 2,202 1,415 1,389 1,185 1,260 8,297
No . . . . . . . . . . . . . . . . . . . . . . . . 433,132 107,027 62,966 86,290 36,869 17,243 16,938 11,047 10,782 9,767 11,637 9,096 6,696 4,358 42,416
Unknown/blank . . . . . . . . . . . . . . . . 217,406 55,528 30,799 6,041 16,645 21,350 17,397 16,743 5,131 6,793 5,294 4,220 5,900 2,862 22,703
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Yes . . . . . . . . . . . . . . . . . . . . . . . . 9.1 11.3 10.2 0.6 10.1 5.2 10.3 4.1 21.6 11.7 7.7 9.4 8.6 14.9 11.3
No . . . . . . . . . . . . . . . . . . . . . . . . 60.5 58.4 60.3 92.9 61.9 42.4 44.3 38.1 53.1 52.1 63.4 61.9 48.6 51.4 57.8
Unknown/blank . . . . . . . . . . . . . . . . 30.4 30.3 29.5 6.5 28.0 52.4 45.5 57.8 25.3 36.2 28.9 28.7 42.8 33.7 30.9

























and over Female Male White Black Other
Number of visits in thousands1
All visits . . . . . . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
Physician . . . . . . . . . . . . . . . . . . . . . . 687,808 131,213 54,822 174,618 158,371 89,392 79,392 409,489 278,319 594,556 66,405 26,846
Physician assistant . . . . . . . . . . . . . . . . 16,776 3,302 1,590 3,902 3,411 2,203 2,369 10,348 6,429 14,198 2,062 516
Nurse practitioner . . . . . . . . . . . . . . . . . 5,663 901 768 2,108 1,313 * 327 3,826 1,838 4,164 1,358 *
Registered nurse . . . . . . . . . . . . . . . . . 96,788 18,763 7,854 23,315 22,430 12,955 11,471 58,205 38,583 84,779 7,310 4,699
Licensed practical nurse . . . . . . . . . . . . . 74,282 15,993 6,533 19,725 15,895 8,018 8,118 44,045 30,237 66,931 5,367 1,984
Medical assistant . . . . . . . . . . . . . . . . . 177,621 31,406 14,761 46,451 41,436 23,628 19,940 108,103 69,519 147,641 21,295 8,685
Other provider . . . . . . . . . . . . . . . . . . . 28,810 2,268 1,907 6,877 7,366 5,323 5,069 16,505 12,305 24,788 3,244 779
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Physician . . . . . . . . . . . . . . . . . . . . . . 96.1 96.3 95.0 95.4 96.1 96.9 97.1 96.3 95.8 96.4 93.9 95.5
Physician assistant . . . . . . . . . . . . . . . . 2.3 2.4 2.8 2.1 2.1 2.4 2.9 2.4 2.2 2.3 2.9 1.8
Nurse practitioner . . . . . . . . . . . . . . . . . 0.8 0.7 1.3 1.2 0.8 * 0.4 0.9 0.6 0.7 1.9 *
Registered nurse . . . . . . . . . . . . . . . . . 13.5 13.8 13.6 12.7 13.6 14.0 14.0 13.7 13.3 13.7 10.3 16.7
Licensed practical nurse . . . . . . . . . . . . . 10.4 11.7 11.3 10.8 9.6 8.7 9.9 10.4 10.4 10.8 7.6 7.1
Medical assistant . . . . . . . . . . . . . . . . . 24.8 23.1 25.6 25.4 25.1 25.6 24.4 25.4 23.9 23.9 30.1 30.9
Other provider . . . . . . . . . . . . . . . . . . . 4.0 1.7 3.3 3.8 4.5 5.8 6.2 3.9 4.2 4.0 4.6 2.8
* Figure does not meet standard of reliability or precision.
. . . Category not applicable.



































diseases Urology Neurology All other
Number of visits in thousands1
All visits . . . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Physician . . . . . . . . . . . . . . . . . 687,808 173,041 100,968 89,050 58,137 40,223 38,036 28,557 218,033 18,586 17,552 14,413 13,507 8,318 69,388
Physician assistant . . . . . . . . . . . 16,776 5,489 2,211 1,349 761 2,458 976 1,070 * 351 * 418 259 * 1,297
Nurse practitioner . . . . . . . . . . . . 5,663 1,885 1,207 * 1,023 * * * * * * * * * 733
Registered nurse . . . . . . . . . . . . 96,788 21,583 13,895 14,147 10,902 1,645 3,707 4,156 910 2,773 1,516 2,442 2,446 808 15,857
Licensed practical nurse . . . . . . . . 74,282 25,484 9,088 12,360 7,634 1,112 2,427 2,052 2,013 1,459 2,263 1,763 1,251 355 5,021
Medical assistant . . . . . . . . . . . . 177,621 50,199 27,077 21,911 17,242 15,472 6,430 5,907 * 3,224 2,952 4,179 2,175 933 19,802
Other . . . . . . . . . . . . . . . . . . . . 28,810 4,975 1,605 414 966 8,315 3,403 366 1,795 302 1,257 616 309 230 4,258
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Physician . . . . . . . . . . . . . . . . . 96.1 94.4 96.7 95.9 97.7 98.8 99.4 98.6 288.9 99.1 95.7 98.0 98.0 98.1 94.5
Physician assistant . . . . . . . . . . . 2.3 3.0 2.1 1.5 1.3 6.0 2.6 3.7 * 1.9 * 2.8 1.9 * 1.8
Nurse practitioner . . . . . . . . . . . . 0.8 1.0 1.2 * 1.7 * * * * * * * * * 1.0
Registered nurse . . . . . . . . . . . . 13.5 11.8 13.3 15.2 18.3 4.0 9.7 14.3 4.5 14.8 8.3 16.6 17.8 9.5 21.6
Licensed practical nurse . . . . . . . . 10.4 13.9 8.7 13.3 12.8 2.7 6.3 7.1 9.9 7.8 12.3 12.0 9.1 4.2 6.8
Medical assistant . . . . . . . . . . . . 24.8 27.4 25.9 23.6 29.0 38.0 16.8 20.4 * 17.2 16.1 28.4 15.8 11.0 27.0
Other . . . . . . . . . . . . . . . . . . . . 4.0 2.7 1.5 0.4 1.6 20.4 8.9 1.3 8.9 1.6 6.9 4.2 2.2 2.7 5.8
* Figure does not meet standard of reliability or precision.
. . . Category not applicable.
1Numbers may not add to totals because more than one provider may be reported per visit.
2This figure is lower than expected because of the inclusion of a provider in the 1995 NAMCS with a substantial number of visits at which patients were seen mainly by a licensed practical nurse or ‘‘other’’ provider for drug dependence and the


























and over Female Male White Black Other
All visits . . . . . . . . . . . . . . . . . . . . . . . 715,788 136,200 57,682 183,019 164,880 92,212 81,795 425,415 290,373 616,928 70,746 28,114
Disposition Number of visits in thousands1
No followup . . . . . . . . . . . . . . . . . . . . . 57,545 17,931 6,165 14,656 10,546 4,413 3,834 31,325 26,219 50,578 4,755 2,213
Return if needed, P.R.N.2 . . . . . . . . . . . . 201,383 56,059 18,482 51,803 41,589 18,125 15,325 118,704 82,679 174,829 17,950 8,603
Return at specified time . . . . . . . . . . . . . 443,239 61,846 32,114 111,653 109,076 67,625 60,925 267,876 175,363 379,419 46,833 16,987
Admit to hospital . . . . . . . . . . . . . . . . . . 5,632 654 377 1,272 1,458 941 930 3,152 2,480 4,830 627 *
Other disposition . . . . . . . . . . . . . . . . . 27,490 4,221 1,775 7,871 7,064 3,769 2,791 15,998 11,492 24,127 2,324 1,038
Duration
‘0’ minutes3 . . . . . . . . . . . . . . . . . . . . . 103,981 19,261 8,340 28,001 24,699 12,929 10,751 60,451 43,530 89,810 9,652 4,518
1–5 minutes . . . . . . . . . . . . . . . . . . . . 26,758 6,460 2,992 7,333 4,887 2,557 2,530 15,168 11,590 23,383 2,853 522
6–10 minutes . . . . . . . . . . . . . . . . . . . . 139,195 37,877 12,638 32,317 27,374 15,672 13,317 81,476 57,719 118,150 15,416 5,629
11–15 minutes . . . . . . . . . . . . . . . . . . . 205,632 41,812 16,312 50,468 45,610 26,722 24,708 123,183 82,449 176,222 20,799 8,611
16–30 minutes . . . . . . . . . . . . . . . . . . . 188,657 26,933 14,178 49,380 46,888 27,437 23,840 114,225 74,431 163,771 17,719 7,166
31–60 minutes . . . . . . . . . . . . . . . . . . . 46,284 3,482 2,838 14,101 14,001 6,115 5,747 27,778 18,506 40,881 3,921 1,483
More than 1 hour . . . . . . . . . . . . . . . . . 5,280 375 384 1,420 1,422 779 901 3,133 2,147 4,711 386 *
Percent distribution
All visits . . . . . . . . . . . . . . . . . . . . . . . 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Disposition
No followup . . . . . . . . . . . . . . . . . . . . . 8.0 13.2 10.7 8.0 6.4 4.8 4.7 7.4 9.0 8.2 6.7 7.9
Return if needed, P.R.N.2 . . . . . . . . . . . . 28.1 41.2 32.0 28.3 25.2 19.7 18.7 27.9 28.5 28.3 25.4 30.6
Return at specified time . . . . . . . . . . . . . 61.9 45.4 55.7 61.0 66.2 73.3 74.5 63.0 60.4 61.5 66.2 60.4
Admit to hospital . . . . . . . . . . . . . . . . . . 0.8 0.5 0.7 0.7 0.9 1.0 1.1 0.7 0.9 0.8 0.9 *
Other disposition . . . . . . . . . . . . . . . . . 3.8 3.1 3.1 4.3 4.3 4.1 3.4 3.8 4.0 3.9 3.3 3.7
Duration
‘0’ minutes3 . . . . . . . . . . . . . . . . . . . . . 14.5 14.1 14.5 15.3 15.0 14.0 13.1 14.2 15.0 14.6 13.6 16.1
1–5 minutes . . . . . . . . . . . . . . . . . . . . 3.7 4.7 5.2 4.0 3.0 2.8 3.1 3.6 4.0 3.8 4.0 1.9
6–10 minutes . . . . . . . . . . . . . . . . . . . . 19.4 27.8 21.9 17.7 16.6 17.0 16.3 19.2 19.9 19.2 21.8 20.0
11–15 minutes . . . . . . . . . . . . . . . . . . . 28.7 30.7 28.3 27.6 27.7 29.0 30.2 29.0 28.4 28.6 29.4 30.6
16–30 minutes . . . . . . . . . . . . . . . . . . . 26.4 19.8 24.6 27.0 28.4 29.8 29.1 26.9 25.6 26.5 25.0 25.5
31–60 minutes . . . . . . . . . . . . . . . . . . . 6.5 2.6 4.9 7.7 8.5 6.6 7.0 6.5 6.4 6.6 5.5 5.3
More than 1 hour . . . . . . . . . . . . . . . . . 0.7 0.3 0.7 0.8 0.9 0.8 1.1 0.7 0.7 0.8 0.5 *
* Figure does not meet standard of reliability or precision.
1Number of visits by disposition may not add to totals because more than one category could be reported per visit. Number of visits by duration may not add to totals because of rounding.
2P.R.N. is pro re nata, as needed.



































diseases Urology Neurology All other
Number of visits in thousands1
All visits . . . . . . . . . . . . . . . . . . 715,788 183,225 104,431 92,888 59,515 40,714 38,267 28,969 20,287 18,762 18,346 14,705 13,780 8,481 73,417
Disposition
No followup . . . . . . . . . . . . . . . . 57,545 23,221 5,620 11,092 2,120 1,829 2,214 1,435 319 1,511 1,814 604 414 829 4,522
Return if needed, P.R.N.2 . . . . . . . 201,383 65,881 28,382 40,830 12,425 7,239 8,923 7,351 886 4,374 5,356 2,131 2,099 1,551 13,955
Return at specified time . . . . . . . . 443,239 89,934 69,812 41,722 44,416 30,820 25,354 20,178 18,978 11,398 10,471 11,741 10,470 6,162 51,784
Admit to hospital . . . . . . . . . . . . . 5,632 890 584 * 583 * 523 * * 626 193 272 318 * 1,021
Other . . . . . . . . . . . . . . . . . . . . 27,490 6,367 4,352 2,641 2,176 1,689 1,598 452 * 1,719 993 497 771 317 3,791
Duration
‘0’ minutes3 . . . . . . . . . . . . . . . . 103,981 30,433 14,127 12,086 7,566 6,060 5,391 4,203 2,732 1,186 2,919 2,961 1,586 1,073 11,661
1–5 minutes . . . . . . . . . . . . . . . 26,758 7,334 3,115 3,688 2,282 1,925 1,854 2,405 * 1,133 943 * 531 * 1,360
6–10 minutes . . . . . . . . . . . . . . . 139,195 40,145 14,560 24,965 12,393 6,722 7,866 7,687 612 4,782 4,640 910 2,853 637 10,424
11–15 minutes . . . . . . . . . . . . . . 205,632 52,792 37,546 30,142 18,922 8,530 9,249 8,237 1,866 5,371 4,630 4,464 4,172 1,718 17,993
16–30 minutes . . . . . . . . . . . . . . 188,657 46,486 29,376 19,842 15,570 10,965 11,543 5,563 4,881 5,323 4,266 4,563 3,969 2,813 23,498
More than 30 minutes . . . . . . . . . 51,565 6,035 5,706 2,166 2,783 6,513 2,364 874 10,161 968 947 1,754 670 2,143 8,480
Percent of visits
All visits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Disposition
No followup . . . . . . . . . . . . . . . . 8.0 12.7 5.4 11.9 3.6 4.5 5.8 5.0 1.6 8.1 9.9 4.1 3.0 9.8 6.2
Return if needed, P.R.N.2 . . . . . . . 28.1 36.0 27.2 44.0 20.9 17.8 23.3 25.4 4.4 23.3 29.2 14.5 15.2 18.3 19.0
Return at specified time . . . . . . . . 61.9 49.1 66.9 44.9 74.6 75.7 66.3 69.7 93.5 60.7 57.1 79.8 76.0 72.7 70.5
Admit to hospital . . . . . . . . . . . . . 0.8 0.5 0.6 * 1.0 * 1.4 * * 3.3 1.1 1.9 2.3 * 1.4
Other . . . . . . . . . . . . . . . . . . . . 3.8 3.5 4.2 2.8 3.7 4.1 4.2 1.6 * 9.2 5.4 3.4 5.6 3.7 5.2
Duration
‘0’ minutes3 . . . . . . . . . . . . . . . . 14.5 16.6 13.5 13.0 12.7 14.9 14.1 14.5 13.5 6.3 15.9 20.1 11.5 12.7 15.9
1–5 minutes . . . . . . . . . . . . . . . 3.7 4.0 3.0 4.0 3.8 4.7 4.8 8.3 * 6.0 5.1 * 3.9 * 1.9
6–10 minutes . . . . . . . . . . . . . . . 19.4 21.9 13.9 26.9 20.8 16.5 20.6 26.5 3.0 25.5 25.3 6.2 20.7 7.5 14.2
11–15 minutes . . . . . . . . . . . . . . 28.7 28.8 36.0 32.5 31.8 21.0 24.2 28.4 9.2 28.6 25.2 30.4 30.3 20.3 24.5
16–30 minutes . . . . . . . . . . . . . . 26.4 25.4 28.1 21.4 26.2 26.9 30.2 19.2 24.1 28.4 23.3 31.0 28.8 33.2 32.0
More than 30 minutes . . . . . . . . . 7.2 3.3 5.5 2.3 4.7 16.0 6.2 3.0 50.1 5.2 5.2 11.9 4.9 25.3 11.6
* Figure does not meet standard of reliability or precision.
. . . Category not applicable.
1Numbers of visits by disposition may not add to totals because more than one category could be reported per visit. Numbers of visits by duration may not add to totals because of rounding.
2P.R.N. is pro re nata, as needed.
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Technical Notes
This report is based on data
collected by the 1995 and 1996 Nation
Ambulatory Medical Care Surveys
(NAMCS) during January 2,
1995–December 31, 1995, and Januar
1, 1996–December 29, 1996. NAMCS
a national probability sample survey of
office-based physicians conducted by t
Centers for Disease Control and
Prevention, National Center for Health
Statistics, Division of Health Care
Statistics. The NAMCS survey design
and procedures are presented in the
following sections.
Statistical Design
Scope of the Survey
The target population of the 1995
and 1996 NAMCS included office visits
made in the United States by
ambulatory patients to nonfederally
employed physicians who were
principally engaged in office-based
patient care, but not in the specialties
anesthesiology, pathology, or radiology
Included were visits to solo, partnershi
and group-practice settings, and visits
that occurred in private,
nonhospital-based clinics and health
maintenance organizations (HMO’s).
Visits made to hospital-based clinics a
government-operated facilities, telepho
contacts, and nonoffice visits were
excluded.
The NAMCS is a component of the
National Health Care Survey (NHCS)
that measures health care utilization
across a variety of providers. Data on
ambulatory care provided by hospital
outpatient departments, emergency
departments, and both hospital-based
and freestanding ambulatory surgery
centers are collected through the
National Hospital Ambulatory Medical
Care Survey and the National Survey
Ambulatory Surgery. These surveys ar
also components of NHCS.Sample Design
The NAMCS utilizes a three-stage
survey design that involves probability
samples of primary sampling units
(PSU’s), physician practices within
PSU’s, and patient visits within
physician practices. The first stage
consisted of 112 PSU’s that comprise
probability subsample of PSU’s used in
the 1985–94 National Health Interview
Survey (NHIS). A PSU is a county, a
group of counties, or county equivalen
(such as parishes or independent cities
towns, townships, or minor civil
divisions (for some PSU’s in New
England), or a metropolitan statistical
area (MSA). MSA’s were defined by th
U.S. Office of Management and Budge
on the basis of the 1980 Census. From
the strata thus formed, the PSU’s were
selected with probability proportional to
the projected 1985 population. For
details of the NHIS PSU sample desig
see Massey et al (24).
The second stage consisted of a
probability sample of practicing
physicians, selected from the master
files maintained by the American
Medical Association (AMA) and the
American Osteopathic Association
(AOA), as of December 31, 1994 (for
the 1995 NAMCS) and as of Decembe
31, 1995 (for the 1996 NAMCS) who
met the following criteria:
+ Office-based, as defined by AMA
and AOA.
+ Principally engaged in patient care
activities.
+ Nonfederally employed.
+ Not in the specialties and
subspecialties of anesthesiology,
pathology, and radiology.
The 1995–96 NAMCS physician
universe included 727,172 doctors of
medicine and 33,450 doctors of
osteopathy. Eligible physicians were
stratified into the following 15 groups:














The number of physicians selected
from each stratum was calculated to
produce strata with similar levels of
precision. The 1995–96 NAMCS
physician samples consisted of 6,897
physicians. Sample physicians were
screened at the time of the survey to
ensure that they met the aforementioned
criteria; 2,168 physicians did not meet
the criteria and were ruled out of scope
(ineligible) for the study. Reasons for
being ruled out of scope included the
following: physician is deceased; retired;
employed in teaching, research, or
administration; or engages mainly in
hospital-based rather than office-based
practice. Of the 4,729 in-scope (eligible)
physicians, 3,383 (71.5 percent)
participated in the study. Of the
participating physicians, 527 saw no
patients during their assigned reporting
period because of vacations, illness, or
other reasons for being temporarily not
in practice. The physician universe,
sample size, and response data by
physician stratum are shown intable I.
The third stage was the selection of
patient visits within the practices of the
sample physicians. This stage involved
two steps. First, the total physician
sample was divided into 52 random
subsamples of approximately equal size;
then each subsample was randomly
assigned to 1 of the 52 weeks in the
survey year. Second, a systematic
random sample of visits was selected by
the physician during the assigned
reporting week. The visit sampling rate
varied for this final step from 100-
percent sample for very small practices
to 20 percent for very large practices.
The method for determining the visit
sampling rate is described later in this
appendix and in the Induction Interview
form in appendix III. Responding
physicians completed a total of 66,680









Table I. Number of physicians in the universe, total sample, total sample response categories, and response rate by physician stratum:












Total . . . . . . . . . . . . . . . . . . . . . . . . . . . 760,622 6,897 2,168 4,729 1,346 3,383 71.5
General and family practice . . . . . . . . . . . . . 116,259 636 226 410 115 295 72.0
Osteopathy . . . . . . . . . . . . . . . . . . . . . . . 33,450 638 218 420 121 299 71.2
Internal medicine . . . . . . . . . . . . . . . . . . . 109,204 736 253 483 151 332 68.7
Pediatrics . . . . . . . . . . . . . . . . . . . . . . . . 67,020 380 144 236 41 195 82.6
General surgery . . . . . . . . . . . . . . . . . . . . 39,188 660 218 442 112 330 74.7
Obstetrics and gynecology . . . . . . . . . . . . . 57,146 383 107 276 82 194 70.3
Orthopedic surgery . . . . . . . . . . . . . . . . . . 34,012 573 123 450 145 305 67.8
Cardiovascular diseases . . . . . . . . . . . . . . . 26,834 324 73 251 94 157 62.5
Dermatology . . . . . . . . . . . . . . . . . . . . . . 13,713 233 39 194 51 143 73.7
Urology . . . . . . . . . . . . . . . . . . . . . . . . . 15,749 229 53 176 59 117 66.5
Psychiatry . . . . . . . . . . . . . . . . . . . . . . . . 53,228 503 207 296 82 214 72.3
Neurology . . . . . . . . . . . . . . . . . . . . . . . . 14,970 282 91 191 55 136 71.2
Ophthalmology . . . . . . . . . . . . . . . . . . . . . 28,858 310 62 248 58 190 76.6
Otolaryngology . . . . . . . . . . . . . . . . . . . . . 14,008 259 47 212 60 152 71.7
All other specialties . . . . . . . . . . . . . . . . . . 136,983 751 307 444 120 324 73.0
1Data are derived from the American Medical Association and the American Osteopathic Association and represent the total number of physicians who are eligible for the NAMCS.
2Response rate is number of respondents divided by number of in-scope physicians.
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Field Procedures
The U.S. Bureau of the Census,
Housing Surveys Branch, participated
with NCHS staff in planning the survey
and collecting survey data. The Censu
Bureau was responsible for carrying ou
all field operations and provided traine
field representatives who worked close
with sample physicians.
Both mail and telephone contacts
were used to enlist sample physicians
for NAMCS. Initially, physicians were
sent introductory letters from the
Director of NCHS (seeappendix III).
When appropriate, a letter from the
physician’s specialty organization
endorsing the survey and urging
participation was enclosed with the
NCHS letter. Approximately 2 weeks
prior to the physician’s assigned
reporting period, a field representative
telephoned the physician to briefly
explain the study and arrange an
appointment for a personal interview.
Physicians who did not initially respond
were usually recontacted via telephone
or special explanatory letter and
requested to reconsider participation in
the study.During the personal interview, the
field representative determined the
physician’s eligibility for the study,
obtained cooperation, delivered survey
materials with verbal and printed
instructions, and assigned a
predetermined Monday–Sunday
reporting week. A short induction
interview concerning basic practice
characteristics, such as type of practice
and expected number of office visits,
was conducted (seeappendix III). Office
staff who were to assist with data
collection were invited to attend the
instructional session or were offered
separate instructional sessions.
The field representative telephoned
the sample physician prior to and durin
the assigned reporting week to answer
questions that might have arisen and to
ensure that survey procedures were
going smoothly. At the end of the
reporting week, the participating
physician mailed the completed survey
materials to the field representative wh
edited the forms for completeness befo
transmitting them for central data
processing. Problems of missing or
incomplete data were resolved through
telephone followup by the field
representative to the sample physiciansData Collection
The actual data collection for
NAMCS was carried out by the sample
physicians, often assisted by their office
staff. Two data collection forms were
used by the physicians: the Patient Log
and the Patient Record form (see
appendix III). The Patient Log was used
to sequentially list all patients seen in
the physician’s office during the
assigned reporting week and served as
the sampling frame to indicate the office
visits for which data were to be
recorded on the Patient Record form. A
perforation between the patient’s name
on the Patient Log and patient visit
information on the Patient Record form
permitted the physician to detach and
retain the listing of patients, thus
assuring the anonymity of the patients.
Based on the physician’s estimate
of the expected number of office visits
and expected number of days in practice
during the assigned reporting week, each
physician was assigned a visit sampling
rate. The visit sampling rates were
designed so that about 30 Patient
Record forms would be completed by
each physician during the assigned
reporting week. Physicians expecting 10
or fewer visits each day recorded data
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every second, third, or fifth visit based
on the predetermined sampling interva
These visit sampling procedures
minimized the physician’s data
collection workload and maintained
approximately equal reporting levels
among sample physicians regardless o
practice size. For physicians recording
data for every second, third, or fifth
patient visit, a random start was
provided on the first page of the Patien
Log so that predesignated sample visit
recorded on each succeeding page of
Patient Log provided a systematic
random sample of patient visits during
the reporting period.
Data Processing
Data from the 1995 and 1996
NAMCS were processed and coded by
trained medical coding personnel at
Analytical Sciences, Inc. in Durham,
North Carolina. Information on the
‘‘patient’s complaint(s), symptom(s), or
other reason(s) for this visit in the
patient’s (or surrogate’s) own words’’
(item 9) was coded according toA
Reason for Visit Classification for
Ambulatory Care(19). The physician’s
diagnoses (item 11) were coded
according to theInternational
Classification of Diseases, 9th Revisio
Clinical Modification (ICD–9–CM) (20).
A maximum of three entries were code
from each of these items.
Medication data collected in item
16 of the Patient Record form were
coded according to a scheme develop
at NCHS based on the American Socie
of Hospital Pharmacists’ Drug Product
Information File, which is maintained
by the American Druggist Blue Book
Data Center. A maximum of six entries
was coded from the medication item. A
description of the medication coding
scheme used has been published (21)
In addition to followups by the field
staff for missing and inconsistent data,
numerous clerical edits were performe
on data received for central data
processing. Detailed editing instruction
were provided to manually review the
Patient Record forms and to recode
entries of ‘‘other’’ where possible.
Computer edits for code ranges and
inconsistencies were also performed.e
y
All medical coding and keying for
the NAMCS, as well as straight-key
items, involved a two-way 10-percent
independent verification procedure.
Medication coding involved a
100-percent independent verification
procedure. As an additional quality
check, all Patient Record forms with
differences between coders or with
illegible entries for the reason for visit,
diagnosis, procedures, or medication
items were reviewed and adjudicated a
NCHS.
Unweighted item nonresponse rate
across the 2-year period were 3 percen
or less for all data items except the
following: race (9.1 percent), ethnicity,
(11.7 percent), whether the patient was
seen before for the current visit’s
diagnosis (5.1 percent), place of injury
(41.0 percent), whether the injury was
work related (33.2 percent), and cause
injury (18.8 percent).
In the case of missing or incomple
data, imputations were performed for t
items listed below, using a ‘‘hot deck’’
procedure by assigning a value from a
randomly selected Patient Record form
with similar characteristics. For the
NAMCS data, imputation procedures
were performed for the following
variables: date of visit, year of birth,
sex, race, ethnicity, referral status,
prior-visit status, provider seen,
disposition of visit, and duration of visit
The sort used the stratified physician
specialty groups by region by the
three-digit ICD–9–CM code for
principal diagnosis. The specialty grou
used were the following: general and
family practice, osteopathy, internal
medicine, pediatrics, general surgery,




otolaryngology, and the residual group
of all other specialties. Records with
imputed variables were flagged as suc
on the public-use data file.
Estimation Procedures
Statistics from the NAMCS were
derived by a multistage estimation
procedure that produces essentially
unbiased national estimates and has fof
r
basic components: (a) inflation by
reciprocals of the probabilities of
selection, (b) adjustment for
nonresponse, (c) ratio adjustment to
fixed totals, and (d) weight smoothing.
Each component is briefly described
below.
Inflation by Reciprocals of the
Probabilities of Selection
Because the survey utilizes a
three-stage sample design, three
probabilities of selection existed: the
probability of selecting the PSU, the
probability of selecting the physician
within the PSU, and the probability of
selecting the office visit within the
physician’s practice. The overall
probability of including a physician in
the sample was the product of the
probability of the PSU being selected
multiplied by the probability of the
physician being selected. The probabilit
of selecting the physician within PSU’s
was 1.0 for physicians in some
nonmetropolitan areas and was the PSU
weight divided by the sampling interval
for physicians in metropolitan areas. Th
probability of selecting the office visit
was defined as the number of office
visits during the physician’s assigned
reporting week divided by the number
of Patient Record forms completed. All
weekly estimates were inflated by a
factor of 52 to derive annual estimates.
Adjustment for Nonresponse
Estimates from NAMCS data were
adjusted to account for sample
physicians who were in scope (eligible)
but did not participate in the study. This
adjustment was calculated to minimize
the impact of response on final
estimates. The weights of visits for
physicians similar to the nonresponding
physicians were inflated to account for
visits represented by the nonresponding
physicians. For this purpose, physicians
were judged similar if they had the
same specialty designation and practice
in the same PSU.
Ratio Adjustment
A post-ratio adjustment was made
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factor that has as its numerator the
number of physicians in the universe in
each physician specialty strata and as
denominator the estimated number of
physicians in that particular specialty
strata. The numerator was based on da
obtained from the AMA and AOA
master files, and the denominator was
based on data from the sample.
Weight Smoothing
Each survey year there tends to be
few NAMCS sample physicians whose
final visit weights are large relative to
those for the remaining physicians. The
concern over the years has been that
those few may adversely affect the
ability of the resulting statistics to
reflect the universe, especially if the
sampled patient visits to some of those
few should be unusual relative to the
universe. Extremes in those weights al
increase the resulting variances. Those
extreme weights could be truncated;
however, truncation of weights leads to
an understatement of the total visit
count. Smoothing is an additional
technique used to manage the largest
NAMCS visit weights. Smoothing
preserves the total estimated visit coun
within specialty by shifting the ‘‘excess’
from visits with the largest weights to
the visits with smaller weights. First,
excessively large visit weights are
truncated and the smoothing technique
is used. The smoothing technique is a
multiplication factor that has as its
numerator the total visit count in each
physician specialty group before the
largest weights are truncated
(unsmoothed) and as its denominator t
total visit count in that particular
specialty group after the largest weight
are truncated. The smoothing techniqu
yields the same estimated total visit
count as the unsmoothed weights and
was made within each of the 15
physician specialty groups.
Reliability of Estimates
Because statistics from the NAMCS
are based on a sample, they may differ
somewhat from the data that would beobtained if a complete census were
taken using the same forms, definitions
instructions, and procedures. However
the probability design of the NAMCS
permitted the calculation of sampling
errors. The standard error is primarily a
measure of sampling variability that
occurs by chance because only a sam
rather than the entire population is
surveyed. The standard error, as
calculated for the NAMCS, also reflect
part of the variation that arises in the
measurement process, but does not
include estimates of any systematic
biases that may be in the data. The
relative standard error (RSE) of an
estimate is obtained by dividing the
standard error by the estimate itself an
is expressed as a percent of the estim
In repeated samples using the sam
forms and procedures, the chances are
about 68 of 100 occurrences that an
estimate from sample would differ from
a complete census by less than the
standard error. The chances are about
of 100 occurrences that the difference
would be less than twice the standard
error and about 99 of 100 that it would
be less than 2½ times as large.
Published and Flagged
Estimates
Estimates are not presented unles
reasonable assumption regarding their
probability distribution is possible on
the basis of the Central Limit Theorem
The Central Limit Theorem states that,
given a sufficiently large sample size,
the sample estimate approximates the
population estimate and, upon repeate
sampling, its distribution would be
approximately normal.
In this report, estimates are not
presented if they are based on fewer
than 30 records in the sample data; on
an asterisk (*) appears in the tables.
Estimates based on 30 or more record
are asterisked only if the relative
standard error of the estimate exceeds
30 percent. The relative standard error
were approximated using a generalize
variance curve and the computed curv







Item 13 on the Patient Record form
instructed the physician to record up to
two surgical procedures performed at
the office visit. In addition, physicians
could record up to five additional
procedures in open fields in item 14,
Diagnostic and Screening Services.
Therefore, a maximum of seven
procedures (surgical and nonsurgical)
could be coded per visit. These write-in
responses were coded using the
International Classification of Diseases,
9th revision, clinical modification
(ICD–9–CM),Volume 3, Procedure
Classification. Estimates relating to
these ambulatory procedures have been
presented in tables in this report with
specific standard errors calculated using
SUDAAN software (25), rather than
using the generalized variance curves
that approximated relative standard
errors for most NAMCS estimates. The
decision to provide specific standard
errors for these estimates was made
following the statistical analysis of the
data that resulted from this survey item.
This analysis suggested that a
generalized variance curve doesn’t fit
the estimates well, given the nature of
the data in question.
Estimation of Standard
Errors
Estimates of sampling variability
were calculated with SUDAAN
software, which computes standard
errors using a first-order Taylor
approximation of the deviation of
estimates from their expected values. A
description of the software and the
approach it uses has been published
(25).
The SUDAAN procedure can be
used to compute directly the standard
errors and relative standard errors for
the NAMCS estimates. However, this is
not practical or feasible for all users of
the data. To derive error estimates that
would be applicable to a wide variety of







Table II. Coefficients appropriate for determining approximate relative standard errors by type of estimate and physician specialty: National
Ambulatory Medical Care Survey, 1995–96
Type of estimate and physician specialty




Overall totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.001513 28.2270 319
General and family practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.005899 27.6000 329
Internal medicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.004813 20.8300 245
Pediatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.007158 20.4300 247
General surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.006310 5.5154 66
Obstetrics and gynecology . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.006091 15.7660 188
Orthopedic surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.005225 6.6703 79
Cardiovascular diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.012207 5.7641 75
Dermatology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.008619 7.8369 97
Urology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.010115 6.5252 82
Psychiatry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.011074 6.0783 78
Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.014090 4.1729 55
Ophthalmology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.008257 10.0400 123
Otolaryngology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.008529 6.6027 82
All other specialties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.006567 20.3810 245
Drug mentions
Overall totals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.001676 71.3680 809
General and family practice . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.006817 47.0910 567
Internal medicine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.005961 47.2570 563
Pediatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.010554 26.6300 336
General surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.029166 6.8226 113
Obstetrics and gynecology . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.010266 27.9520 351
Orthopedic surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.007408 10.1800 124
Cardiovascular diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.019274 12.6040 179
Dermatology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.012986 9.7592 127
Urology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.017795 7.2158 100
Psychiatry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.018001 11.4620 160
Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.042139 4.5706 96
Ophthalmology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.014995 16.8740 225
Otolaryngology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.014318 7.8315 104
All other specialties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.014644 34.7750 462
NOTES: These coefficients are appropriate for use with NAMCS data where doctors of osteopathy are aggregated with doctors of medicine according to their self-designated practice specialty.
Coefficients for use with NAMCS data where doctors of osteopathy are considered separately from doctors of medicine are available from the Ambulatory Care Statistics Branch.
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for approximating the sampling
variability for NAMCS estimates was
developed. Sampling variability
computed using this procedure require
several approximations and should be
interpreted as approximate rather than
exact for any specific estimate. Most
estimates of sampling variability in this
report are approximations. Exceptions
are described below.
Relative standard errors were
computed for estimates in theAdvance
Data reports on office-based physicians
(17,18). Regression techniques were
then used to produce equations from
which a standard error for any estimat
may be approximated. The regression
equations, represented by the parame
a andb, are shown intable II. It shouldrs
be noted that these coefficients apply t
NAMCS data where doctors of
osteopathy have been aggregated with
doctors of medicine according to their
self-designated practice specialty.
Separate equations were produced for
estimates of visits and drug mentions.
Rules explaining the use of these
equations are presented in the followin
section.
The coefficients of determination
(r2) for the NAMCS are 0.58 for the
visit equation and 0.66 for the drug
mention equation. Particular attention
should be exercised when the estimate
of interest is small or when this
procedure is used for estimates based
American Indian/Eskimo/Aleut or
Asian/Pacific Islander race categories.n
Estimates of Standard Errors
for Aggregate Estimates
Approximate relative standard errors
for estimates of number of visits (or
drug mentions) with a particular
characteristic may be computed using
the following formula, wherex is the
aggregate estimate of interest anda and
b are the appropriate coefficients from
table II:
RSE(x) = Œa + bx
Approximate relative standard errors
for aggregate estimates are shown in
tables III andIV. Table III presents
approximate relative standard errors for
aggregate estimates of visits to












































Relative standard error in percent
100 . . . . . . . . . 53.3 53.1 46.2 46.0 24.8 40.5 26.8 26.4 29.5 27.5 26.8 23.6 33.0 27.3 45.9
200 . . . . . . . . . 37.8 37.9 33.0 33.1 18.4 29.1 19.6 20.3 21.9 20.7 20.4 18.7 24.2 20.4 32.9
500 . . . . . . . . . 24.1 24.7 21.6 21.9 13.2 19.4 13.6 15.4 15.6 15.2 15.2 15.0 16.8 14.7 21.8
1,000 . . . . . . . . 17.2 18.3 16.0 16.6 10.9 14.8 10.9 13.4 12.8 12.9 13.1 13.5 13.5 12.3 16.4
2,000 . . . . . . . . 12.5 14.0 12.3 13.2 9.5 11.8 9.3 12.3 11.2 11.6 11.9 12.7 11.5 10.9 12.9
5,000 . . . . . . . . 8.5 10.7 9.5 10.6 8.6 9.6 8.1 11.6 10.1 10.7 11.1 12.2 10.1 9.9 10.3
10,000 . . . . . . . 6.6 9.3 8.3 9.6 8.3 8.8 7.7 11.3 9.7 10.4 10.8 12.0 9.6 9.6 9.3
20,000 . . . . . . . 5.4 8.5 7.7 9.0 8.1 8.3 7.5 11.2 9.5 10.2 10.7 12.0 9.4 9.4 8.7
50,000 . . . . . . . 4.6 8.0 7.2 8.7 8.0 8.0 7.3 11.1 9.4 10.1 10.6 11.9 9.2 9.3 8.4
100,000 . . . . . . 4.2 7.9 7.1 8.6 8.0 7.9 7.3 11.1 9.3 10.1 10.6 11.9 9.1 9.3 8.2
200,000 . . . . . . 4.1 7.8 7.0 8.5 8.0 7.9 7.3 11.1 9.3 10.1 10.5 11.9 9.1 9.3 8.2
500,000 . . . . . . 4.0 7.7 7.0 8.5 8.0 7.8 7.2 11.1 9.3 10.1 10.5 11.9 9.1 9.2 8.1
1,000,000 . . . . . 3.9 7.7 7.0 8.5 7.9 7.8 7.2 11.1 9.3 10.1 10.5 11.9 9.1 9.2 8.1
Example of use of table: An estimate of 10 million visits per year for 1995 and 1996 to orthopedic surgeons has a relative standard error of 7.7 percent or a standard error of 770,000 (7.7 percent of 10
million).
NOTE: Estimates based on fewer than 30 sample records are considered unreliable, regardless of the magnitude of the relative standard error.







































Relative standard error in percent
100 . . . . . . . . . 84.6 69.1 69.2 52.6 31.2 53.8 33.0 38.1 33.3 30.0 36.4 29.6 42.9 30.4 60.2
200 . . . . . . . . . 59.9 49.2 49.2 37.9 25.2 38.7 24.1 28.7 24.9 23.2 27.4 25.5 31.5 23.1 43.4
500 . . . . . . . . . 38.0 31.8 31.7 25.3 20.7 25.7 16.7 21.1 18.0 18.0 20.2 22.6 22.1 17.3 29.0
1,000 . . . . . . . . 27.0 23.2 23.1 19.3 19.0 19.5 13.3 17.9 15.1 15.8 17.2 21.6 17.9 14.9 22.2
2,000 . . . . . . . . 19.3 17.4 17.2 15.4 18.0 15.6 11.2 16.0 13.4 14.6 15.4 21.1 15.3 13.5 17.9
5,000 . . . . . . . . 12.6 12.7 12.4 12.6 17.5 12.6 9.7 14.8 12.2 13.9 14.2 20.7 13.6 12.6 14.7
10,000 . . . . . . . 9.4 10.7 10.3 11.5 17.3 11.4 9.2 14.3 11.8 13.6 13.8 20.6 12.9 12.3 13.5
20,000 . . . . . . . 7.2 9.6 9.1 10.9 17.2 10.8 8.9 14.1 11.6 13.5 13.6 20.6 12.6 12.1 12.8
50,000 . . . . . . . 5.6 8.8 8.3 10.5 17.1 10.4 8.7 14.0 11.5 13.4 13.5 20.6 12.4 12.0 12.4
100,000 . . . . . . 4.9 8.5 8.0 10.4 17.1 10.3 8.7 13.9 11.4 13.4 13.5 20.5 12.3 12.0 12.2
200,000 . . . . . . 4.5 8.4 7.9 10.3 17.1 10.2 8.6 13.9 11.4 13.4 13.4 20.5 12.3 12.0 12.2
500,000 . . . . . . 4.3 8.3 7.8 10.3 17.1 10.2 8.6 13.9 11.4 13.3 13.4 20.5 12.3 12.0 12.1
1,000,000 . . . . . 4.2 8.3 7.8 10.3 17.1 10.1 8.6 13.9 11.4 13.3 13.4 20.5 12.3 12.0 12.1
Example of use of table: An estimate of 10 million drug mentions per year for 1995 and 1996 at office visits to orthopedic surgeons has a relative standard error of 9.2 percent or a standard error of
920,000 (9.2 percent of 10 million).
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errors for aggregate estimates of drug
mentions.
Estimates of Standard Errors
of Percents
Alternatively, approximate relative
standard errors (in percent) for estimat
of percents of visits (or drug mentions)
may be computed using the followings
formula, where thep is the percent of
interest,x is the denominator of the
percent, andb is the appropriate
coefficient fromtable II:
RSE(p) = Œ b c (1 –p)p c x c 100
The approximation of the absolute
or relative standard error is valid if the
relative standard error of thedenominator is less than 0.05 (26,27) o
if the relative standard errors of the
numerator and denominator are both les
than 0.10 (27).
Approximate relative standard errors
(in percent) for estimates of percents ar












percent1 1 or 99 5 or 95 10 or 90 20 or 80 30 or 70 40 or 60 50
Standard error in percentage points
All specialties . . . . . . . . . . . . . . . . . . . . . . . . . . 715,788 0.1 0.1 0.2 0.3 0.3 0.3 0.3
General and family pr . . . . . . . . . . . . . . . . . . . . . 183,225 0.1 0.3 0.4 0.5 0.6 0.6 0.6
Internal medicine . . . . . . . . . . . . . . . . . . . . . . . . 104,431 0.1 0.3 0.4 0.6 0.6 0.7 0.7
Pediatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92,888 0.2 0.3 0.4 0.6 0.7 0.7 0.7
General surgery . . . . . . . . . . . . . . . . . . . . . . . . . 18,762 0.2 0.4 0.5 0.7 0.8 0.8 0.9
Obstetrics and gyneco . . . . . . . . . . . . . . . . . . . . . 59,515 0.2 0.4 0.5 0.7 0.8 0.8 0.8
Orthopedic surgery . . . . . . . . . . . . . . . . . . . . . . . 38,267 0.1 0.3 0.4 0.5 0.6 0.7 0.7
Cardiovascular diseas . . . . . . . . . . . . . . . . . . . . . 14,705 0.2 0.4 0.6 0.8 0.9 1.0 1.0
Dermatology . . . . . . . . . . . . . . . . . . . . . . . . . . . 28,969 0.2 0.4 0.5 0.7 0.8 0.8 0.8
Urology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13,780 0.2 0.5 0.7 0.9 1.0 1.1 1.1
Psychiatry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20,287 0.2 0.4 0.5 0.7 0.8 0.9 0.9
Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,481 0.2 0.5 0.7 0.9 1.0 1.1 1.1
Ophthalmology . . . . . . . . . . . . . . . . . . . . . . . . . . 40,714 0.2 0.3 0.5 0.6 0.7 0.8 0.8
Otolaryngolgy . . . . . . . . . . . . . . . . . . . . . . . . . . 18,346 0.2 0.4 0.6 0.8 0.9 0.9 1.0
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73,417 0.2 0.4 0.5 0.7 0.8 0.8 0.8
1Visits in thousands, expressed as annual averages.
Example of use of table: An estimate of 10 percent based on a total of 38,267,000 visits to orthopedic surgeons per year for 1995 and 1996 has a standard error of 0.4 percent or a relative standard
error of 4.0 percent (0.4 percent divided by 10 percent).
Table VI. Approximate standard errors of percents of estimated numbers of drug mentions by physician specialty: National Ambulatory




percent1 1 or 99 5 or 95 10 or 90 20 or 80 30 or 70 40 or 60 50
Standard error in percentage points
All specialties . . . . . . . . . . . . . . . . . . . . . . . . . . 954,925 0.1 0.2 0.3 0.3 0.4 0.4 0.4
General and family pract . . . . . . . . . . . . . . . . . . . . 279,861 0.1 0.3 0.4 0.5 0.6 0.6 0.7
Internal medicine . . . . . . . . . . . . . . . . . . . . . . . . 196,956 0.2 0.3 0.5 0.6 0.7 0.8 0.8
Pediatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111,281 0.2 0.3 0.5 0.6 0.7 0.8 0.8
General surgery . . . . . . . . . . . . . . . . . . . . . . . . . 10,347 0.5 1.1 1.5 2.0 2.3 2.5 2.5
Obstetrics and gynecolog . . . . . . . . . . . . . . . . . . . 41,959 0.3 0.6 0.8 1.0 1.2 1.3 1.3
Orthopedic surgery . . . . . . . . . . . . . . . . . . . . . . . 17,126 0.3 0.5 0.7 1.0 1.1 1.2 1.2
Cardiovascular diseases . . . . . . . . . . . . . . . . . . . . 40,389 0.2 0.4 0.5 0.7 0.8 0.9 0.9
Dermatology . . . . . . . . . . . . . . . . . . . . . . . . . . . 34,273 0.2 0.4 0.5 0.7 0.8 0.8 0.9
Urology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,979 0.3 0.6 0.9 1.1 1.3 1.4 1.4
Psychiatry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27,718 0.2 0.5 0.6 0.8 0.9 1.0 1.0
Neurology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12,009 0.2 0.4 0.6 0.8 0.9 1.0 1.0
Ophthalmology . . . . . . . . . . . . . . . . . . . . . . . . . . 42,261 0.2 0.4 0.6 0.8 0.9 1.0 1.0
Otolaryngolgy . . . . . . . . . . . . . . . . . . . . . . . . . . 15,808 0.2 0.5 0.7 0.9 1.0 1.1 1.1
All other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115,959 0.2 0.4 0.5 0.7 0.8 0.9 0.9
1Visits in thousands, expressed as annual averages.
Example of use of table: An estimate of 30 percent based on a total of 17,126,000 drug mentions at office visits to orthopedic surgeons per year for 1995 and 1996 has a standard error of 1.1 percent
or a relative standard error of 3.7 percent (1.1 percent divided by 30 percent).
Series 13, No. 142 [ Page 99Estimates of Rates Where the
Denominator is Assumed to
Have Negligible Error
The approximate relative standard
error for a rate in which the
denominator is the total U.S. population
or one or more of the age-sex-race
groups of the total population is
equivalent to the relative standard erro
of the numerator. This is obtained using
the relative standard error formula abowith the appropriate coefficients from
table II. The standard error is then give
by:
SE (r) = r c RSE(r)
Estimates of Rates (r=x/y)
Where the Numerator Is Not A
Subclass of the Denominator
The standard error for a rate may
approximated by:RSE~r)=RSE(x/y)=√RSE2(x)+RSE2(y)c100
SE~r) = r c RSE(r)
This approximation is valid if the
relative standard error of the
denominator is less than 0.05 (26) or if
the relative standard errors of the




























All races . . . . . . . . . . . . . . . . . . . . . . . . . 263,164,954 59,476,892 36,277,705 83,277,174 52,462,324 18,272,004 13,398,856
Male . . . . . . . . . . . . . . . . . . . . . . . . . . 128,303,352 30,436,465 18,260,703 40,994,209 25,351,707 8,167,207 5,093,062
Female . . . . . . . . . . . . . . . . . . . . . . . . 134,861,603 29,040,427 18,017,003 42,282,966 27,110,617 10,104,798 8,305,794
White . . . . . . . . . . . . . . . . . . . . . . . . . . 217,575,584 46,763,886 28,893,536 68,631,785 44,982,046 16,191,841 12,112,492
Male . . . . . . . . . . . . . . . . . . . . . . . . . . 106,815,630 23,986,250 14,673,784 34,264,499 21,980,879 7,291,312 4,618,908
Female . . . . . . . . . . . . . . . . . . . . . . . . 110,759,954 22,777,636 14,219,753 34,367,286 23,001,167 8,900,529 7,493,584
Black . . . . . . . . . . . . . . . . . . . . . . . . . . . 33,638,928 9,594,974 5,475,175 10,548,881 5,421,594 1,578,487 1,019,818
Male . . . . . . . . . . . . . . . . . . . . . . . . . . 15,658,010 4,860,774 2,610,101 4,762,130 2,405,176 658,767 361,063
Female . . . . . . . . . . . . . . . . . . . . . . . . 17,980,919 4,734,201 2,865,075 5,786,751 3,016,418 919,721 658,755
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . 11,950,443 3,118,032 1,908,994 4,096,509 2,058,684 501,677 266,547
Male . . . . . . . . . . . . . . . . . . . . . . . . . . 5,829,713 1,589,442 976,819 1,967,580 965,653 217,128 113,092
Female . . . . . . . . . . . . . . . . . . . . . . . . 6,120,730 1,528,590 932,176 2,128,929 1,093,032 284,549 153,456
Geographic region
Northeast . . . . . . . . . . . . . . . . . . . . . . . . 52,938 . . . . . . . . . . . . . . . . . .
Midwest . . . . . . . . . . . . . . . . . . . . . . . . . 61,581 . . . . . . . . . . . . . . . . . .
South . . . . . . . . . . . . . . . . . . . . . . . . . . 91,793 . . . . . . . . . . . . . . . . . .
West . . . . . . . . . . . . . . . . . . . . . . . . . . . 56,601 . . . . . . . . . . . . . . . . . .
MSA status1
MSA . . . . . . . . . . . . . . . . . . . . . . . . . . . 210,672 . . . . . . . . . . . . . . . . . .
Non-MSA . . . . . . . . . . . . . . . . . . . . . . . . 52,241 . . . . . . . . . . . . . . . . . .
. . . Category not applicable.
1MSA is metropolitan statistical area.
SOURCE: Figures represent the average of the U.S. population for 1995 and 1996. For 1995, figures are based on U.S. Bureau of the Census monthly postcensal estimates of the civilian
noninstitutionalized population of the United States as of July 1, 1995. Figures are consistent with Census reports PE-10PPL-41, Addendum 1, and have been adjusted for net underenumeration using
the 1990 National Population Adjustment Matrix.
For 1996, figures are based on U.S. Bureau of the Census monthly postcensal estimates of the civilian noninstitutionalized population of the United States as of July 1, 1996. Figures are consistent
with an unpublished hard-copy national population estimates release package PPL-57 (U.S. Population Estimates by Age, Sex, Race and Hispanic Origin: 1990–96) and have been adjusted for net
underenumeration using the 1990 National Population Adjustment Matrix.
Regional estimates were provided by the Division of Health Interview Statistics, National Center for Health Statistics, and are also based on U.S. Bureau of the Census estimates of the civilian
noninstitutionalized U.S. population as of July 1, 1995, and July 1, 1996. These estimates differ slightly from the monthly postcensal estimates because of differences in the adjustment process.
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Between Two Statistics
The standard error of the difference
between two statistics is approximated
by the following formula, where SE(x1)
and SE(x2) are computed using the
formulas given above:
SE(x1–x2) = √SE
2 (x1) + SE
2(x 2)
This formula represents the standa
error for the difference between separa
and uncorrelated characteristics,
although it is only a rough
approximation in most other cases.
Tests of Significance
In this report, the determination of
statistical inference is based on the
two-tailed t-test. The Bonferroni
inequality was used to establish the
critical value for statistically significant
differences (0.05 level of significance)
based on the number of possible
comparisons with a particular variabled
e
(or combination of variables) of interest
Terms relating to differences such as
‘‘greater than’’ and ‘‘less than’’ indicate
that the differences are statistically
significant. Terms such as ‘‘similar’’ or
‘‘no difference’’ mean that no statistical
significance exists between the estimat
being compared. A lack of comment
regarding the differences between any
two estimates does not mean that the
difference was tested and found to be
not significant.
A linear contrast method, available
through SUDAAN software and the
PROC DESCRIPT procedure, was use
to analyze trends in visit rates to
primary care physicians, surgical
specialties, and nonsurgical specialties
between 1980 and 1996. Alternatively,
weighted least-squares method is
available for data users who need to
approximate standard errors for visit
estimates using the generalized varianc
curve described above. A description o
the weighted least-squares method has
been published (28).Population Figures
The population figures used in
computing annual visit rates by age, sex,
and race for this report are shown in
table VII. The figures represent U.S.
Bureau of the Census estimates of the
civilian noninstitutionalized population
as of July 1, 1995, and July 1, 1996.
Figures are based on monthly postcensa
estimates and, for 1995, are consistent
with census reports PE-10/PPL-41,
Addendum 1. For 1996, they are
consistent with an unpublished national
estimates release package PPL-57 (U.S.
Population Estimates by Age, Sex, Race
and Hispanic Origin: 1990–96). All
estimates have been adjusted for net
underenumeration using the 1990
National Population Adjustment Matrix.
Regional U.S. population estimates were
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ZIP Code of Residence
Median household income in ZIP
Code of residence (figure 3) based on
the 1990 decennial Census was used a
a measure of socioeconomic status sin
the source data did not include a
measure of socioeconomic status at th
individual level. Four categories of
median household income were used:
under $20,000 (13 percent of the U.S.
population), $20,000–$29,999
(39 percent of the U.S. population),
$30,000–$39,999 (27 percent of the U.
population), and $40,000 and over
(21 percent of the U.S. population) (29)
Office visits among all ages and
among children under 18 years by
median household income of ZIP Code
of residence were estimated by linking
records from the 1995 and 1996
National Ambulatory Medical Care
Surveys with 1990 Census data on
median household income of ZIP code
of residence. Ratios of the number of
office visits during 1995 and 1996 to
Census population estimates in 1990 b
median household income of ZIP Code
of residence were estimated. ZIP Code
level data were collected in the 1995
and 1996 NAMCS. The only year for
which information on median househol
income by ZIP Code was readily
available from the Bureau of the Censu
is 1990.
Rounding of Numbers
Estimates presented in this report
are rounded to the nearest thousand. F
this reason, detailed figures within table
do not always add to totals. Rates and
percents are calculated on the basis of
the original, unrounded figures and ma
not agree precisely with rates and
percents calculated from rounded data
Nonsampling Errors
Estimates from the 1995 and 1996
NAMCS are subject to nonsampling as
well as sampling errors. Nonsampling
errors include reporting and processing
errors as well as biases due to
nonresponse or incomplete response.
Although the magnitude of the
nonsampling errors cannot be compute
these errors are kept to a minimum byr
,
procedures built into the operation of
the survey. To eliminate ambiguities an
encourage uniform reporting, careful
attention was given to the phrasing of
questions, terms, and definitions. Also,
extensive pretesting of most data items
and survey procedures was also
performed. Quality control procedures,
consistency, and edit checks discussed
the data processing section reduced
errors in data coding and processing.
Because survey results are subject to
sampling and nonsampling errors, the
total error will be larger than the error
due to sampling variability.
Systematic Bias
No formal attempt was undertaken
to determine or measure systematic bi
in the 1995 or 1996 NAMCS data. The
steps taken to reduce bias in the data
discussed in the section on field
procedures and data collection. It shou
be noted, however, that there are seve
factors affecting the data that indicate
these data underrepresent the total
number of office visits. Some of these
factors are briefly discussed below:
+ Physicians who participated in
NAMCS generally did a thorough
and conscientious job in keeping th
Patient Log. However a postsurvey
evaluation study conducted in the
1985 NAMCS among a random
sample of participating physicians
indicated that a small number of
patient visits may be accidentally
omitted from the Patient Log.
Although this number is quite smal
such omissions would result in an
undercoverage of office visits. The
same postsurvey study indicates th
the inclusion of patient visits that
did not actually occur was
infrequent and would have an
negligible effect on survey estimate
+ As previously stated, the physician
universe for the 1995 and 1996
NAMCS included all non-Federal,
office-based, patient care physician
on the AMA and AOA masterfiles.
The NAMCS was designed to
provide statistically unbiased
estimates of office visits to this
designated population. Not included
in the universe were physicians wh
were classified as federallyemployed or hospital-based, or who
were principally engaged in
research, teaching, administration, or
other nonpatient care activity.
Consequently, ambulatory patient
visits in an office setting to these
physicians would not be included in
the NAMCS estimates. In an attempt
to measure the number of office
visits to physicians not in the
NAMCS universe, a NAMCS
Complement Survey was conducted
in 1980 (30). This study involved a
sample of approximately 230,000
physicians in the AMA and AOA
masterfiles who were not eligible (in
scope) for the 1980 NAMCS.
Results indicate that about
17 percent of the Complement
Survey physicians saw some
ambulatory patients in an office
setting and that an estimated 69
million office visits were made to
these physicians in 1980.
Diagnosis and Injury
Groupings
Physicians’ diagnoses, shown in
tables 16, 17, and20 of this report, are
grouped according to a classification
system developed for use with NAMCS
data. This grouping is based on the
International Classification of Diseases,
9th Revision, Clinical Modification
(ICD–9–CM) (20), but also reflects the
frequency of particular diagnoses
occurring in the NAMCS data. It is
meant to provide additional detail on the
diagnostic content of ambulatory care as
characterized by the surveys.Table VIII




Terms Relating to the
Survey
Office—An office is the space
identified by the physician as a location
for his or her ambulatory practice.
Offices customarily include consultation,











Page 102 [ Series 13, No. 142patients associate with the particular
physician. Responsibility over time for
patient care and professional services
rendered generally resides with the
individual physician rather than with
any institution.
Ambulatory patient —An
ambulatory patient is an individual
seeking personal health services who
not currently admitted to any health ca
institution on the premises.
Physician—A physician is a duly
licensed doctor of medicine or doctor o
osteopathy. For purposes of the
NAMCS, physicians are classified as in
scope (eligible) or out of scope
(ineligible) as follows:
+ In scope—Physicians currently in
practice who spend time caring for
ambulatory patients in office
locations except as excluded below
+ Out of scope—Physicians who treat
patients only indirectly, including
specialists in anesthesiology,
pathology, forensic pathology,
radiology, therapeutic radiology, an
diagnostic radiology.
Physicians who are federally
employed, including those
physicians who work for the
Department of Veterans Affairs or
who are in military service.
Physicians who treat patients only
in institutional settings, such as
nursing homes and hospitals.
Physicians employed full time in
industry or by institutions and
having no private practice, for
example, physicians who work for
the Ford Motor Company.
Physicians who spend no time
seeing ambulatory patients or who
patient care activity is secondary t
another principal activity, such as
teaching, administration, or
research.
Patient—A person under a
physician’s care for health reasons. Fo
purposes of the NAMCS, patients are
defined as in scope (eligible) or out of
scope (ineligible) as follows:
+ In scope—A patient seen by an in
scope physician or a staff membere
e
n
the physician’s office except as
excluded below.
+ Out of scope—Patients seen by a
physician in a hospital, nursing
home, or other extended care
institution, or in the patient’s home.
NOTE: If the physician has a
private office (which fits definition
of ‘‘office’’) located in a hospital,
the ambulatory patients seen there
are considered in scope.
Patients seen by the physician in an
institution, including outpatient
clinics of hospitals, for whom the
institution has primary responsibility
over time.
Patients who contact and receive
advice from the physician via
telephone.
Patients who come to the office
only to leave a specimen, to pick up
insurance forms, or to pay a bill.
Patients who come to the office to
pick up medications previously
prescribed by the physician.
Visit—A direct, personal exchange
between an ambulatory patient and a
physician or a staff member working
under the physician’s supervision for the
purpose of seeking care and rendering
personal health services.
Drug mention—The physician’s
entry of a pharmaceutical agent ordered
or provided—by any route of
administration—for prevention,
diagnosis, or treatment. Generic as well
as brand name medications are included
as are nonprescription as well as
prescription medications. Along with all
new medications, the physician also
records continued medications if the
patient was specifically instructed during
the visit to continue the medication.
Physician specialty—Principal
specialty, including general practice, as
designated by the physician at the time
of the survey. Those physicians for
whom a specialty was not obtained were
assigned the principal specialty recorded
in the physician masterfiles maintained
by the American Medical Association or
the American Osteopathic Association.,
For some analyses in this report,
physician specialty was regrouped into
broader categories of primary care,
surgical, and nonsurgical specialties.







and fetal medicine, obstetrics and
gynecology, obstetrics, geriatric
medicine (internal medicine), and
sports medicine (internal medicine).
Surgical specialties—Hand surgery,
adult reconstructive orthopedics,











critical care medicine (obstetrics
and gynecology), abdominal
surgery, cardiovascular surgery,
colon and rectal surgery,
cardiothoracic surgery, facial plastic
surgery, head and neck surgery,
hand surgery (plastic surgery), hand




plastic surgery, surgical oncology,





































care medicine, pediatric emergency
medicine (emergency medicine),







rheumatology, spinal cord injury,
sleep medicine, and undersea
medicine.
Region of practice location—The
four geographic regions that correspon




Hampshire, New Jersey, New
York, Pennsylvania, Rhode
Island, and Vermont.
Midwest Illinois, Indiana, Iowa,
Kansas, Michigan, Minnesota
Missouri, Nebraska, North









Virginia, and West Virginia.




Washington, and Wyoming.Terms Relating to the
Patient Record Form
Age—The age calculated from date
of birth is the age at last birthday on th
date of visit.
Race—Physicians were instructed
to check the category they judged to be
the most appropriate for each patient
based on observation or prior
knowledge. The following definitions
were provided to the physicians:
+ White—A person having origins in
any of the original peoples of
Europe, North Africa, or the Middle
East.
+ Black—A person having origins in
any of the black racial groups of
Africa.
+ Asian/Pacific Islander—A person
having origins in any of the original
peoples of the Far East, Southeast
Asia, the Indian subcontinent, or the
Pacific Islands, including for
example, China, India, Japan, Kore
the Philippine Islands, and Samoa.
+ American Indian/Eskimo/Aleut—A
person having origins in any of the
original peoples of North America
and who maintains cultural
identification through tribal
affiliation or community recognition.
Ethnicity —Category judged by the
physician to be the most appropriate.
The following definitions were provided
+ Hispanic origin—A person of
Mexican, Puerto Rican, Cuban,
Central or South American, or other
Spanish culture or origin, regardles
of race.
+ Not Hispanic—A person not of
Hispanic origin.
Expected source(s) of
payment—The physician was instructed
to check (a) the type of payment and (b
the expected source(s) of insurance if
any, that were expected to pay for the
visit. The following definitions were
given for type of payment, and only on
category was to be checked:
Type of payment—
+ Preferred provider option—Charges




paid by a third-party insurer either
directly to the physician or
reimbursed to the patient or patient’s
family.
+ HMO/other prepaid—Charges




(IPA’s). If the prepayment plan was
a preferred provider organization
(PPO), the respondent should have
checked the ‘‘preferred provider
option’’ box, not ‘‘HMO/other
prepaid.’’
NOTE: If one of the above three types
of payments (PPO; insured,
fee-for-service; or HMO/other prepaid)
was selected, then (b) Expected
Source(s) of Insurance was also to have
been completed.
+ Self pay—Charges to be paid by the
patient or patient’s family, which
will not be reimbursed by a third
party.
+ No charge—Visits for which no fee
is charged. Respondents were to
exclude visits paid for as part of a
total care package, for example,
prepaid plan visits, post-operative
visits included in a surgical fee, and
pregnancy visits included in a flat
fee charge for the entire pregnancy.
Instead, they were to mark the box,
or boxes, that indicate how the
services were originally paid.
+ Other—Any other source of
payment not covered in above
categories.
The physician was instructed to check
all that apply for part (b) of the item.
Expected source(s) of insurance
+ Blue Cross/Blue Shield—Charges
paid in part or in full by Blue Cross
and Blue Shield either directly to
the physician or reimbursed to the
patient. If charges were covered
under a Blue Cross/Blue Shield
prepaid plan, the respondent was to
mark this box.
+ Other private insurance—Charges
paid in part or in full by a private
insurance company. Includes




















Page 104 [ Series 13, No. 142physician as well as payments
reimbursed to the patient.
+ Medicare—Charges paid in part or
in full by a Medicare plan. Includes
payments made directly to the
physician as well as payments
reimbursed to the patient. If charge
were covered under a
Medicare-sponsored prepaid plan,
this box should have been marked.
+ Medicaid—Charges paid in part or
in full by a Medicaid plan. Includes
payments made directly to the
physician as well as payments
reimbursed to the patient.
+ Workers Compensation—Includes
payments made under local, State,
or Federal health care programs to
reimburse an employer for damage
paid to an employee for injury
occurring in the course of his or he
employment.
+ Other—Any other source of
insurance not covered by the above
categories, such as CHAMPUS and
private charitable organizations.
If the type of insurance was not known
the physician was instructed to check
the ‘‘Unknown’’ box.
Patient’s complaint(s),
symptom(s), or other reason(s) for this
visit (in patient’s own words)—The
patient’s problem, complaint, symptom,
or other reason for this visit as
expressed by the patient. Physicians
were instructed to record key words or
phrases verbatim to the extent possible
‘‘Most important’’ refers to that
problem, which in the physician’s
judgement was most responsible for th
patient’s visit.
Is this visit injury related? —The
physician was instructed to mark the
‘‘Yes’’ or ‘‘No’’ box to indicate whether
the patient’s visit was due to an injury.
The injury does not need to be recent.
also includes those visits for followup o
previously treated injuries and visits for
flare-ups of problems due to old injurie
Does patient smoke
cigarettes?—The physician was
instructed to check ‘‘Yes’’ if it is known
that the patient currently smokes
cigarettes, regardless of quantity. ‘‘No’’
is checked if it is known that the patien
currently does not smoke cigarettes.Physician’s diagnoses—Up to three
could be recorded. The first-listed
diagnosis, recorded in item 11a, should
be the physician’s best assessment of
diagnosis of the patient’s most importa
problem, complaint, or symptom. In the
event of multiple diagnoses, the
physician was instructed to list them in
order of decreasing importance. The
term ‘‘principal’’ refers to the first-listed
diagnosis. The diagnosis represents th
physician’s best judgement at the time
of the visit and may be tentative,
provisional, or definitive. Physicians
were also asked to list other conditions
known to exist for the patient at this
time, regardless of their relationship to
the present problem, in items 11b and
11c.
Does patient have—The physician
was asked to check all of the following
conditions that applied to the patient,
regardless of any entry made in item 1
physician’s diagnoses: Arthritis,
atherosclerosis, COPD (chronic
obstructive pulmonary disease), chronic




deficit disorder), hypertension, and
obesity.
Ambulatory surgical
procedures—The physician was to
record the specific names of up to two
surgical procedures performed at the
visit, if any. Routine surgical procedure
(for example, wound care) as well as
more complex procedures (for example
cataract extraction, vasectomy, hernia
repair, growth removal, etc.) were to be
reported.
Diagnostic and screening
services—The physician was asked to
mark all services that were ordered or
provided during this visit for the
purpose of screening (that is, early
detection of health problems in
asymptomatic individuals) or diagnosis
(that is, identification of health problem
causing individuals to be symptomatic)
During a visit for a complete physical
exam, several of the services might ha
been ordered or provided; each service
should have been marked. If services
were ordered or provided but were notincluded as a check box category, the
physician was asked to check the
‘‘Other’’ box and specify in the space
provided.
Therapeutic and preventive
services—The physician was to check
all appropriate boxes for any of the
following types of counseling, advice,
education, instructions, or
recommendations to the patient that
were provided or ordered during the
visit:
+ Diet—Any topics related to the
foods and/or beverages consumed b
the patient. Examples include
general dietary guidelines of health
promotion and disease prevention,
dietary restrictions to treat or control
a specific medical problem or
condition, and dietary instructions
related to medications. Includes
referrals to other health
professionals, for example, dietitians
and nutritionists.
+ Exercise—Any topics related to the
patient’s physical conditioning or
fitness. Examples include
information aimed at general health
promotion and disease prevention
and information given to treat or
control a specific medical condition.
Includes referrals to other health and
fitness professionals. Does not
include referrals for physiotherapy.
Physiotherapy ordered or provided
at the visit is listed as a separate
check box under ‘‘Other Therapy.’’
+ Weight reduction—Information
given to the patient to assist in the
goal of weight reduction. Includes
referrals to other health
professionals for the purpose of
weight reduction.
+ Cholesterol reduction—information
given to the patient to assist in the
goal of cholesterol reduction.
+ HIV transmission—Information
intended to help the patient
understand how HIV (human
immunodeficiency virus) is
transmitted. Includes topics such as
‘‘safe sex,’’ IV drug use, and
exchange of bodily fluids.
+ Injury prevention—Any topic aimed
at minimizing the chances of injury
in one’s daily life. May include
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injury through proper techniques fo
various physical activities, etc.
+ Tobacco use/exposure—Information
given to the patient on issues relat
to tobacco use in any form,
including cigarettes, cigars, snuff,
and chewing tobacco, and on the
exposure to tobacco in the form of
‘‘secondhand smoke.’’ Includes
information on smoking cessation a
well as prevention of tobacco use.
Includes referrals to other health
professionals for smoking cessation
programs.
+ Growth/development—Any topics
related to human growth and
development.
+ Mental health—General advice or
counseling about mental health
issues; education about mental
disorders. Includes referrals to othe
mental health professionals for
mental health counseling.
+ Other—Any counseling involving a
current or potential health problem
that is not listed in any of the other
check boxes.
Other therapy—The physician was to
check all appropriate boxes for
therapeutic services (excluding
medication) ordered or performed. The
check box categories were:
+ Psychotherapy—All treatments
involving the intentional use of
verbal techniques to explore or alte
the patient’s emotional life in order
to effect symptom reduction or
behavior change.
+ Corrective lenses—Provision,
ordering or prescription for glasses
or contact lenses.
+ Physiotherapy—Any form of
physical therapy including
treatments using heat, light, sound
physical pressure or movement. Fo
example, ultrasonic, ultraviolet,
infrared, whirlpool, diathermy, cold,
and manipulative therapy.
Services not included in the check box
categories should have been marked i
the ‘‘Other’’ box and specified in the
space provided.
Medication—The physician was
instructed to list all medications,
including biologicals, that were orderedr
injected, administered, or otherwise




agents. Physicians were requested to
record the same specific medication
name (brand or generic) that was used
on any prescription of office medical
record. Also included are medications
ordered or provided prior to the visit
that the physician instructed or expecte
the patient to continue taking.
Have you or anyone in your
practice seen patient before?—‘‘Seen
before’’ means provided care for at any
time in the past. The second part of ite
18 refers to the patient’s current episod
of illness.
Was patient referred for this visit
by another physician?—Referrals are
any visits that are made at the advice o
direction of a physician other than the
one being visited. The interest is in
referrals for the current visit and not in
referrals for any prior visit.
Visit disposition—Five codes were
provided to describe the physician’s
disposition of the case on this visit. The
physician was to mark as many
categories as applied:
+ No followup planned—No return
visit or telephone contact was
scheduled for the patient’s problem
+ Return at specified time—Patient
was told to schedule an appointmen
or was instructed to return at a
particular time.
+ Return if needed, P.R.N.—No future
appointment was made, but the
patient was instructed to make an
appointment with the physician if
the patient considered it necessary
(P.R.N., pro re nata, as necessary).
+ Admit to hospital—Patient was
instructed that further care or
treatment would be provided in a
hospital. No further office visits
were expected prior to hospital
admission.
+ Other—Any other disposition of the
case not included in the preceding
categories.
Visit duration —Time the physician
spent with the patient, not includingtime the patient spent waiting to see th
physician, time the patient spent
receiving care from someone other tha
the physician without the presence of
the physician, and time the physician
spent in reviewing such things as
records and test results. If the patient
was provided care by a member of the
physician’s staff, but did not see the
physician during the visit, the duration
of the visit was recorded as zero (0)
minutes.
Table VIII. Reclassification of principal diagnosis codes for use with National Ambulatory Medical Care Survey data
Principal diagnosis ICD–9–CM code1
Infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 001–139
Streptococcal sore throat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 034.0
HIV infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 042
Viral warts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 078.1
Unspecified viral and chlamydial infections . . . . . . . . . . . . . . . . . . . . . . . 079.9
Dermatophytosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
Candidiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
Other infectious and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . 001–033, 034.1–041.9, 045.0–078.0, 078.2–079.8, 080–104, 111, 114–139
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140–239
Malignant neoplasm of colon and rectum . . . . . . . . . . . . . . . . . . . . . . . . 153–154, 197.5
Malignant neoplasm of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172–173, 176.0, 198.2
Malignant neoplasm of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174–175, 198.81
Malignant neoplasm of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
Malignant neoplasm of lymphatic and hematopoietic tissue . . . . . . . . . . . . . 176.5, 196, 200–208
Other malignant neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140–152, 155–171, 176.1–176.4, 176.6–184, 186–195, 197.0–197.4,
197.6–198.1, 198.3–198.7, 198.82–199, 230–234
Benign neoplasm of skin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 216
Other benign neoplasm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210–215, 217–229
Neoplasm of uncertain behavior and unspecified nature . . . . . . . . . . . . . . . 235–239
Endocrine, nutritional and metabolic diseases, and immunity disorders . . . . . . . 240–279
Acquired hypothyroidism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 244
Other disorders of the thyroid gland . . . . . . . . . . . . . . . . . . . . . . . . . . . 240–243, 245–246
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 250
Disorders of lipoid metabolism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 272
Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278.0
Other endocrine, nutritional and metabolic diseases, and immunity disorders . . 251–271, 273–277, 278.1–279
Diseases of the blood and blood-forming organs . . . . . . . . . . . . . . . . . . . . . 280–289
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 280–285
Other diseases of the blood and blood-forming organs . . . . . . . . . . . . . . . . 286–289
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290–319
Schizophrenic disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295
Major depressive disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296.2–296.3
Other psychoses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290–294, 296.0–296.1, 296.4–299
Anxiety states . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300.0
Neurotic depression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300.4
Alcohol dependence syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303
Drug dependence and nondependent use of drugs . . . . . . . . . . . . . . . . . . 304–305
Acute reaction to stress and adjustment reaction . . . . . . . . . . . . . . . . . . . 308–309
Depressive disorder, not elsewhere classified . . . . . . . . . . . . . . . . . . . . . 311
Attention deficit disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 314.0
Other mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300.1–300.3, 300.5–300.9, 301–302, 306–307, 310, 312–313, 314.1–319
Diseases of the nervous system and sense organs . . . . . . . . . . . . . . . . . . . 320–389
Migraine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 346
Other disorders of the central nervous system . . . . . . . . . . . . . . . . . . . . . 320–326, 330–337, 340–345, 347–349
Carpal tunnel syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 354.0
Other disorders of the nervous system . . . . . . . . . . . . . . . . . . . . . . . . . . 350–353, 354.1–359
Retinal detachment and other retinal disorders . . . . . . . . . . . . . . . . . . . . . 361–362
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 365
Cataract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 366
Disorders of refraction and accommodation . . . . . . . . . . . . . . . . . . . . . . . 367
Conjunctivitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 372.0–372.3
Disorders of eyelids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 373–374
Other disorders of the eye and adnexa . . . . . . . . . . . . . . . . . . . . . . . . . 360, 363–364, 368–369, 370–371, 372.4–372.9, 375–379
Disorders of external ear . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 380
Otitis media and Eustachian tube disorders . . . . . . . . . . . . . . . . . . . . . . . 381–382
Other diseases of the ear and mastoid process . . . . . . . . . . . . . . . . . . . . 383–389
Diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 390–459
Angina pectoris . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 413
Coronary atherosclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 414.0
Other ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 410–412, 414.1–414.9
Cardiac dysrhythmias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 427
Congestive heart failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 428.0
Other heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 391–392.0, 393–398, 402, 404, 415–416, 420–426, 428.1–429
Essential hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 401
Cerebrovascular disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 430–438
See footnotes at end of table.
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Table VIII. Reclassification of principal diagnosis codes for use with National Ambulatory Medical Care Survey data—Con.
Principal diagnosis ICD–9–CM code1
Diseases of the circulatory system—Con.
Diseases of the arteries, arterioles, and capillaries . . . . . . . . . . . . . . . . . . 0440–448
Hemorrhoids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 455
Other diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . 390, 392.9, 403, 405, 417, 451–454, 456–459
Diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 460–519
Acute sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 461
Acute pharyngitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 462
Acute tonsillitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 463
Acute bronchitis and bronchiolitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 466
Other acute respiratory infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 460, 464–465
Chronic sinusitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 473
Allergic rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 477
Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 480–486
Chronic and unspecified bronchitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 490–491
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 493
Other chronic obstructive pulmonary disease and allied conditions . . . . . . . . 492, 494–496
Other diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . 470–472, 474–476, 478, 487, 500–519
Diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 520–579
Diseases of the teeth and supporting structures . . . . . . . . . . . . . . . . . . . . 520–525
Gastritis and duodenitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 535
Esophagitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 530.1
Ulcer of stomach and small intestine . . . . . . . . . . . . . . . . . . . . . . . . . . . 531–534
Hernia of abdominal cavity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 550–553
Noninfectious enteritis and colitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 555–558
Diverticula of intestine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 562
Constipation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 564.0
Irritable colon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 564.1
Anal and rectal diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 565–566, 569.0–569.4
Disorders of the gallbladder and biliary tract . . . . . . . . . . . . . . . . . . . . . . 574–576
Gastrointestinal hemorrhage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 578
Other diseases of the digestive system . . . . . . . . . . . . . . . . . . . . . . . . .
526.0–530.0, 530.2–530.9, 536–543, 560, 564.2–564.9, 567, 568, 569.5–573.9,
577, 579
Diseases of the genitourinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . . 580–629
Calculus of kidney and ureter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 592
Cystitis and other disorders of the bladder . . . . . . . . . . . . . . . . . . . . . . . 595–596
Urinary tract infection, site not specified . . . . . . . . . . . . . . . . . . . . . . . . . 599.0
Other diseases of the urinary system . . . . . . . . . . . . . . . . . . . . . . . . . . 580–589, 590–591, 593–594, 597–598, 599.1–599.9
Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 600
Other disorders of male genital organs . . . . . . . . . . . . . . . . . . . . . . . . . 601–608
Disorders of breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 610–611
Inflammatory disorders of female pelvic organs . . . . . . . . . . . . . . . . . . . . 614–616
Noninflammatory disorders of female genital organs . . . . . . . . . . . . . . . . . 620, 622–624
Disorders of menstruation and abnormal bleeding . . . . . . . . . . . . . . . . . . . 626
Menopausal and postmenopausal disorders . . . . . . . . . . . . . . . . . . . . . . 627
Other disorders of the female genital tract . . . . . . . . . . . . . . . . . . . . . . . 617–619, 621, 625, 628, 629
Complications of pregnancy, childbirth, and the puerperium . . . . . . . . . . . . . . 630–677
Diseases of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . . . . . 680–709
Cellulitis and abscess . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 681–682
Other infection of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . 680, 683–686
Contact dermatitis and other eczema . . . . . . . . . . . . . . . . . . . . . . . . . . 692
Psoriasis and similar disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 696
Other inflammatory conditions of skin and subcutaneous tissue . . . . . . . . . . 690–691, 693–695, 697–698
Corns, callosities, and other hypertrophic and atrophic skin conditions . . . . . . 700–701
Actinic and seborrheic keratosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 702.0–702.1
Acne . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 706.0–706.1
Sebaceous cyst . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 706.2
Urticaria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 708
Other disorders of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . 702.8, 703–705, 706.3–707.9, 709
Diseases of the musculoskeletal system and connective tissue . . . . . . . . . . . . 710–739
Rheumatoid arthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 714.0
Osteoarthrosis and allied disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . 715
Other arthropathies and related disorders . . . . . . . . . . . . . . . . . . . . . . . . 710–713, 714.1–714.9, 716
Derangements and other and unspecified joint disorders . . . . . . . . . . . . . . 717–719
Intervertebral disc disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 722
Lumbago . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 724.2
Other dorsopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 720–721, 723.0–724.1, 724.3–724.9
See footnotes at end of table.
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Table VIII. Reclassification of principal diagnosis codes for use with National Ambulatory Medical Care Survey data—Con.
Principal diagnosis ICD–9–CM code1
Diseases of the circulatory system—Con.
Peripheral enthesopathies and allied disorders . . . . . . . . . . . . . . . . . . . . . 726
Synovitis and tenosynovitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 727.0
Myalgia and myositis, unspecified . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0729.1
Other rheumatism, excluding back . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725, 727.1–727.9, 728, 729.0, 729.2–729.9
Disorders of bone and cartilage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 730–733
Other diseases of the musculoskeletal system and connective tissue . . . . . . . 734–739
Congenital anomalies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 740–759
Certain conditions originating in the perinatal period . . . . . . . . . . . . . . . . . . . 760–779
Symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . . . . . . . 780–799
Syncope and collapse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 780.2
Convulsions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 780.3
Dizziness and giddiness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 780.4
Pyrexia of unknown origin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 780.6
Symptoms involving skin and other integumentary tissue . . . . . . . . . . . . . . 782
Headache . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 784.0
Epistaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 784.7
Abnormal heart sounds . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 785.0–785.3
Dyspnea and respiratory abnormalities . . . . . . . . . . . . . . . . . . . . . . . . . 786.0
Cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 786.2
Chest pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 786.5
Symptoms involving urinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . 788
Abdominal pain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 789.0
Other symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . .
780.0–780.1, 780.5, 780.7–780.9, 781, 783, 784.1–784.6, 784.8–784.9,
785.4–785.9, 786.1, 786.3–786.4, 786, 6–787, 789.1–799.9
Injury and poisoning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 800–999
Fracture of radius and ulna . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 813
Fracture of hand and fingers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 814–817
Fracture of lower limb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 820–829
Other fractures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 800–812, 818–819
Sprains and strains of wrist and hand . . . . . . . . . . . . . . . . . . . . . . . . . . 842
Sprains and strains of knee and leg . . . . . . . . . . . . . . . . . . . . . . . . . . . 844
Sprains and trains of ankle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 845.0
Sprains and strains of neck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 847.0
Other sprains and strains of back . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 846, 847.1–847.9
Other sprains and strains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 840–841, 843, 845.1, 848
Intracranial injury, excluding those with skull fracture . . . . . . . . . . . . . . . . . 850–854
Open wound of head . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 870–873
Open wound of hand and fingers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 882–883
Other open wound . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 874–881, 884–897
Superficial injury of cornea . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 918.1
Other superficial injury . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 910.0–918.0, 918.2, 919.9
Contusions with intact skin surfaces . . . . . . . . . . . . . . . . . . . . . . . . . . . 920–924
Other injuries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 830–839, 860–869, 900–909, 925–959
Poisonings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 960–989
Other and unspecified effects of external causes . . . . . . . . . . . . . . . . . . . 990–995
Complications of surgical and medical care, not elsewhere classified . . . . . . . 996–999
Supplementary classification of factors influencing health status and contact with
health services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V01–V82
Potential health hazards related to communicable diseases . . . . . . . . . . . . . V01–V09
Potential health hazards related to personal and family history . . . . . . . . . . . V10–V19
Routine infant or child health check . . . . . . . . . . . . . . . . . . . . . . . . . . . V20.2
Normal pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V22
Postpartum care and examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . V24
Encounter for contraceptive management . . . . . . . . . . . . . . . . . . . . . . . . V25
Other encounter related to reproduction . . . . . . . . . . . . . . . . . . . . . . . . . V23, V26–V28
Lens replaced by pseudophakos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V43.1
Artificial opening status and other postsurgical states . . . . . . . . . . . . . . . . . V44–V45
Attention to surgical dressing and sutures . . . . . . . . . . . . . . . . . . . . . . . . V58.3
Followup examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V67
General medical examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V70
Observation and evaluation for suspected conditions not found . . . . . . . . . . V71
Gynecological examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V72.3
Other factors influencing health status and contact with health services . . . . .
V20.0–V20.1, V21, V29.0–V43.0, V43.2–V43.8, V46–V66, V68–V69,
V72.0–V72.2, V72.4–V82.9
1Based on the International Classification of Diseases, 9th Revision, Clinical Modification (ICD–9–CM) (20).
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Vital and Health Statistics
series descriptions
SERIES 1. Programs and Collection Procedures—These reports describe
the data collection programs of the National Center for Health
Statistics. They include descriptions of the methods used to
collect and process the data, definitions, and other material
necessary for understanding the data.
SERIES 2. Data Evaluation and Methods Research—These reports are
studies of new statistical methods and include analytical
techniques, objective evaluations of reliability of collected data,
and contributions to statistical theory. These studies also include
experimental tests of new survey methods and comparisons of
U.S. methodology with those of other countries.
SERIES 3. Analytical and Epidemiological Studies—These reports present
analytical or interpretive studies based on vital and health
statistics. These reports carry the analyses further than the
expository types of reports in the other series.
SERIES 4. Documents and Committee Reports—These are final reports of
major committees concerned with vital and health statistics and
documents such as recommended model vital registration laws
and revised birth and death certificates.
SERIES 5. International Vital and Health Statistics Reports—These
reports are analytical or descriptive reports that compare U.S.
vital and health statistics with those of other countries or present
other international data of relevance to the health statistics
system of the United States.
SERIES 6. Cognition and Survey Measurement—These reports are from
the National Laboratory for Collaborative Research in Cognition
and Survey Measurement. They use methods of cognitive science
to design, evaluate, and test survey instruments.
SERIES 10. Data From the National Health Interview Survey—These
reports contain statistics on illness; unintentional injuries;
disability; use of hospital, medical, and other health services; and
a wide range of special current health topics covering many
aspects of health behaviors, health status, and health care
utilization. They are based on data collected in a continuing
national household interview survey.
SERIES 11. Data From the National Health Examination Survey, the
National Health and Nutrition Examination Surveys, and the
Hispanic Health and Nutrition Examination Survey—Data
from direct examination, testing, and measurement on
representative samples of the civilian noninstitutionalized
population provide the basis for (1) medically defined total
prevalence of specific diseases or conditions in the United States
and the distributions of the population with respect to physical,
physiological, and psychological characteristics, and (2) analyses
of trends and relationships among various measurements and
between survey periods.
SERIES 12. Data From the Institutionalized Population Surveys—
Discontinued in 1975. Reports from these surveys are included in
Series 13.
SERIES 13. Data From the National Health Care Survey—These reports
contain statistics on health resources and the public’s use of
health care resources including ambulatory, hospital, and
long-term care services based on data collected directly from
health care providers and provider records.
SERIES 14. Data on Health Resources: Manpower and Facilities—
Discontinued in 1990. Reports on the numbers, geographic
distribution, and characteristics of health resources are now
included in Series 13.
SERIES 15. Data From Special Surveys—These reports contain statistics on
health and health-related topics collected in special surveys that
are not part of the continuing data systems of the National
Center for Health Statistics.
SERIES 16. Compilations of Advance Data From Vital and Health
Statistics—Advance Data Reports provide early release of
information from the National Center for Health Statistics’ health
and demographic surveys. They are compiled in the order in
which they are published. Some of these releases may be
followed by detailed reports in Series 10–13.
SERIES 20. Data on Mortality —These reports contain statistics on mortality
that are not included in regular, annual, or monthly reports.
Special analyses by cause of death, age, other demographic
variables, and geographic and trend analyses are included.
SERIES 21. Data on Natality, Marriage, and Divorce—These reports
contain statistics on natality, marriage, and divorce that are not
included in regular, annual, or monthly reports. Special analyses
by health and demographic variables and geographic and trend
analyses are included.
SERIES 22. Data From the National Mortality and Natality
Surveys—Discontinued in 1975. Reports from these sample
surveys, based on vital records, are now published in Series 20
or 21.
SERIES 23. Data From the National Survey of Family Growth—These
reports contain statistics on factors that affect birth rates,
including contraception, infertility, cohabitation, marriage,
divorce, and remarriage; adoption; use of medical care for family
planning and infertility; and related maternal and infant health
topics. These statistics are based on national surveys of women
of childbearing age.
SERIES 24. Compilations of Data on Natality, Mortality, Marriage,
Divorce, and Induced Terminations of Pregnancy—These
include advance reports of births, deaths, marriages, and divorces
based on final data from the National Vital Statistics System that
were published as supplements to theMonthly Vital Statistics
Report(MVSR). These reports provide highlights and summaries
of detailed data subsequently published inV tal Statistics of the
United States. Other supplements to the MVSR published here
provide selected findings based on final data from the National
Vital Statistics System and may be followed by detailed reports
in Series 20 or 21.
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Hyattsville, MD 20782-2003
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